FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Califf

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Geographic Areas

United States

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Ranee Chatterjee; Frederick L Brancati; Robert M Califf; Laura Svetkey; Laine Thomas; David Edelman
Effects of Changes in Potassium With Valsartan Use on Diabetes Risk: Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
Jonathan Piccini; Daniel E Singer; Susanna R Stevens; Richard C Becker; Günter Breithardt; Robert M Califf; Keith A A Fox; Werner Hacke; Jonathan L Halperin; Graeme J Hankey; Yuliya Lokhnygina; Kenneth W Mahaffey; Christopher C. Nessel; Manesh R Patel
Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial.
Jason J Rose; Frans Van de Werf; Harvey D White; Kenneth W Mahaffey; L Kristin Newby; E Magnus Ohman; Paul W Armstrong; Samuel Broderick; Robert M Califf; Karen Chiswell; Robert P Giugliano; Shaun G Goodman; Christopher B Granger; Robert A Harrington; Renato D Lopes
Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Califf (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ranee Chatterjee; Frederick L Brancati; Robert M Califf; Laura Svetkey; Laine Thomas; David Edelman
Effects of Changes in Potassium With Valsartan Use on Diabetes Risk: Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
American journal of hypertension 2013;26(6):723-6.
2013: Jonathan Piccini; Daniel E Singer; Susanna R Stevens; Richard C Becker; Günter Breithardt; Robert M Califf; Keith A A Fox; Werner Hacke; Jonathan L Halperin; Graeme J Hankey; Yuliya Lokhnygina; Kenneth W Mahaffey; Christopher C. Nessel; Manesh R Patel
Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial.
Journal of the American College of Cardiology 2013;61(19):1998-2006.
2013: Jason J Rose; Frans Van de Werf; Harvey D White; Kenneth W Mahaffey; L Kristin Newby; E Magnus Ohman; Paul W Armstrong; Samuel Broderick; Robert M Califf; Karen Chiswell; Robert P Giugliano; Shaun G Goodman; Christopher B Granger; Robert A Harrington; Renato D Lopes
Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes.
Journal of the American College of Cardiology 2013;61(13):1461-3.
2013: Peter B Berger; Karen Chiswell; Vic Hasselblad; Karen S Pieper; Judson B Williams; Robert M Califf
Would tirofiban have been shown non-inferior to abciximab had the TENACITY trial not been terminated for financial reasons?
Journal of interventional cardiology 2013;26(2):123-30.
2013: Robert J Mentz; Christopher M O'Connor; Randall C Starling; Amanda L Stebbins; John R Teerlink; Dan Atar; Robert M Califf; Justin A Ezekowitz; G Michael Felker; Vic Hasselblad; Gretchen M Heizer; Adrian F Hernandez; Barry M Massie; Piotr Ponikowski
Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF.
European journal of heart failure 2013;15(4):456-64.
2013: Robert M Califf
Conflicting information about conflict of interest.
Journal of the American College of Cardiology 2013;61(11):1144-5.
2013: Cynthia M Westerhout; Robert M Califf; Frans Van de Werf; Christopher B Granger; Stefan K James; Kenneth W Mahaffey; Karen S Pieper; Paul W Armstrong
Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
American heart journal 2013;165(3):354-62.e2.
2013: Robert M Califf
Attribution of causality in clinical research: an important element for learning health systems.
American heart journal 2013;165(3):252-3.
2013: Yee Weng Wong; Thomas Giles; Steven M Haffner; Adrian F Hernandez; Henry Krum; Lawrence A Leiter; Felipe A Martinez; Theodore Mazzone; John J V McMurray; Guy E H M Rutten; Eberhard Standl; Jie Lena Sun; Laine Thomas; Gianni Tognoni; Robert M Califf
Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study.
Circulation. Heart failure 2013;6(2):203-10.
2013: Manesh R Patel; Jonathan Piccini; Daniel E Singer; Zhongxin Zhang; Surya Mohanty; Christopher C. Nessel; Richard C Becker; Scott D Berkowitz; Günter Breithardt; Robert M Califf; Keith A A Fox; Werner Hacke; Jonathan L Halperin; Graeme J Hankey; Anne S Hellkamp; Yuliya Lokhnygina; Kenneth W Mahaffey
Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
Journal of the American College of Cardiology 2013;61(6):651-8.
2013: Daniel E Singer; Richard C Becker; Günter Breithardt; Robert M Califf; Keith A A Fox; Werner Hacke; Jonathan L Halperin; Graeme J Hankey; Anne S Hellkamp; Yuliya Lokhnygina; Kenneth W Mahaffey; Christopher C Nessel; Guohua Pan; Manesh R Patel; Jonathan P Piccini
Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.
Journal of the American Heart Association 2013;2(1):e000067.
2013: Jonathan Piccini; Daniel E Singer; Susanna R Stevens; Richard C Becker; Günter Breithardt; Robert M Califf; Yuchiao Chang; Keith A A Fox; Alan S Go; Werner Hacke; Jonathan L Halperin; Graeme J Hankey; Yuliya Lokhnygina; Kenneth W Mahaffey; Christopher C. Nessel; Manesh R Patel
Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
Circulation 2013;127(2):224-32.
2013: Robert M Califf
Biomarkers, putative surrogates, surrogates, and decision making.
Circulation. Cardiovascular imaging 2013;6(1):6-7.
2012: Sergio Leonardi; Renato D Lopes; Elliott M Antman; Paul W Armstrong; Robert M Califf; Robert P Giugliano; Megan L Neely; L Kristin Newby; Laine Thomas; Pierluigi Tricoci; Harvey D White; Kenneth W Mahaffey
Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
Journal of the American College of Cardiology 2012;60(22):2296-304.
2012: Robert M Califf; Iain Sanderson; Marie Lynn Miranda
The future of cardiovascular clinical research: informatics, clinical investigators, and community engagement.
JAMA : the journal of the American Medical Association 2012;308(17):1747-8.
2012: Eric L Eisenstein; Eric D Peterson; Daniel Wojdyla; Kevin J Anstrom; J Matthew Brennan; Robert M Califf; Pamela S Douglas
Evaluating the impact of public health notification: Duke clopidogrel experience.
Circulation. Cardiovascular quality and outcomes 2012;5(6):767-74.
2012: G Michael Felker; Gregg C Fonarow; Vic Hasselblad; Gretchen M Heizer; Adrian F Hernandez; Barry M Massie; John J V McMurray; Marco Metra; Stefan D Anker; Paul W Armstrong; Dan Atar; Javed Butler; Robert M Califf; Kenneth Dickstein; Randall C Starling; W H Wilson Tang; Richard W Troughton; Adriaan A Voors; Christopher M O'Connor
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study.
European journal of heart failure 2012;14(11):1257-64.
2012: John J V McMurray; Robert M Califf; Steven M Haffner; Rury R Holman
Prediabetes and the risk of diabetes.
Lancet 2012;380(9849):1225-6; author reply 1226.
2012: John J V McMurray; Angelyn M Bethel; Robert M Califf; Steven M Haffner; Rury R Holman
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study.
Journal of clinical hypertension (Greenwich, Conn.) 2012;14(10):731.
2012: Sue Duval; Kim A Eagle; Gregg C Fonarow; Alan T Hirsch; Michael R Jaff; Joseph M Massaro; Joanne M Murabito; Alison Pedley; P Gabriel Steg; Mark J Alberts; Deepak L Bhatt; William E Boden; Robert M Califf; Ralph B D'Agostino
An evidence-based score to detect prevalent peripheral artery disease (PAD).
Vascular medicine (London, England) 2012;17(5):342-51.
2012: Valentin Fuster; Dominick J Angiolillo; Eric R Bates; Deepak L Bhatt; Robert M Califf; David J Cohen; Barry S Coller; Bruce Furie; W Keith Hoots; Jean-Sebastien Hulot; Kenneth G Mann; Jessica L Mega; Alan D Michelson; Kiran Musunuru; Christopher J O'Donnell; Matthew J Price; Yves D Rosenberg; Marc S Sabatine; David J Schneider; Daniel I Simon; Jeffrey I Weitz; Marlene S Williams; Ahmed A K Hasan
Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group.
Circulation 2012;126(13):1645-62.
2012: Yuri B Pride; Cafer Zorkun; Eugene Braunwald; Robert M Califf; C Michael Gibson; Robert P Giugliano; Robert A Harrington; Vijayalakshmi Kunadian; Satishkumar Mohanavelu; L Kristin Newby
Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy.
JACC. Cardiovascular interventions 2012;5(9):927-35.
2012: Renato D Lopes; Todd J Lorenz; Michael J Mack; Rajendra H Mehta; Eric D Peterson; Eric M Reyes; Judson B Williams; Keith B Allen; Robert M Califf; T. Bruce Ferguson; C Michael Gibson; Gail E Hafley; Robert A Harrington; Nicholas T Kouchoukos; John H Alexander
Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results.
American heart journal 2012;164(3):379-386.e1.
2012: Jula K Inrig; Uptal D Patel; Donal N Reddan; Shelly Sapp; Ajay Singh; Huiman Barnhart; Robert M Califf; Lynda Szczech
Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(9):3606-14.
2012: Jula K Inrig; Uptal D Patel; Donal N Reddan; Shelly Sapp; Ajay K Singh; Huiman X Barnhart; Robert M Califf; Lynda A Szczech
Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2012;60(3):390-401.
2012: Robert M Califf
In search of the efficient way to medical decisions: the case of acute heart failure syndrome.
American heart journal 2012;164(2):135-7.
2012: Robert M Califf
The trouble with ischemia.
American heart journal 2012;164(2):133-4.
2012: Jonathan Piccini; Charles V Pollack; Pierluigi Tricoci; Frans Van de Werf; Jennifer A White; Sana M Al-Khatib; Robert M Califf; C Michael Gibson; Robert P Giugliano; Robert A Harrington; Yuliya Lokhnygina; Rajendra H Mehta; Gilles Montalescot; L Kristin Newby
Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes.
Circulation 2012;126(1):41-9.
2012: Michael P Thomas; Elliott M Antman; Robert M Califf; Karen Chiswell; Marc Cohen; James J Ferguson; Shaun G Goodman; Michael C Kontos; Kenneth W Mahaffey; Richard C Becker
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin.
Journal of thrombosis and thrombolysis 2012;34(1):114-9.
2012: Julie Adams; Jude D Alexander; Robert M Califf; Eric J Christopher; Greg L Clary; Michael S Cuffe; Ranga R Krishnan; Maragatha Kuchibhatla; Christopher M O'Connor; Wei Jiang
Association of depression and survival in patients with chronic heart failure over 12 Years.
Psychosomatics 2012;53(4):339-46.
2012: Robert M Califf; Sally Kornbluth
Establishing a framework for improving the quality of clinical and translational research.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(14):1725-6.
2012: Robert M Califf
A new look at an old therapy.
JAMA : the journal of the American Medical Association 2012;307(18):1972-3.
2012: Robert M Califf; Judith M Kramer; Rachel E Sherman; Laura H Aberle; Deborah A Zarin; Asba Tasneem
Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
JAMA : the journal of the American Medical Association 2012;307(17):1838-47.
2012: Svati H Shah; Robert D Stevens; Jie Lena Sun; Christopher B Newgard; Karen S Pieper; James R Bain; Robert M Califf; Christopher B Granger; Elizabeth R Hauser; Carol Haynes; William E Kraus; Michael J Muehlbauer; L Kristin Newby
Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease.
American heart journal 2012;163(5):844-850.e1.
2012: Justin A Ezekowitz; Adrian F Hernandez; John J V McMurray; Christopher M O'Connor; Guy Proulx; Randall C Starling; Mason H Weiss; Jeffrey Bakal; Robert M Califf; Paul W Armstrong
Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow.
Journal of the American College of Cardiology 2012;59(16):1441-8.
2012: Graeme J Hankey; Kenneth W Mahaffey; Jean-Louis Mas; Ayrton Massaro; Christopher C Nessel; Bo Norrving; John F Paolini; Manesh R Patel; Risto O Roine; Daniel E Singer; Susanna R Stevens; Lawrence Wong; Richard C Becker; Günter Breithardt; Robert M Califf; Antonio Carolei; Hans-Christoph Diener; Geoffrey A Donnan; Keith A A Fox; Werner Hacke; Jonathan L Halperin
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.
Lancet neurology 2012;11(4):315-22.
2012: Matthew T Roe; Jorge F Saucedo; Pierluigi Tricoci; Frans Van de Werf; Arnoud W van't Hof; Jennifer A White; E Magnus Ohman; Charles V Pollack; Paul W Armstrong; Robert M Califf; Robert P Giugliano; Robert A Harrington; Judith S Hochman; Stefan K James; Padma Kaul; Yuliya Lokhnygina; Chadwick D Miller; Gilles Montalescot; L Kristin Newby
Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial.
Circulation. Cardiovascular quality and outcomes 2012;5(2):205-13.
2012: Bradi B Granger; Diane Holditch-Davis; Pamela H Mitchell; Janet Prvu-Bettger; Deborah Roth; Julia Aucoin; Robert M Califf; Mary Ann Fuchs; Catherine L Gilliss
An academic-health service partnership in nursing: lessons from the field.
Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing / Sigma Theta Tau 2012;44(1):71-9.
2012: J M Kramer; P Brian Smith; Robert M Califf
Impediments to clinical research in the United States.
Clinical pharmacology and therapeutics 2012;91(3):535-41.
2012: Renato D Lopes; Michael J Mack; Rajendra H Mehta; Eric D Peterson; Judson B Williams; John H Alexander; Keith B Allen; Robert M Califf; T. Bruce Ferguson; C Michael Gibson; Gail E Hafley; Robert A Harrington; Nicholas T Kouchoukos
Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery.
Circulation 2012;125(6):749-56.
2012: Rajendra H Mehta; Karen S Pieper; Amanda S Stebbins; Eric J Topol; Frans Van de Werf; Harvey D White; John H Alexander; Paul W Armstrong; Robert M Califf; Judith S Hochman; Renato D Lopes; Christopher B Granger
Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis.
The American journal of cardiology 2012;109(3):320-6.
2012: David Preiss; Guy E Rutten; Eberhard Standl; Jie Lena Sun; Laine E Thomas; Gianni Tognoni; Robert M Califf; Fu-Tien Chiang; Steven M Haffner; Rury R Holman; Lawrence A Leiter; Felipe A Martinez; Theodore Mazzone; John J McMurray
Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial.
BMJ open 2012;2(6):.
2012: Sayanti Bhattacharya; Robert M Califf; Victoria A Christian; Melissa A Cornish; Rowena J Dolor; Ashley A Dunham; Geoffrey S Ginsburg; Marie Lynn Miranda; Meredith L Nahm; Jessica D Tenenbaum; L Kristin Newby
The Measurement to Understand Reclassification of Disease of Cabarrus/Kannapolis (MURDOCK) Study Community Registry and Biorepository.
American journal of translational research 2012;4(4):458-70.
2012: Jessica D Tenenbaum; Krishna Udayakumar; Victoria Christian; Melissa A Cornish; Rowena J Dolor; Ashley A Dunham; Geoffrey S Ginsburg; Virginia B Kraus; John G McHutchison; Meredith L Nahm; L Kristin Newby; Laura P Svetkey; Robert M Califf
The MURDOCK Study: a long-term initiative for disease reclassification through advanced biomarker discovery and integration with electronic health records.
American journal of translational research 2012;4(3):291-301.
2011: Chiara Melloni; Gilles Montalescot; Pierluigi Tricoci; Frans Van de Werf; Jennifer A White; Paul W Armstrong; Robert M Califf; Robert P Giugliano; Robert A Harrington; Kurt Huber; Stefan K James; L Kristin Newby
Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal function.
American heart journal 2011;162(5):884-892.e1.
2011: Mona Fiuzat; Robert M Califf
Conduct of clinical trials in acute heart failure: regional differences in heart failure clinical trials.
Heart failure clinics 2011;7(4):539-44.
2011: Keith A A Fox; Jonathan L Halperin; Graeme J Hankey; Kenneth W Mahaffey; Christopher C. Nessel; John F Paolini; Manesh R Patel; Jonathan P Piccini; Daniel E Singer; Daniel Wojdyla; Richard C Becker; Robert M Califf
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment.
European heart journal 2011;32(19):2387-94.
2011: Rajendra H Mehta; Sean M O'Brien; Uptal D Patel; Linda K Shaw; Robert M Califf; Emily Honeycutt; G Chad Hughes; Renato D Lopes; Judson B Williams; Michael H Sketch
Relationship of the time interval between cardiac catheterization and elective coronary artery bypass surgery with postprocedural acute kidney injury.
Circulation 2011;124(11 Suppl):S149-55.
2011: Manesh R Patel; Jonathan P Piccini; Daniel E Singer; Richard C Becker; Scott Darrell Berkowitz; Günter Breithardt; Robert M Califf; Keith A A Fox; Jyotsna Garg; Werner Hacke; Jonathan L Halperin; Graeme J Hankey; Kenneth W Mahaffey; Christopher C. Nessel; Guohua Pan; John F Paolini
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
The New England journal of medicine 2011;365(10):883-91.
2011: Robert M Califf; Robert A Harrington
American industry and the U.S. Cardiovascular Clinical Research Enterprise an appropriate analogy?
Journal of the American College of Cardiology 2011;58(7):677-80.
2011: Renato D Lopes; Kenneth W Mahaffey; Helena B Nader; L Kristin Newby; Eric D Peterson; Karen S Pieper; Frans Van de Werf; Lars Wallentin; Harvey D White; John H Alexander; Paul W Armstrong; Richard C Becker; Joyce M A Bizzachi; Robert M Califf; Antonio C Carvalho; Mark Y Chan; Mark Crowther; Roberto R Giraldez; Christopher B Granger; Helio P Guimaraes; Robert A Harrington; Elaine M Hylek; Stefan K James; E Marc Jolicoeur; Renato A K Kalil; Antonio C Lopes; David A Garcia
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil.
Journal of thrombosis and thrombolysis 2011;32(2):242-66.
2011: Rajendra H Mehta; Eric D Peterson; John H Alexander; Robert M Califf; T. Bruce Ferguson; C Michael Gibson; Gail E Hafley; Robert A Harrington; Nicholas T Kouchoukos; Renato D Lopes; Michael J Mack
Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial.
Circulation 2011;124(3):280-8.
2011: Pierluigi Tricoci; Frans Van de Werf; Harvey D White; Paul W Armstrong; Leonardo Bolognese; Eugene Braunwald; Robert M Califf; Eric Durand; Robert P Giugliano; Vic Hasselblad; David F Kong; David J Moliterno; L Kristin Newby; Dorairaj Prabhakaran; Saman Rasoul; Gregg W Stone; Pierre Théroux; Robert A Harrington
Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials.
Circulation. Cardiovascular quality and outcomes 2011;4(4):448-58.
2011: Anil Verma; Marc A Pfeffer; Hicham Skali; Jean Rouleau; Aldo Maggioni; John J V McMurray; Robert M Califf; Eric J Velazquez; Scott D Solomon
Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarction.
American heart journal 2011;161(6):1156-62.
2011: Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation 2011;123(18):e426-579.
2011: Paul W Armstrong; Cynthia M Westerhout; Frans Van de Werf; Robert M Califf; Robert C Welsh; Robert G Wilcox; Jeffrey Bakal
Refining clinical trial composite outcomes: an application to the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trial.
American heart journal 2011;161(5):848-54.
2011: Harry P Selker; Robert M Califf
The need for academic leadership in full-spectrum translational research.
Clinical and translational science 2011;4(2):78-9.
2011: Deborah A Zarin; Tony Tse; Rebecca J Williams; Robert M Califf; Nicholas C Ide
The ClinicalTrials.gov results database--update and key issues.
The New England journal of medicine 2011;364(9):852-60.
2011: Ajay S Vamadevan; Bimal R Shah; Robert M Califf; Dorairaj Prabhakaran
Cardiovascular research in India: a perspective.
American heart journal 2011;161(3):431-8.
2011: Kenneth W Mahaffey; Karen S Pieper; Yuliya Lokhnygina; Robert M Califf; Elliott M Antman; Neal S Kleiman; Shaun G Goodman; Harvey D White; Sunil V Rao; Judith S Hochman; Marc Cohen; Jacques J Col; Matthew T Roe; James J Ferguson
The impact of postrandomization crossover of therapy in acute coronary syndromes care.
Circulation. Cardiovascular quality and outcomes 2011;4(2):211-9.
2011: Tracy Y Wang; Jennifer A White; Pierluigi Tricoci; Robert P Giugliano; Uwe Zeymer; Robert A Harrington; Gilles Montalescot; Stefan K James; Frans Van de Werf; Paul W Armstrong; Eugene Braunwald; Robert M Califf; L Kristin Newby
Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial.
Circulation 2011;123(7):722-30.
2011: David L DeMets; Robert M Califf
A historical perspective on clinical trials innovation and leadership: where have the academics gone?
JAMA : the journal of the American Medical Association 2011;305(7):713-4.
2011: Rajendra H Mehta; J Conor O'Shea; Amanda L Stebbins; Christopher B Granger; Paul W Armstrong; Harvey D White; Eric J Topol; Robert M Califf; E Magnus Ohman
Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis.
Journal of the American College of Cardiology 2011;57(2):138-46.
2011: Rajendra H Mehta; Amanda Stebbins; Renato D Lopes; Sunil V Rao; Eric R Bates; Karen S Pieper; Paul W Armstrong; Frans Van de Werf; Harvey D White; Robert M Califf; John H Alexander; Christopher B Granger
Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy.
The American journal of medicine 2011;124(1):48-57.
2011: Jonathan P Piccini; Phillip J Schulte; Karen S Pieper; Rajendra H Mehta; Harvey D White; Frans Van de Werf; Diego Ardissino; Robert M Califf; Christopher B Granger; E Magnus Ohman; John H Alexander
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
Critical care medicine 2011;39(1):78-83.
2010: Rajendra H Mehta; Emily Honeycutt; Uptal D Patel; Renato D Lopes; Linda K Shaw; Donald D Glower; Robert A Harrington; Robert M Califf; Michael H Sketch
Impact of recovery of renal function on long-term mortality after coronary artery bypass grafting.
The American journal of cardiology 2010;106(12):1728-34.
2010: Amil M Shah; Hajime Uno; Lars Køber; Eric J Velazquez; Aldo P Maggioni; Michael R MacDonald; Mark C Petrie; John J V McMurray; Robert M Califf; Marc A Pfeffer; Scott D Solomon
The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction.
European journal of heart failure 2010;12(11):1229-37.
2010: Andrea H Tackett; Alison L Bailey; Joanne Micale Foody; Julie M Miller; Carolyn Apperson-Hansen; E Magnus Ohman; Judith S Hochman; Sharon L Karnash; Robert M Califf; Eric J Topol; David J Moliterno
Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial.
American heart journal 2010;160(4):678-84.
2010: Jeffrey Taekman; Mark Stafford-Smith; Eric J Velazquez; Melanie C Wright; Barbara Phillips-Bute; Marc A Pfeffer; M A Sellers; Karen S Pieper; Mark F Newman; Frans Van de Werf; R Diaz; J Leimberger; Robert M Califf
Departures from the protocol during conduct of a clinical trial: a pattern from the data record consistent with a learning curve.
Quality & safety in health care 2010;19(5):405-10.
2010: Sarah A Spinler; Kenneth W Mahaffey; Dianne Gallup; Glenn N Levine; James J Ferguson; Sunil V Rao; Richard Gallo; John Ducas; Shaun G Goodman; Elliott Antman; Harvey D White; Luigi Biasucci; Richard C Becker; Jacques J Col; Marc Cohen; Robert A Harrington; Robert M Califf
Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY.
International journal of cardiology 2010;144(1):36-41.
2010: Abhinav Goyal; Deepak L Bhatt; P Gabriel Steg; Bernard J Gersh; Mark J Alberts; E Magnus Ohman; Ramón Corbalán; Kim A Eagle; Efrain Gaxiola; Runlin Gao; Shinya Goto; Ralph B D'Agostino; Robert M Califf; Sidney C Smith; Peter W F Wilson
Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries.
Circulation 2010;122(12):1167-75.
2010: Svati H Shah; Christopher B Granger; Elizabeth R Hauser; William E Kraus; Jie Lena Sun; Karen Pieper; Charlotte L Nelson; Elizabeth R DeLong; Robert M Califf; L Kristin Newby
Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study.
American heart journal 2010;160(3):371-379.e2.
2010: William E Boden; Gregory S Cherr; Kim A Eagle; Christopher P Cannon; Robert M Califf; Alan T Hirsch; Mark J Alberts; Michael Criqui; Mark A Creager; Joseph M Massaro; Ralph B D'Agostino; P Gabriel Steg; Deepak L Bhatt
Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosis.
Critical pathways in cardiology 2010;9(3):116-25.
2010: Anne-Catherine Pouleur; Ebrahim Barkoudah; Hajime Uno; Hicham Skali; Peter V Finn; Steven L Zelenkofske; Yuri N Belenkov; Viacheslav Mareev; Eric J Velazquez; Jean L Rouleau; Aldo P Maggioni; Lars Køber; Robert M Califf; John J V McMurray; Marc A Pfeffer; Scott D Solomon
Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
Circulation 2010;122(6):597-602.
2010: Ryenn L West; Adrian F Hernandez; Christopher M O'Connor; Randall C Starling; Robert M Califf
A review of dyspnea in acute heart failure syndromes.
American heart journal 2010;160(2):209-14.
2010: Melissa H Kong; Linda K Shaw; Christopher O'Connor; Robert M Califf; Michael A Blazing; Sana M Al-Khatib
Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure?
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2010;15(3):209-17.
2010: Faisal Shamshad; Satish Kenchaiah; Peter V Finn; Jordi Soler-Soler; John J V McMurray; Eric J Velazquez; Aldo P Maggioni; Robert M Califf; Karl Swedberg; Lars Kober; Yuri Belenkov; Sergei Varshavsky; Marc A Pfeffer; Scott D Solomon
Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT).
American heart journal 2010;160(1):145-51.
2010: Kent R Nilsson; Sana M Al-Khatib; Yi Zhou; Karen Pieper; Harvey D White; Aldo P Maggioni; Lars Kober; Christopher B Granger; Eldrin F Lewis; John J V McMurray; Robert M Califf; Eric J Velazquez
Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial.
Heart (British Cardiac Society) 2010;96(11):838-42.
2010: Carissa Marrie Baker-Smith; Daniel K Benjamin; Robert M Califf; M D Murphy; J S Li; P Brian Smith
Cough in pediatric patients receiving angiotensin-converting enzyme inhibitor therapy or angiotensin receptor blocker therapy in randomized controlled trials.
Clinical pharmacology and therapeutics 2010;87(6):668-71.
2010: Robert A Harrington; Robert M Califf
There is a role for industry-sponsored education in cardiology.
Circulation 2010;121(20):2221-7.
2010: Kai M Eggers; Paul W Armstrong; Robert M Califf; Maarten L Simoons; Per Venge; Lars Wallentin; Stefan K James
ST2 and mortality in non-ST-segment elevation acute coronary syndrome.
American heart journal 2010;159(5):788-94.
2010: Sunil V Rao; Robert M Califf
Is old blood bad blood?
American heart journal 2010;159(5):710-2.
2010: Robert M Califf; Yuliya Lokhnygina; Christopher P Cannon; Michael E Stepanavage; Carolyn H McCabe; Thomas A Musliner; Richard C Pasternak; Michael A Blazing; Robert P Giugliano; Robert A Harrington; Eugene Braunwald
An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design.
American heart journal 2010;159(5):705-9.
2010: Marc Cohen; Glenn N Levine; Karen S Pieper; Lan Lan; Elliott M Antman; Philip E Aylward; Harvey D White; Neal S Kleiman; Robert M Califf; Kenneth W Mahaffey
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2010;75(6):928-35.
2010: Henry Krum; John J V McMurray; Edward Horton; Teresa Gerlock; Bjoern Holzhauer; Lineke Zuurman; Steven M Haffner; M Angelyn Bethel; Rury R Holman; Robert M Califf
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
Cardiovascular therapeutics 2010;28(2):124-32.
2010: Robert M Califf; Paul W Armstrong; Christopher B Granger; Robert A Harrington; Kerry Lee; R John Simes; Frans Van de Werf; Lars Wallentin; Harvey D White
Towards a new order in cardiovascular medicine: re-engineering through global collaboration.
European heart journal 2010;31(8):911-7.
2010: Robert M Califf; Svati H Shah; L Kristin Newby
Biomarker bonanza?
Journal of the American College of Cardiology 2010;55(12):1197-9.
2010: Victor J Dzau; D Clay Ackerly; Pamela Sutton-Wallace; Michael H Merson; R Sanders Williams; K Ranga Krishnan; Robert C Taber; Robert M Califf
The role of academic health science systems in the transformation of medicine.
Lancet 2010;375(9718):949-53.
2010: Sung-Hee Shin; Chung-Lieh Hung; Hajime Uno; Amira H Hassanein; Anil Verma; Mikhail Bourgoun; Lars Køber; Jalal K Ghali; Eric J Velazquez; Robert M Califf; Marc A Pfeffer; Scott D Solomon
Mechanical dyssynchrony after myocardial infarction in patients with left ventricular dysfunction, heart failure, or both.
Circulation 2010;121(9):1096-103.
2010: Kenneth W Mahaffey; Simon T Tonev; Sarah A Spinler; Glenn N Levine; Richard Gallo; John Ducas; Shaun G Goodman; Elliott M Antman; Richard C Becker; Anatoly Langer; Harvey D White; Philip E Aylward; Jacques J Col; James J Ferguson; Robert M Califf
Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
International journal of cardiology 2010;139(2):123-33.
2010: Christopher M O'Connor; Vic Hasselblad; Rajendra H Mehta; Gudaye Tasissa; Robert M Califf; Mona Fiuzat; Joseph G Rogers; Carl V Leier; Lynne W Stevenson
Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score.
Journal of the American College of Cardiology 2010;55(9):872-8.
2010: John L Petersen; John J Barron; Bradley G Hammill; Mark J Cziraky; Kevin J Anstrom; Peter M Wahl; Eric L Eisenstein; Mitchell W Krucoff; Robert M Califf; Kevin Schulman; Lesley H Curtis
Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore Integrated Research Database.
American heart journal 2010;159(3):462-470.e1.
2010: Steven E Reis; Lars Berglund; gordon bernard; Robert M Califf; Garret A Fitzgerald; Peter C Johnson
Reengineering the national clinical and translational research enterprise: the strategic plan of the National Clinical and Translational Science Awards Consortium.
Academic medicine : journal of the Association of American Medical Colleges 2010;85(3):463-9.
2010: Robert M Califf; Lars Berglund
Linking scientific discovery and better health for the nation: the first three years of the NIH's Clinical and Translational Science Awards.
Academic medicine : journal of the Association of American Medical Colleges 2010;85(3):457-62.
2010: Christopher P Cannon; Karen E Rhee; Robert M Califf; William E Boden; Alan T Hirsch; Mark J Alberts; Greg Cable; Mingyuan Shao; Erik Ohman; P Gabriel Steg; Kim A Eagle; Deepak L Bhatt
Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
The American journal of cardiology 2010;105(4):445-52.
2010: Erik Ohman; Robert M Califf
When can noninferior be superior? The multidimensional nature of clinical decision-making calls for innovative approaches to clinical trials.
Journal of the American College of Cardiology 2010;55(6):555-7.
2010: Jason N Katz; Bimal R Shah; Elizabeth M Volz; John R Horton; Linda K Shaw; L Kristin Newby; Christopher B Granger; Daniel B Mark; Robert M Califf; Richard C Becker
Evolution of the coronary care unit: clinical characteristics and temporal trends in healthcare delivery and outcomes.
Critical care medicine 2010;38(2):375-81.
2010: Lynda A Szczech; Huiman X Barnhart; Shelly Sapp; G Michael Felker; Adrian Hernandez; Donal N Reddan; Robert M Califf; Jula K Inrig; Uptal D Patel; Ajay K Singh
A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment.
Kidney international 2010;77(3):239-46.
2010: Jonathan P Piccini; Min Zhang; Karen Pieper; Scott D Solomon; Sana M Al-Khatib; Frans Van de Werf; Marc A Pfeffer; John J V McMurray; Robert M Califf; Eric J Velazquez
Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial.
European heart journal 2010;31(2):211-21.
2009: Brett D Atwater; Vivian P Thompson; Richard N Vest; Linda K Shaw; Walter R Mazzei; Sana M Al-Khatib; Patrick M Hranitzky; Tristram D Bahnson; Eric J Velazquez; Robert M Califf; Kerry L Lee; Matthew T Roe
Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery disease.
The American journal of cardiology 2009;104(12):1624-30.
2009: Barry S Coller; Robert M Califf
Traversing the valley of death: a guide to assessing prospects for translational success.
Science translational medicine 2009;1(10):10cm9.
2009: M Angelyn Bethel; P Deedwania; N S Levitt; O Schmitz; A Huntsman-Labed; Robert M Califf; Steven M Haffner; P Diem
Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population.
Diabetic medicine : a journal of the British Diabetic Association 2009;26(12):1204-11.
2009: Daniel K Benjamin; P Brian Smith; M Jessica M Sun; M Dianne Murphy; Debbie Avant; Lisa Mathis; William Rodriguez; Robert M Califf; Jennifer S Li
Safety and transparency of pediatric drug trials.
Archives of pediatrics & adolescent medicine 2009;163(12):1080-6.
2009: Telly A Meadows; Deepak L Bhatt; Alan T Hirsch; Mark A Creager; Robert M Califf; Erik Ohman; Christopher P Cannon; Kim A Eagle; Mark J Alberts; Shinya Goto; Sidney C Smith; Peter W F Wilson; Karol E Watson; P Gabriel Steg
Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry.
American heart journal 2009;158(6):1038-45.
2009: Pascal J Goldschmidt-Clermont; Chunming Dong; Nancy M Rhodes; Diana B McNeill; Martha B Adams; Catherine L Gilliss; Michael S Cuffe; Robert M Califf; eric peterson; David A Lubarsky
Perspective: Autonomic care systems for hospitalized patients.
Academic medicine : journal of the Association of American Medical Colleges 2009;84(12):1727-31.
2009: Jason P Linefsky; Min Lin; Karen S Pieper; Craig J Reist; Lisa G Berdan; Elliott M Antman; Shaun G Goodman; John K French; Sema Guneri; Matthew T Roe; L Kristin Newby; Robert A Harrington; James J Ferguson; Robert M Califf; Kenneth W Mahaffey
Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).
The American journal of cardiology 2009;104(10):1330-5.
2009: Robert M Califf
Clinical research sites--the underappreciated component of the clinical research system.
JAMA : the journal of the American Medical Association 2009;302(18):2025-7.
2009: Sana M Al-Khatib; Gail E Hafley; Robert A Harrington; Michael J Mack; Thomas Bruce Ferguson; eric peterson; Robert M Califf; Nicholas T Kouchoukos; John H Alexander
Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) Trial.
American heart journal 2009;158(5):792-8.
2009: Lisa M Mielniczuk; Marc A Pfeffer; Eldrin F Lewis; Michael A Blazing; James A de Lemos; Satishkumar Mohanavelu; Jean Rouleau; Keith Fox; Terje R Pedersen; Robert M Califf
Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(11):1811-7.
2009: Jonathan P Piccini; Vic Hasselblad; eric peterson; Jeffrey B Washam; Robert M Califf; David F Kong
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
Journal of the American College of Cardiology 2009;54(12):1089-95.
2009: Marc P Bonaca; Philippe Gabriel STEG; Laurent J Feldman; John F Canales; James J Ferguson; Lars Wallentin; Robert M Califf; Robert A Harrington; Robert P Giugliano
Antithrombotics in acute coronary syndromes.
Journal of the American College of Cardiology 2009;54(11):969-84.
2009: Amit Kumar; Gregg C Fonarow; Kim A Eagle; Alan T Hirsch; Robert M Califf; Mark J Alberts; William E Boden; P Gabriel Steg; Mingyuan Shao; Deepak L Bhatt; Christopher P Cannon
Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
Critical pathways in cardiology 2009;8(3):104-11.
2009: George V Moukarbel; James E Signorovitch; Marc A Pfeffer; John J V McMurray; Harvey D White; Aldo P Maggioni; Eric J Velazquez; Robert M Califf; James M Scheiman; Scott D Solomon
Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial.
European heart journal 2009;30(18):2226-32.
2009: Jeffrey S Berger; Laine Elliott; Dianne Gallup; Matthew Roe; Christopher B Granger; Paul W Armstrong; R John Simes; Harvey D White; Frans Van de Werf; Eric J Topol; Judith S Hochman; L Kristin Newby; Robert A Harrington; Robert M Califf; Richard C Becker; Pamela S Douglas
Sex differences in mortality following acute coronary syndromes.
JAMA : the journal of the American Medical Association 2009;302(8):874-82.
2009: Robert M Califf
Key issues for global cardiovascular medicine.
Lancet 2009;374(9689):508-10.
2009: Robert M Califf; Robert A Harrington; Michael A Blazing
Premature release of data from clinical trials of ezetimibe.
The New England journal of medicine 2009;361(7):712-7.
2009: Renato D Lopes; Gail E Hafley; Keith B Allen; T Bruce Ferguson; eric peterson; Robert A Harrington; Rajendra H Mehta; C Michael Gibson; Michael J Mack; Nicholas T Kouchoukos; Robert M Califf; John H Alexander
Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery.
The New England journal of medicine 2009;361(3):235-44.
2009: Robert M Califf; Yuliya Lokhnygina; Eric J Velazquez; John J V McMurray; Jeffrey D Leimberger; Eldrin F Lewis; Rafael Diaz; Jan Murin; Marc A Pfeffer
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
The American journal of cardiology 2009;104(2):151-7.
2009: Robert M Califf
Rational use of medications: if Canada can't do it ...
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2009;181(1-2):15-6.
2009: Robert M Califf
Angiographic profiles in courage.
Circulation. Cardiovascular quality and outcomes 2009;2(4):292-3.
2009: Mark Y Chan; Jie L Sun; L Kristin Newby; Linda K Shaw; Min Lin; eric peterson; Robert M Califf; David F Kong; Matthew T Roe
Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction.
Circulation 2009;119(24):3110-7.
2009: Robert A Harrington; Robert M Califf; Patricia K Hodgson; eric peterson; Matthew T Roe; Daniel B Mark
Careers for clinician investigators.
Circulation 2009;119(22):2945-50.
2009: Aslan T Turer; Kenneth W Mahaffey; Emily Honeycutt; Robert H Tuttle; Linda K Shaw; Michael H Sketch; Peter K Smith; Robert M Califf; John H Alexander
Influence of body mass index on the efficacy of revascularization in patients with coronary artery disease.
The Journal of thoracic and cardiovascular surgery 2009;137(6):1468-74.
2009: Kim A Eagle; Alan T Hirsch; Robert M Califf; Mark J Alberts; Philippe Gabriel STEG; Christopher P Cannon; Danielle M Brennan; Deepak L Bhatt
Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH Registry.
Critical pathways in cardiology 2009;8(2):91-7.
2009: C Berry; Karen S Pieper; Harvey D White; Scott D Solomon; Frans Van de Werf; Eric J Velazquez; Aldo P Maggioni; Robert M Califf; Marc A Pfeffer; John J V McMurray
Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT).
European heart journal 2009;30(12):1450-6.
2009: Robert P Giugliano; Jennifer A White; Christoph Bode; Paul W Armstrong; Gilles Montalescot; Basil S. Lewis; Arnoud van 't Hof; Lisa G Berdan; Kerry L Lee; John Strony; Steven Hildemann; Enrico Veltri; Frans Van de Werf; Eugene Braunwald; Robert A Harrington; Robert M Califf; L Kristin Newby
Early versus delayed, provisional eptifibatide in acute coronary syndromes.
The New England journal of medicine 2009;360(21):2176-90.
2009: Robert M Califf; eric peterson
Public reporting of quality measures what are we trying to accomplish?
Journal of the American College of Cardiology 2009;53(10):831-3.
2009: Pierluigi Tricoci; Joseph M Allen; Judith M Kramer; Robert M Califf; Sidney C Smith
Scientific evidence underlying the ACC/AHA clinical practice guidelines.
JAMA : the journal of the American Medical Association 2009;301(8):831-41.
2009: Seth Glickman; John G McHutchison; eric peterson; Charles Cairns; Robert A Harrington; Robert M Califf; Kevin Schulman
Ethical and scientific implications of the globalization of clinical research.
The New England journal of medicine 2009;360(8):816-23.
2009: Adrian F Hernandez; Christopher M O'Connor; Randall C Starling; Craig J Reist; Paul W Armstrong; Kenneth Dickstein; Todd J Lorenz; W Brian Gibler; Vic Hasselblad; Michel Komajda; Barrie Massie; John J V McMurray; Markku Nieminen; Jean L Rouleau; Karl Swedberg; Robert M Califf
Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
American heart journal 2009;157(2):271-7.
2009: Justin A Ezekowitz; Adrian F Hernandez; Randall C Starling; Clyde W Yancy; Barrie Massie; James A Hill; Henry Krum; Rafael Diaz; Piotr Ponikowski; Marco Metra; Jonathon G Howlett; Daniel Gennevois; Christopher M O'Connor; Robert M Califf; Gregg C Fonarow
Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF).
American heart journal 2009;157(2):219-28.
2009: Robert M Califf
A virtuous cycle to improve hypertension outcomes at a national level: linking public health and individualized medicine.
Hypertension 2009;53(2):105-7.
2009: Rajendra H Mehta; Joseph G Rogers; Vic Hasselblad; Gudaye Tasissa; Cynthia Binanay; Robert M Califf; Christopher M O'Connor
Association of weight change with subsequent outcomes in patients hospitalized with acute decompensated heart failure.
The American journal of cardiology 2009;103(1):76-81.
2008: Robert M Califf
The benefits of moving quality to a national level.
American heart journal 2008;156(6):1019-22.
2008: Jonathan Piccini; Patrick M Hranitzky; Rakhi Kilaru; Jean-Lucien Rouleau; Harvey D White; Philip E Aylward; Frans Van de Werf; Scott D Solomon; Robert M Califf; Eric J Velazquez
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
The American journal of cardiology 2008;102(11):1427-32.
2008: Robert M Califf; Geoffrey S Ginsburg
Organizational improvements to enhance modern clinical epidemiology.
JAMA : the journal of the American Medical Association 2008;300(19):2300-2.
2008: Lynne Warner Stevenson; Anne S Hellkamp; Carl V Leier; George Sopko; Todd M Koelling; J Wayne Warnica; William T Abraham; Edward K Kasper; Joseph G Rogers; Robert M Califf; Elizabeth E Schramm; Christopher M O'Connor
Changing preferences for survival after hospitalization with advanced heart failure.
Journal of the American College of Cardiology 2008;52(21):1702-8.
2008: Herbert D Aronow; Robert M Califf; Robert A Harrington; Marc Vallee; Carmelo Graffagnino; Ashfaq Shuaib; Desmond J Fitzgerald; J Donald Easton; Frans Van de Werf; Hans-Christoph Diener; James Ferguson; Peter J Koudstaal; Pierre Amarenco; Pierre Theroux; Stephen Davis; Eric J Topol
Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial).
The American journal of cardiology 2008;102(10):1285-90.
2008: Christopher M O'Connor; Wei Jiang; Maragatha Kuchibhatla; Rajendra H Mehta; Greg L Clary; Michael S Cuffe; Eric J Christopher; Jude D Alexander; Robert M Califf; Ranga R Krishnan
Antidepressant use, depression, and survival in patients with heart failure.
Archives of internal medicine 2008;168(20):2232-7.
2008: Robert M Califf; Emma B Rasiel; Kevin Schulman
Considerations of net present value in policy making regarding diagnostic and therapeutic technologies.
American heart journal 2008;156(5):879-85.
2008: Christopher P Cannon; Robert P Giugliano; Michael A Blazing; Robert A Harrington; John L Peterson; Christine McCrary Sisk; John Strony; Thomas A Musliner; Carolyn H McCabe; Enrico Veltri; Eugene Braunwald; Robert M Califf
Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes.
American heart journal 2008;156(5):826-32.
2008: Rajendra H Mehta; Gail E Hafley; C Michael Gibson; Robert A Harrington; eric peterson; Michael J Mack; Nicholas T Kouchoukos; Robert M Califf; T. Bruce Ferguson; John H Alexander
Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery.
The Journal of thoracic and cardiovascular surgery 2008;136(5):1149-55.
2008: James E Novak; Jula K Inrig; Uptal D Patel; Robert M Califf; Lynda A Szczech
Negative trials in nephrology: what can we learn?
Kidney international 2008;74(9):1121-7.
2008: Robert M Califf; Mitradev Boolell; Steven M Haffner; M Angelyn Bethel; John McMurray; Anil Duggal; Rury R Holman
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
American heart journal 2008;156(4):623-32.
2008: Larry A Allen; Joseph G Rogers; J Wayne Warnica; Thomas G Disalvo; Gudaye Tasissa; Cynthia Binanay; Christopher M O'Connor; Robert M Califf; Carl V Leier; Monica R Shah; Lynne Warner Stevenson
High mortality without ESCAPE: the registry of heart failure patients receiving pulmonary artery catheters without randomization.
Journal of cardiac failure 2008;14(8):661-9.
2008: Carissa Marrie Baker-Smith; Daniel K Benjamin; Henry G Grabowski; Elizabeth D Reid; Barry Mangum; John V Goldsmith; M Dianne Murphy; Rex Edwards; Eric L Eisenstein; Jessica Sun; Robert M Califf; Jennifer S Li
The economic returns of pediatric clinical trials of antihypertensive drugs.
American heart journal 2008;156(4):682-8.
2008: M Angelyn Bethel; Rury Holman; Steven M Haffner; Robert M Califf; Alice Huntsman-Labed; Tsushung Hua; John McMurray
Determining the most appropriate components for a composite clinical trial outcome.
American heart journal 2008;156(4):633-40.
2008: Richard Peto; Jonathan R Emberson; Martin J Landray; Colin Baigent; Rory Collins; Robert Clare; Robert M Califf
Analyses of cancer data from three ezetimibe trials.
The New England journal of medicine 2008;359(13):1357-66.
2008: Mark H Drazner; Anne S Hellkamp; Carl V Leier; Monica R Shah; Leslie W Miller; Stuart D Russell; James B Young; Robert M Califf; Anju Nohria
Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial.
Circulation. Heart failure 2008;1(3):170-7.
2008: Anil Verma; Alessandra Meris; Hicham Skali; Jalal K Ghali; J Malcolm O Arnold; Mikhail Bourgoun; Eric J Velazquez; John J V McMurray; Lars Kober; Marc A Pfeffer; Robert M Califf; Scott D Solomon
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
JACC. Cardiovascular imaging 2008;1(5):582-91.
2008: P Brian Smith; Daniel K Benjamin; M Dianne Murphy; Rosemary Johann-Liang; Solomon Iyasu; Barbara Gould; Robert M Califf; Jennifer S Li; William Rodriguez
Safety monitoring of drugs receiving pediatric marketing exclusivity.
Pediatrics 2008;122(3):e628-33.
2008: Emmanouil Brilakis; James A de Lemos; Christopher P Cannon; Stephen D Wiviott; Sabina A Murphy; David A Morrow; Marc S Sabatine; Subhash Banerjee; Michael A Blazing; Robert M Califf; Eugene Braunwald
Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials).
The American journal of cardiology 2008;102(5):552-8.
2008: James M Yau; John H Alexander; Gail E Hafley; Kenneth W Mahaffey; Michael J Mack; Nicholas T Kouchoukos; Abhinav Goyal; eric peterson; C Michael Gibson; Robert M Califf; Robert A Harrington; T. Bruce Ferguson
Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV).
The American journal of cardiology 2008;102(5):546-51.
2008: Shelby D Reed; Kevin J Anstrom; Damon M Seils; Robert M Califf; Kevin Schulman
Use of larger versus smaller drug-safety databases before regulatory approval: the trade-offs.
Health affairs (Project Hope) 2008;27(5):w360-70.
2008: K A Payne; Jaime Caro; W L Daley; Z M Khan; K J Ishak; K Stark; D Purkayastha; John M Flack; E Velázquez; S Nesbitt; D Morisky; Robert M Califf
The design of an observational study of hypertension management, adherence and pressure control in Blood Pressure Success Zone Program participants.
International journal of clinical practice 2008;62(9):1313-21.
2008: Lynda A Szczech; Huiman X Barnhart; Jula K Inrig; Donal N Reddan; Shelly Sapp; Robert M Califf; Uptal D Patel; Ajay K Singh
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.
Kidney international 2008;74(6):791-8.
2008: J S Li; Carissa Marrie Baker-Smith; P B Smith; V Hasselblad; M D Murphy; Robert M Califf; D K Benjamin
Racial differences in blood pressure response to angiotensin-converting enzyme inhibitors in children: a meta-analysis.
Clinical pharmacology and therapeutics 2008;84(3):315-9.
2008: Kevin J Anstrom; David F Kong; Linda K Shaw; Robert M Califf; Judith M Kramer; eric peterson; Sunil V Rao; David B Matchar; Daniel B Mark; Robert A Harrington; Eric L Eisenstein
Long-term clinical outcomes following coronary stenting.
Archives of internal medicine 2008;168(15):1647-55.
2008: Mark Y Chan; Kenneth W Mahaffey; Lena J Sun; Karen S Pieper; Harvey D White; Philip E Aylward; James J Ferguson; Robert M Califf; Matthew T Roe
Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease.
JACC. Cardiovascular interventions 2008;1(4):369-78.
2008: Sunil V Rao; Robert M Califf; Judith M Kramer; eric peterson; Thomas P Gross; Carl J Pepine; David O Williams; Dennis Donohoe; Ron Waksman; Roxana Mehran; Mitchell W Krucoff
Postmarket evaluation of breakthrough technologies.
American heart journal 2008;156(2):201-8.
2008: Robert M Califf; Judith M Kramer
The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessment.
Pharmacoepidemiology and drug safety 2008;17(8):782-6.
2008: Renato D Lopes; Karen P Alexander; Gretchen Marcucci; Harvey D White; Sarah Spinler; Jacques Col; Philip E Aylward; Robert M Califf; Kenneth W Mahaffey
Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial.
European heart journal 2008;29(15):1827-33.
2008: Matthew T Roe; Anita Y Chen; Elizabeth R DeLong; William E Boden; James E Calvin; Charles Cairns; Sidney C Smith; Charles V Pollack; Ralph G Brindis; Robert M Califf; W Brian Gibler; Erik Ohman; eric peterson
Patterns of transfer for patients with non-ST-segment elevation acute coronary syndrome from community to tertiary care hospitals.
American heart journal 2008;156(1):185-92.
2008: Steve Leung; Dianne Gallup; Kenneth W Mahaffey; Marc Cohen; Elliott M Antman; Shaun G Goodman; Robert A Harrington; Anatoly Langer; Philip Aylward; James J Ferguson; Robert M Califf
Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.
American heart journal 2008;156(1):177-84.
2008: Jonathan P Piccini; Manesh R Patel; Kenneth W Mahaffey; Keith A A Fox; Robert M Califf
Rivaroxaban, an oral direct factor Xa inhibitor.
Expert opinion on investigational drugs 2008;17(6):925-37.
2008: Louis Michael Prisant; Kevin L Thomas; Eldrin F Lewis; Zhen Huang; Gary S Francis; W Douglas Weaver; Marc A Pfeffer; John J V McMurray; Robert M Califf; Eric J Velazquez
Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both.
Journal of the American College of Cardiology 2008;51(19):1865-71.
2008: Liviu Klein; Barry M Massie; Jeffrey D Leimberger; Christopher M O'Connor; Ileana L Piña; Kirkwood F Adams; Robert M Califf; Mihai Gheorghiade
Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
Circulation. Heart failure 2008;1(1):25-33.
2008: Derek P Chew; Kenneth W Mahaffey; Harvey D White; Zhen Huang; James W Hoekstra; James J Ferguson; Robert M Califf; Philip E Aylward
Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict.
American heart journal 2008;155(5):841-7.
2008: Kevin Jackson; Bernard J Gersh; Norman Stockbridge; Thomas R Fleming; Robert Temple; Robert M Califf; Stuart J Connolly; Lars Wallentin; Christopher B Granger
Antithrombotic drug development for atrial fibrillation: proceedings, Washington, DC, July 25-27, 2005.
American heart journal 2008;155(5):829-40.
2008: Richard P Konstance; Eric L Eisenstein; Kevin J Anstrom; Linda K Shaw; Robert M Califf; Robert A Harrington; David B Matchar; Kevin Schulman; David F Kong
Outcomes of second revascularization procedures after stent implantation.
Journal of medical systems 2008;32(2):177-86.
2008: Anju Nohria; Vic Hasselblad; Amanda Stebbins; Daniel F Pauly; Gregg C Fonarow; Monica Shah; Clyde W Yancy; Robert M Califf; Lynne Warner Stevenson; James A Hill
Cardiorenal interactions: insights from the ESCAPE trial.
Journal of the American College of Cardiology 2008;51(13):1268-74.
2008: Monica R Shah; David Whellan; Eric D Peterson; Anju Nohria; Vic Hasselblad; Zhenyi Xue; Margaret T Bowers; Christopher M O'Connor; Robert M Califf; Lynne Warner Stevenson
Delivering heart failure disease management in 3 tertiary care centers: key clinical components and venues of care.
American heart journal 2008;155(4):764.e1-5.
2008: Lisa M Mielniczuk; Marc A Pfeffer; Eldrin F Lewis; Michael A Blazing; James A de Lemos; Amy Shui; Satish Mohanavelu; Robert M Califf; Eugene Braunwald
Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome.
American heart journal 2008;155(4):725-31.
2008: Rachel E Anderson; Marc A Pfeffer; Jens jakob Thune; John J V McMurray; Robert M Califf; Eric J Velazquez; Harvey D White; Jean-Lucien Rouleau; Hicham Skali; Aldo Maggioni; Scott D Solomon
High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
American heart journal 2008;155(4):706-11.
2008: Patricia J M Best; Steven R Steinhubl; Peter B Berger; Arijit Dasgupta; Danielle M Brennan; Lynda A Szczech; Robert M Califf; Eric J Topol
The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
American heart journal 2008;155(4):687-93.
2008: J Lloyd Michener; Susan Yaggy; Michelle Lyn; Samuel Warburton; Mary Champagne; MaryAnn Black; Michael Cuffe; Robert M Califf; Catherine Gilliss; R Sanders Williams; Victor J Dzau
Improving the health of the community: Duke's experience with community engagement.
Academic medicine : journal of the Association of American Medical Colleges 2008;83(4):408-13.
2008: Nagesh S Anavekar; Scott D Solomon; John J V McMurray; Aldo Maggioni; Jean-Lucien Rouleau; Robert M Califf; Harvey White; Lars Kober; Eric J Velazquez; Marc A Pfeffer
Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus.
The American journal of cardiology 2008;101(7):925-9.
2008: Rajendra H Mehta; Sunil V Rao; Erik Ohman; Eric R Bates; Gretchen Marcucci; Min Zhang; Karen S Pieper; Paul W Armstrong; Harvey D White; Frans Van de Werf; Robert M Califf; Christopher B Granger
Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb.
European heart journal 2008;29(7):880-7.
2008: Daniel K Benjamin; P Brian Smith; Pravin Jadhav; Jogarao V S Gobburu; M Dianne Murphy; Vic Hasselblad; Carissa Marrie Baker-Smith; Robert M Califf; Jennifer S Li
Pediatric antihypertensive trial failures: analysis of end points and dose range.
Hypertension 2008;51(4):834-40.
2008: P Brian Smith; Jennifer S Li; M Dianne Murphy; Robert M Califf; Daniel K Benjamin
Safety of placebo controls in pediatric hypertension trials.
Hypertension 2008;51(4):829-33.
2008: Robert M Califf
Review: PCI has lower risk for procedural stroke but higher risks for angina and repeated revascularization than CABG.
ACP journal club 2008;148(2):44.
2008: Eldrin F Lewis; Eric J Velazquez; Scott D Solomon; Anne S Hellkamp; John J V McMurray; Jasmine Mathias; Jean-Lucien Rouleau; Aldo P Maggioni; Karl Swedberg; Lars Kober; Harvey White; Anthony J Dalby; Gary S Francis; Faiez Zannad; Robert M Califf; Marc A Pfeffer
Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.
European heart journal 2008;29(6):748-56.
2008: Nagesh S Anavekar; Hicham Skali; Mikhail Bourgoun; Jalal K Ghali; Lars Kober; Aldo P Maggioni; john mcmurray; Eric J Velazquez; Robert M Califf; Marc A Pfeffer; Scott D Solomon
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study).
The American journal of cardiology 2008;101(5):607-12.
2008: E Marc Jolicoeur; Erik Ohman; Robert Temple; Norman Stockbridge; Sidney Smith; Daniel Mark; Robert M Califf; Timothy D Henry; Bernard R Chaitman; Christopher B Granger
Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues.
American heart journal 2008;155(3):435-44.
2008: Kenneth W Mahaffey; Qinghong Yang; Karen S Pieper; Elliott M Antman; Harvey D White; Shaun G Goodman; Marc Cohen; Neal S Kleiman; Anatoly Langer; Philip E G Aylward; Jacques J Col; Craig J Reist; James J Ferguson; Robert M Califf
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.
Journal of general internal medicine 2008;23(3):310-6.
2008: Stephen A Olenchock; Dimitri Karmpaliotis; William Gibson; Sabina A Murphy; Matthew C Southard; Lauren N Ciaglo; Jacqueline Buros; Michael J Mack; John H Alexander; Robert A Harrington; Robert M Califf; Nicholas T Kouchoukos; T. Bruce Ferguson; C Michael Gibson
Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters.
The Annals of thoracic surgery 2008;85(2):520-4.
2008: Mitchell J Magee; John H Alexander; Gail E Hafley; T. Bruce Ferguson; C Michael Gibson; Robert A Harrington; Eric D Peterson; Robert M Califf; Nicholas T Kouchoukos; Morley A Herbert; Michael J Mack
Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV.
The Annals of thoracic surgery 2008;85(2):494-9; discussion 499-500.
2008: Sunil V Rao; Padma Kaul; Lawrence Liao; Paul W Armstrong; Erik Ohman; Christopher B Granger; Robert M Califf; Robert A Harrington; Eric L Eisenstein; Daniel B Mark
Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes.
American heart journal 2008;155(2):369-74.
2008: Derek P Chew; Zhen Huang; Karen S Pieper; Harvey White; Kenneth W Mahaffey; James J Ferguson; Robert M Califf; Philip G Aylward
Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.
American heart journal 2008;155(2):239-44.
2008: Jeffrey S Berger; Amanda L Stebbins; Christopher B Granger; Erik Ohman; Paul W Armstrong; Frans Van de Werf; Harvey D White; R John Simes; Robert A Harrington; Robert M Califf; Eric D Peterson
Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy.
Circulation 2008;117(2):192-9.
2008: Kevin P Weinfurt; Damon M Seils; Janice P Tzeng; Li Lin; Kevin Schulman; Robert M Califf
Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents.
PloS one 2008;3(5):e2128.
2008: Eric L Eisenstein; Rory Collins; Beena S Cracknell; Oscar Podesta; Elizabeth D Reid; Peter Sandercock; Yuriy Shakhov; Michael L Terrin; Mary Ann Sellers; Robert M Califf; Christopher B Granger; Rafael Diaz
Sensible approaches for reducing clinical trial costs.
Clinical trials (London, England) 2008;5(1):75-84.
2008: Salim Yusuf; Jackie Bosch; Philip J Devereaux; Philip J Devereaus; Rory Collins; Colin Baigent; Christopher Granger; Robert M Califf; Robert Temple
Sensible guidelines for the conduct of large randomized trials.
Clinical trials (London, England) 2008;5(1):38-9.
2008: Robert A Harrington; Vic Hasselblad; Robert M Califf
Defining and utilizing surrogates in the evaluation of coronary stents: what do we really want and need to know?
Journal of the American College of Cardiology 2008;51(1):33-6.
2008: Sunil V Rao; Karen Chiswell; Jie Lena Sun; Christopher B Granger; L Kristin Newby; Frans Van de Werf; Harvey D White; Paul W Armstong; Robert M Califf; Robert A Harrington
International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes.
The American journal of cardiology 2008;101(1):25-29.
2008: Kevin L Thomas; Sana M Al-Khatib; Yuliya Lokhnygina; Scott D Solomon; Lars Kober; john mcmurray; Robert M Califf; Eric J Velazquez
Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.
American heart journal 2008;155(1):87-93.
2008: Jens jakob Thune; James Signorovitch; Lars Kober; Eric J Velazquez; john mcmurray; Robert M Califf; Aldo P Maggioni; Jean-Lucien Rouleau; Jonathan Howlett; Steven Zelenkofske; Marc A Pfeffer; Scott D Solomon
Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.
Hypertension 2008;51(1):48-54.
2007: Pierluigi Tricoci; Yuliya Lokhnygina; Lisa G Berdan; Steven R Steinhubl; Dietrich C Gulba; Harvey D White; Neal S Kleiman; Philip E G Aylward; Anatoly Langer; Robert M Califf; James J Ferguson; Elliott M Antman; L Kristin Newby; Robert A Harrington; Shaun G Goodman; Kenneth W Mahaffey
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
Circulation 2007;116(23):2669-77.
2007: Sana M Al-Khatib; Linda K Shaw; Christopher O'Connor; Melissa Kong; Robert M Califf
Incidence and predictors of sudden cardiac death in patients with diastolic heart failure.
Journal of cardiovascular electrophysiology 2007;18(12):1231-5.
2007: James A de Lemos; David A Morrow; Michael A Blazing; Petr Jarolim; Stephen D Wiviott; Marc S Sabatine; Robert M Califf; Eugene Braunwald
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.
Journal of the American College of Cardiology 2007;50(22):2117-24.
2007: Robert M Califf; Rajendra H Mehta; eric peterson
Clinical quality in non-ST-elevation acute coronary syndromes.
The American journal of medicine 2007;120(11):930-5.
2007: Monica R Shah; Vic Hasselblad; Gudaye Tasissa; Robert H Christenson; Cynthia Binanay; Christopher M O'Connor; Erik Ohman; Lynne Warner Stevenson; Robert M Califf
Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial).
The American journal of cardiology 2007;100(9):1427-33.
2007: Daniel B Mark; Frans Van de Werf; R John Simes; Harvey D White; Lars Wallentin; Robert M Califf; Paul W Armstrong
Cardiovascular disease on a global scale: defining the path forward for research and practice.
European heart journal 2007;28(21):2678-84.
2007: Mandeep Singh; Jennifer White; David Hasdai; Patricia K Hodgson; Peter B Berger; Eric J Topol; Robert M Califf; David R Holmes
Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial.
Journal of the American College of Cardiology 2007;50(18):1752-8.
2007: Elliott Bennett-Guerrero; Tim H Veldman; Allan doctor; Marilyn J Telen; Thomas L Ortel; T Scott Reid; Melissa A Mulherin; Hongmei Zhu; Raymond D Buck; Robert M Califf; Timothy J McMahon
Evolution of adverse changes in stored RBCs.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(43):17063-8.
2007: Sabina A Murphy; Christopher P Cannon; Stephen D Wiviott; James A de Lemos; Michael A Blazing; Carolyn H McCabe; Robert M Califf; Eugene Braunwald
Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
The American journal of cardiology 2007;100(7):1047-51.
2007: Rajendra H Mehta; Adam B Greenbaum; Yuliya Lokhnygina; L Kristin Newby; Frans Van de Werf; Paul W Armstrong; Karen S Pieper; Robert M Califf; Christopher B Granger; Robert A Harrington
Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials.
Journal of interventional cardiology 2007;20(5):299-306.
2007: Vic Hasselblad; Wendy Gattis-Stough; Monica R Shah; Yuliya Lokhnygina; Christopher M O'Connor; Robert M Califf; Kirkwood F Adams
Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial.
European journal of heart failure 2007;9(10):1064-9.
2007: Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette K Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Jonathan L Halperin; Sharon Ann Hunt; Harlan Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.
Journal of the American College of Cardiology 2007;50(7):e1-e157.
2007: Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette K Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Jonathan L Halperin; Sharon Ann Hunt; Harlan Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.
Circulation 2007;116(7):e148-304.
2007: Cheuk-Kit Wong; L Kristin Newby; Manju V Bhapker; Phil E Aylward; Matthias Pfisterer; Karen P Alexander; Paul W Armstrong; Judith S Hochman; Frans Van de Werf; Robert M Califf; Harvey D White
Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials.
American heart journal 2007;154(2):313-21.
2007: Cynthia M Westerhout; Judy Gnarpe; Wei-Ching Chang; Susan FitzPatrick; Elliot S Barnathan; eric boersma; Robert M Califf; Lars Wallentin; Maarten L Simoons; Paul W Armstrong
No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial.
American heart journal 2007;154(2):306-12.
2007: Hugh Tilson; L K Madre; Robert M Califf
Role of the centers for education and research on therapeutics (CERTs) in pharmacovigilance and proper use of therapeutics.
Clinical pharmacology and therapeutics 2007;82(2):118-21.
2007: Jennifer S Li; Eric Yow; Katherine Y Berezny; John F Rhodes; Paula M Bokesch; John R Charpie; Geoffrey A Forbus; Lynn Mahony; Lynn K Boshkov; Virginie Lambert; Damien Bonnet; Ina Michel-Behnke; Thomas P Graham; Masato Takahashi; James Jaggers; Robert M Califf; Amit Rakhit; Sylvie Fontecave; Stephen P Sanders
Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference?
Circulation 2007;116(3):293-7.
2007: Wei Jiang; Maragatha Kuchibhatla; Greg L Clary; Michael S Cuffe; Eric J Christopher; Jude D Alexander; Robert M Califf; Ranga R Krishnan; Christopher M O'Connor
Relationship between depressive symptoms and long-term mortality in patients with heart failure.
American heart journal 2007;154(1):102-8.
2007: Alejandro Barbagelata; Eduardo Perna; Peter Clemmensen; Barry F Uretsky; Juan P Cimbaro Canella; Robert M Califf; Christopher B Granger; George L Adams; ramanna merla; Yochai Birnbaum
Time to reperfusion in acute myocardial infarction. It is time to reduce it!
Journal of electrocardiology 2007;40(3):257-64.
2007: Gillian D Sanders; Sana M Al-Khatib; Elise Berliner; J Thomas Bigger; Alfred E Buxton; Robert M Califf; Mark Carlson; Anne B Curtis; Jeptha P Curtis; Michael Domanski; Eric Fain; Bernard J Gersh; Michael R Gold; Jeffrey Goldberger; Ali Haghighi-Mood; Stephen C Hammill; Joel Harder; Jeff Healey; Mark A Hlatky; Stefan H Hohnloser; Kerry L Lee; Daniel B Mark; Brent Mitchell; Steve Phurrough; Eric N Prystowsky; Joseph M Smith; Norman Stockbridge; Robert Temple
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy.
American heart journal 2007;153(6):951-9.
2007: Sana M Al-Khatib; Gillian D Sanders; J Thomas Bigger; Alfred E Buxton; Robert M Califf; Mark Carlson; Anne Curtis; Jeptha Curtis; Eric Fain; Bernard J Gersh; Michael R Gold; Ali Haghighi-Mood; Stephen C Hammill; Jeff Healey; Mark Hlatky; Stefan H Hohnloser; Raymond J Kim; Kerry Lee; Daniel Mark; Marcus Mianulli; Brent Mitchell; Eric N Prystowsky; Joseph Smith; David Steinhaus; Wojciech Zareba
Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death.
American heart journal 2007;153(6):941-50.
2007: Rajendra H Mehta; eric peterson; Robert M Califf
Performance measures have a major effect on cardiovascular outcomes: a review.
The American journal of medicine 2007;120(5):398-402.
2007: Sunil V Rao; John A Eikelboom; Christopher B Granger; Robert A Harrington; Robert M Califf; Jean-Pierre Bassand
Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes.
European heart journal 2007;28(10):1193-204.
2007: Chadwick D Miller; Anindita Banerjee; Kenneth W Mahaffey; Michael C Kontos; Gregory Fermann; Charles V Pollack; Elliott M Antman; Philip E G Aylward; Shaun G Goodman; Renato Santos; James J Ferguson; Robert M Califf; James W Hoekstra
Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial.
European heart journal 2007;28(9):1079-84.
2007: Aslan T Turer; Kenneth W Mahaffey; Kate L Compton; Robert M Califf; Kevin Schulman
Publication or presentation of results from multicenter clinical trials: evidence from an academic medical center.
American heart journal 2007;153(4):674-80.
2007: Adrián V Hernández; Cynthia M Westerhout; Ewout W Steyerberg; John Ioannidis; Hector BUENO; Harvey White; Pierre Theroux; David J Moliterno; Paul W Armstrong; Robert M Califf; Lars Wallentin; Maarten L Simoons; eric boersma
Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups.
Heart (British Cardiac Society) 2007;93(4):450-5.
2007: Rajendra H Mehta; Robert M Califf; Qinghong Yang; Karen S Pieper; Harvey D White; Erik Ohman; Robert A Harrington; Christopher B Granger
Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock.
The American journal of cardiology 2007;99(6):793-6.
2007: Kent Stephenson; Hicham Skali; john mcmurray; Eric J Velazquez; Philip G Aylward; Lars Kober; Frans Van de Werf; Harvey D White; Karen Pieper; Robert M Califf; Scott D Solomon; Marc A Pfeffer
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.
Heart rhythm : the official journal of the Heart Rhythm Society 2007;4(3):308-13.
2007: M Angelyn Bethel; Robert M Califf
Role of lifestyle and oral anti-diabetic agents to prevent type 2 diabetes mellitus and cardiovascular disease.
The American journal of cardiology 2007;99(5):726-31.
2007: J Scott Rankin; Robert H Tuttle; Andrew S Wechsler; Tracey L Teichmann; Donald D Glower; Robert M Califf
Techniques and benefits of multiple internal mammary artery bypass at 20 years of follow-up.
The Annals of thoracic surgery 2007;83(3):1008-14; discussion 1014-5.
2007: Abhinav Goyal; John H Alexander; Gail E Hafley; Stacy H Graham; Rajendra H Mehta; Michael J Mack; Randall K Wolf; Lawrence H Cohn; Nicholas T Kouchoukos; Robert A Harrington; Daniel Gennevois; C Michael Gibson; Robert M Califf; T. Bruce Ferguson; eric peterson
Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
The Annals of thoracic surgery 2007;83(3):993-1001.
2007: Kai C Wollert; Tibor Kempf; Timo Peter; Sylvia Olofsson; Stefan James; Nina Johnston; Bertil Lindahl; Rüdiger Horn-Wichmann; Georg Brabant; Maarten L Simoons; Paul W Armstrong; Robert M Califf; Helmut Drexler; Lars Wallentin
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.
Circulation 2007;115(8):962-71.
2007: Jennifer S Li; Eric L Eisenstein; Henry G Grabowski; Elizabeth D Reid; Barry Mangum; Kevin Schulman; John V Goldsmith; M Dianne Murphy; Robert M Califf; Daniel K Benjamin
Economic return of clinical trials performed under the pediatric exclusivity program.
JAMA : the journal of the American Medical Association 2007;297(5):480-8.
2007: Kenneth W Mahaffey; Matthew T Roe; Rakhi Kilaru; John H Alexander; Frans Van de Werf; Robert M Califf; Maarten L Simoons; Eric J Topol; Robert A Harrington
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials.
European heart journal 2007;28(4):425-32.
2007: Melvin R Echols; Kenneth W Mahaffey; Anindita Banerjee; Karen S Pieper; Amanda L Stebbins; Alexandra Lansky; Mauricio G. Cohen; Eric Velazquez; Renato Santos; L Kristin Newby; Enrique P Gurfinkel; Luigi Biasucci; James J Ferguson; Robert M Califf
Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial).
The American journal of cardiology 2007;99(3):315-21.
2007: Rajendra H Mehta; Robert M Califf; Jyotsna Garg; Harvey D White; Frans Van de Werf; Paul W Armstrong; Karen S Pieper; Eric J Topol; Christopher B Granger
The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction.
European heart journal 2007;28(4):415-24.
2007: Eric L Eisenstein; Kevin J Anstrom; David F Kong; Linda K Shaw; Robert H Tuttle; Daniel B Mark; Judith M Kramer; Robert A Harrington; David B Matchar; David E Kandzari; eric peterson; Kevin Schulman; Robert M Califf
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.
JAMA : the journal of the American Medical Association 2007;297(2):159-68.
2007: Robert M Califf; Robert A Harrington; Leanne K Madre; eric peterson; Deborah Roth; Kevin Schulman
Curbing the cardiovascular disease epidemic: aligning industry, government, payers, and academics.
Health affairs (Project Hope) 2007;26(1):62-74.
2007: Warren J Cantor; Kenneth W Mahaffey; Zhen Huang; Pranab Das; Dietrich C Gulba; Stanislav Glezer; Richard Gallo; John Ducas; Marc Cohen; Elliott M Antman; Anatoly Langer; Neal S Kleiman; Harvey D White; Robert J Chisholm; Robert A Harrington; James J Ferguson; Robert M Califf; Shaun G Goodman
Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;69(1):73-83.
2007: Robert M Califf
Benefit assessment of therapeutic products: the Centers for Education and Research on Therapeutics.
Pharmacoepidemiology and drug safety 2007;16(1):5-16.
2006: Robert A Harrington; Robert M Califf
Late ischemic events after clopidogrel cessation following drug-eluting stenting: should we be worried?
Journal of the American College of Cardiology 2006;48(12):2592-5.
2006: Melvin R Echols; G Michael Felker; Kevin L Thomas; Karen S Pieper; Jyotsna Garg; Michael S Cuffe; Mihai Gheorghiade; Robert M Califf; Christopher M O'Connor
Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trial.
Journal of cardiac failure 2006;12(9):684-8.
2006: Harvey D White; Neal S Kleiman; Kenneth W Mahaffey; Yuliya Lokhnygina; Karen S Pieper; Karen Chiswell; Marc Cohen; Robert A Harrington; Derek P Chew; John L Petersen; Lisa G Berdan; Philip E G Aylward; Christopher C. Nessel; James J Ferguson; Robert M Califf
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
American heart journal 2006;152(6):1042-50.
2006: Cynthia M Westerhout; Adrián V Hernández; Ewout W Steyerberg; Hector BUENO; Harvey White; Pierre Théroux; David J Moliterno; Paul W Armstrong; Robert M Califf; Lars Wallentin; Maarten L Simoons; eric boersma
Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes.
European heart journal 2006;27(24):2956-61.
2006: Rajendra H Mehta; Matthew T Roe; Anita Y Chen; Barbara L Lytle; Charles V Pollack; Ralph G Brindis; Sidney C Smith; Robert A Harrington; Dan Fintel; Elizabeth S Fraulo; Robert M Califf; W Brian Gibler; Erik Ohman; eric peterson
Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
Archives of internal medicine 2006;166(18):2027-34.
2006: Marc Cohen; Kenneth W Mahaffey; Karen Pieper; Charles V Pollack; Elliott M Antman; James Hoekstra; Shaun G Goodman; Anatoly Langer; Jacques J Col; Harvey D White; Robert M Califf; James J Ferguson
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes.
Journal of the American College of Cardiology 2006;48(7):1346-54.
2006: Peter K Smith; Robert M Califf; Robert H Tuttle; Linda K Shaw; Kerry L Lee; Elizabeth R DeLong; R Eric Lilly; Michael H Sketch; eric peterson; Robert H Jones
Selection of surgical or percutaneous coronary intervention provides differential longevity benefit.
The Annals of thoracic surgery 2006;82(4):1420-8; discussion 1428-9.
2006: Karina W Davidson; David J Kupfer; J Thomas Bigger; Robert M Califf; Robert M Carney; James C Coyne; Susan M Czajkowski; Ellen Frank; Nancy Frasure-Smith; Kenneth E Freedland; Erika S Froelicher; Alexander H Glassman; Wayne J Katon; Peter G Kaufmann; Ronald C Kessler; Helena C Kraemer; K Ranga Rama Krishnan; François Lespérance; Nina Rieckmann; David S Sheps; Jerry M Suls
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute working group report.
Annals of behavioral medicine : a publication of the Society of Behavioral Medicine 2006;32(2):121-6.
2006: Lars Køber; Karl Swedberg; john mcmurray; Marc A Pfeffer; Eric J Velazquez; Rafael Diaz; Aldo P Maggioni; Viatcheslav Mareev; Grzegorz Opolski; Frans Van de Werf; Faiez Zannad; Georg Ertl; Scott D Solomon; Steven Zelenkofske; Jean-Lucien Rouleau; Jeffrey D Leimberger; Robert M Califf
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction.
European journal of heart failure 2006;8(6):591-8.
2006: Stefan K James; Johan Lindbäck; Johanna Tilly; Agneta Siegbahn; Per Venge; Paul Armstrong; Robert M Califf; Maarten L Simoons; Lars Wallentin; Bertil Lindahl
Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy.
Journal of the American College of Cardiology 2006;48(6):1146-54.
2006: James A de Lemos; Stephen D Wiviott; Sabina A Murphy; Michael A Blazing; Eldrin F Lewis; Robert M Califf; Marc A Pfeffer; Eugene Braunwald
Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trial.
The American journal of cardiology 2006;98(6):739-42.
2006: Daniel K Benjamin; Philip Brian Smith; M Dianne Murphy; Rosemary Roberts; Lisa Mathis; Debbie Avant; Robert M Califf; Jennifer S Li
Peer-reviewed publication of clinical trials completed for pediatric exclusivity.
JAMA : the journal of the American Medical Association 2006;296(10):1266-73.
2006: Cynthia M Westerhout; Yuling Fu; Michael Lauer; Stefan James; Paul W Armstrong; Eyad Al-Hattab; Robert M Califf; Maarten L Simoons; Lars Wallentin; eric boersma
Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers.
Journal of the American College of Cardiology 2006;48(5):939-47.
2006: Karina W Davidson; David J Kupfer; J Thomas Bigger; Robert M Califf; Robert M Carney; James C Coyne; Susan M Czajkowski; Ellen Frank; Nancy Frasure-Smith; Kenneth E Freedland; Erika S Froelicher; Alexander H Glassman; Wayne J Katon; Peter G Kaufmann; Ronald C Kessler; Helena C Kraemer; K Ranga Rama Krishnan; François Lespérance; Nina Rieckmann; David S Sheps; Jerry M Suls
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report.
Psychosomatic medicine 2006;68(5):645-50.
2006: Shelby D Reed; Robert M Califf; Kevin Schulman
How changes in drug-safety regulations affect the way drug and biotech companies invest in innovation.
Health affairs (Project Hope) 2006;25(5):1309-17.
2006: Jennifer Rubin Grandis; James F Battey; Robert M Califf; Richard A Chole; Bruce J Gantz; George A Gates; Lester Gorelic; Maureen Hannley; Kevin S Hardwick; Jeffrey P Harris; Wishwa N Kapoor; Stephen Y Lai; Anil K Lalwani; Lloyd B Minor; Joseph P Nadol; J Christopher Post; Peter S Roland; Alan M Schechter; David E Schuller; Daniel A Sklare; P Ashley Wackym; Randal S Weber; Ernest A Weymuller; Gregory T Wolf; Gayle E Woodson
Research education and training in otolaryngology: meeting summary and research opportunities.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2006;135(3):361-7.
2006: Shelby D Reed; john mcmurray; Eric J Velazquez; Kevin Schulman; Robert M Califf; Lars Kober; Aldo P Maggioni; Frans Van de Werf; Harvey D White; Rafael Diaz; Viatcheslav Mareev; Jan Murin
Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
American heart journal 2006;152(3):500-8.
2006: Sharad Menon; Katherine Y Berezny; Rakhi Kilaru; Daniel K Benjamin; Joseph D Kay; Lydie Hazan; Ronald Portman; Ronald Hogg; David Deitchman; Robert M Califf; Jennifer S Li
Racial differences are seen in blood pressure response to fosinopril in hypertensive children.
American heart journal 2006;152(2):394-9.
2006: David Whellan; Robert H Tuttle; Eric J Velazquez; Linda K Shaw; James G Jollis; Wendell Ellis; Christopher M O'Connor; Robert M Califf; Salvador Borges-Neto
Predicting significant coronary artery disease in patients with left ventricular dysfunction.
American heart journal 2006;152(2):340-7.
2006: Shaun G Goodman; Yuling Fu; Anatoly Langer; Aiala Barr; Mary Tan; Galen S Wagner; Alejandro Barbagelata; Elena B Sgarbossa; Yochai Birnbaum; Christopher B Granger; Robert M Califf; Frans Van de Werf; Eric J Topol; Paul W Armstrong
The prognostic value of the admission and predischarge electrocardiogram in acute coronary syndromes: the GUSTO-IIb ECG Core Laboratory experience.
American heart journal 2006;152(2):277-84.
2006: David A Morrow; James A de Lemos; Marc S Sabatine; Stephen D Wiviott; Michael A Blazing; Amy Shui; Nader Rifai; Robert M Califf; Eugene Braunwald
Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial.
Circulation 2006;114(4):281-8.
2006: Rajendra H Mehta; Emily Honeycutt; eric peterson; Christopher B Granger; Abdul R Halabi; Linda K Shaw; Peter K Smith; Robert M Califf; Robert A Harrington; Michael H Sketch
Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft.
Circulation 2006;114(1 Suppl):I396-401.
2006: Rajesh Janardhanan; Satish Kenchaiah; Eric J Velazquez; Yuhyun Park; john mcmurray; W Douglas Weaver; Peter V Finn; Harvey D White; José Antonio Marin-Neto; Chris O'Connor; Marc A Pfeffer; Robert M Califf; Scott D Solomon
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
American heart journal 2006;152(1):183-9.
2006: Robert M Califf
Evaluation of diagnostic imaging technologies and therapeutics devices: better information for better decisions: proceedings of a multidisciplinary workshop.
American heart journal 2006;152(1):50-8.
2006: Karen P Alexander; L Kristin Newby; Manjushri Bhapkar; Harvey D White; Judith S Hochman; Matthias E Pfisterer; David J Moliterno; eric peterson; Frans Van de Werf; Paul W Armstrong; Robert M Califf
International variation in invasive care of the elderly with acute coronary syndromes.
European heart journal 2006;27(13):1558-64.
2006: Matthew T Roe; eric peterson; L Kristin Newby; Anita Y Chen; Charles V Pollack; Ralph G Brindis; Robert A Harrington; Robert H Christenson; Sidney C Smith; Robert M Califf; Eugene Braunwald; W Brian Gibler; Erik Ohman
The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes.
American heart journal 2006;151(6):1205-13.
2006: Cheryl D Bushnell; Jeffrey Griffin; L Kristin Newby; Larry B Goldstein; Kenneth W Mahaffey; Carmelo Graffagnino; Robert A Harrington; Harvey D White; R John Simes; Robert M Califf; Eric J Topol; J Donald Easton
Statin use and sex-specific stroke outcomes in patients with vascular disease.
Stroke; a journal of cerebral circulation 2006;37(6):1427-31.
2006: Nancy M Allen LaPointe; Elizabeth R DeLong; Anita Chen; Bradley G Hammill; Lawrence H Muhlbaier; Robert M Califf; Judith M Kramer
Multifaceted intervention to promote beta-blocker use in heart failure.
American heart journal 2006;151(5):992-8.
2006: J Conor O'Shea; Robert M Califf
24-hour ambulatory blood pressure monitoring.
American heart journal 2006;151(5):962-8.
2006: Padma Kaul; Wei-Ching Chang; A Michael Lincoff; Philip E Aylward; Amadeo Betriu; Christoph Bode; Robert M Califf; Erik Ohman; Victor Guetta; Philippe Gabriel STEG; Frans Van de Werf; Paul W Armstrong
Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial.
European heart journal 2006;27(10):1198-206.
2006: Colin B Begg; Otis W Brawley; Robert M Califf; David L DeMets; Susan S Ellenberg; Richard S. Kaplan
Marketing drugs too early in testing.
Science (New York, N.Y.) 2006;312(5771):195.
2006: Robert M Califf
Fondaparinux in ST-segment elevation myocardial infarction: the drug, the strategy, the environment, or all of the above?
JAMA : the journal of the American Medical Association 2006;295(13):1579-80.
2006: Stephen D Wiviott; James A de Lemos; Christopher P Cannon; Michael A Blazing; Sabina A Murphy; Carolyn H McCabe; Robert M Califf; Eugene Braunwald
A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.
Circulation 2006;113(11):1406-14.
2006: Manesh R Patel; Mark P Donahue; Peter W F Wilson; Robert M Califf
Clinical trial issues in weight-loss therapy.
American heart journal 2006;151(3):633-42.
2006: Andrés Orlandini; Rafael Díaz; Daniel Wojdyla; Karen Pieper; Frans Van de Werf; Christopher B Granger; Robert A Harrington; Eric Boersma; Robert M Califf; Paul Armstrong; Harvey White; R John Simes; Ernesto Andres Cesar Paolasso
Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes.
European heart journal 2006;27(5):527-33.
2006: Sunil V Rao; Kristi O'Grady; Karen S Pieper; Christopher B Granger; L Kristin Newby; Kenneth W Mahaffey; David J Moliterno; A Michael Lincoff; Paul W Armstrong; Frans Van de Werf; Robert M Califf; Robert A Harrington
A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes.
Journal of the American College of Cardiology 2006;47(4):809-16.
2006: john mcmurray; Scott Solomon; Karen Pieper; Shelby Reed; Jean Rouleau; Eric J Velazquez; Harvey White; Jonathan G Howlett; Karl Swedberg; Aldo Maggioni; Lars Køber; Frans Van de Werf; Robert M Califf; Marc Pfeffer
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Journal of the American College of Cardiology 2006;47(4):726-33.
2006: Manesh R Patel; Trip J Meine; Lauren Lindblad; Jeffrey Griffin; Christopher B Granger; Richard C Becker; Frans Van de Werf; Harvey White; Robert M Califf; Robert A Harrington
Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction.
American heart journal 2006;151(2):316-22.
2006: L Kristin Newby; Nancy M Allen LaPointe; Anita Y Chen; Judith M Kramer; Bradley G Hammill; Elizabeth R DeLong; Lawrence H Muhlbaier; Robert M Califf
Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease.
Circulation 2006;113(2):203-12.
2006: Stefan K James; Bertil Lindahl; Jorik R Timmer; Jan Paul Ottervanger; Agneta Siegbahn; Mats Stridsberg; Paul Armstrong; Robert M Califf; Lars Wallentin; Maarten L Simoons
Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).
The American journal of cardiology 2006;97(2):167-72.
2006: Robert M Califf
Clinical trials bureaucracy: unintended consequences of well-intentioned policy.
Clinical trials (London, England) 2006;3(6):496-502.
2006: Robert M Califf
Translating clinical trials into practice.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2006;33(2):192-6.
2006: John F Heitner; Mat Lotfi; J Kevin Harrison; Christopher H Cabell; Igor Klem; Lesan Banko; Raymond J Kim; Robert M Califf
Where's the flap?
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2006;8(3):549-50.
2006: Rajendra H Mehta; David Marks; Robert M Califf; SeeHyang Sohn; Karen S Pieper; Frans Van de Werf; Eric D Peterson; Erik Ohman; Harvey D White; Eric J Topol; Christopher B Granger
Differences in the clinical features and outcomes in African Americans and whites with myocardial infarction.
The American journal of medicine 2006;119(1):70.e1-8.
2006: Teresa L Kauf; Eric J Velazquez; David R Crosslin; W Douglas Weaver; Rafael Diaz; Christopher B Granger; john mcmurray; Jean-Lucien Rouleau; Philip E Aylward; Harvey D White; Robert M Califf; Kevin Schulman
The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry.
American heart journal 2006;151(1):206-12.
2006: John M Galla; Kenneth W Mahaffey; Shelly K Sapp; John H Alexander; Matthew T Roe; Erik Ohman; Christopher B Granger; Paul W Armstrong; Robert A Harrington; Harvey D White; Maarten L Simoons; L Kristin Newby; Robert M Califf; Eric J Topol
Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.
American heart journal 2006;151(1):16-24.
2005: David A Morrow; James A de Lemos; Michael A Blazing; Marc S Sabatine; Sabina A Murphy; Petr Jarolim; Harvey D White; Keith A A Fox; Robert M Califf; Eugene Braunwald
Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease.
JAMA : the journal of the American Medical Association 2005;294(22):2866-71.
2005: Harvey D White; Philip E G Aylward; Zhen Huang; Anthony J Dalby; W Douglas Weaver; Ståle Barvik; José Antonio Marin-Neto; Jan Murin; Rolf O Nordlander; Wiek H van Gilst; Faiez Zannad; john mcmurray; Robert M Califf; Marc A Pfeffer
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Circulation 2005;112(22):3391-9.
2005: Kenneth W Mahaffey; Marc Cohen; Jyotsna Garg; Elliott M Antman; Neal S Kleiman; Shaun G Goodman; Lisa G Berdan; Craig J Reist; Anatoly Langer; Harvey D White; Philip E G Aylward; Jacques J Col; James J Ferguson; Robert M Califf
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial.
JAMA : the journal of the American Medical Association 2005;294(20):2594-600.
2005: John H Alexander; Gail E Hafley; Robert A Harrington; eric peterson; T. Bruce Ferguson; Todd J Lorenz; Abhinav Goyal; Michael Gibson; Michael J Mack; Daniel Gennevois; Robert M Califf; Nicholas T Kouchoukos
Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2005;294(19):2446-54.
2005: Monica R Shah; Karen A Claise; Margaret T Bowers; Manjushri Bhapkar; Julie Little; Anju Nohria; Laura H Gaulden; Vickie K McKee; Kara L Cozart; Karen L Mancinelli; Helen Daniels; Tesca Kinard; Lynne Warner Stevenson; Donna M Mancini; Christopher M O'Connor; Robert M Califf
Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE) trial.
American heart journal 2005;150(5):893-8.
2005: Sunil V Rao; Kristi O'Grady; Karen S Pieper; Christopher B Granger; L Kristin Newby; Frans Van de Werf; Kenneth W Mahaffey; Robert M Califf; Robert A Harrington
Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes.
The American journal of cardiology 2005;96(9):1200-6.
2005: Timothy J McMahon; Gregory S Ahearn; Martin P Moya; Andrew J Gow; Yuh-Chin T Huang; Benjamin P Luchsinger; Raphael Nudelman; Yun Yan; Abigail Krichman; Thomas M Bashore; Robert M Califf; David J Singel; Claude A Piantadosi; Victor F Tapson; Jonathan S Stamler
A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(41):14801-6.
2005: Adrian F Hernandez; Eric J Velazquez; Scott D Solomon; Rakhi Kilaru; Rafael Diaz; Christopher M O'Connor; George Ertl; Aldo P Maggioni; Jean-Lucien Rouleau; Wiek H van Gilst; Marc A Pfeffer; Robert M Califf
Left ventricular assessment in myocardial infarction: the VALIANT registry.
Archives of internal medicine 2005;165(18):2162-9.
2005: Monica R Shah; Vic Hasselblad; Lynne Warner Stevenson; Cynthia Binanay; Christopher M O'Connor; George Sopko; Robert M Califf
Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials.
JAMA : the journal of the American Medical Association 2005;294(13):1664-70.
2005: Cynthia Binanay; Robert M Califf; Vic Hasselblad; Christopher M O'Connor; Monica R Shah; George Sopko; Lynne Warner Stevenson; Gary S Francis; Carl V Leier; Leslie W Miller
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.
JAMA : the journal of the American Medical Association 2005;294(13):1625-33.
2005: Alejandro Barbagelata; Marcelo F Di Carli; Robert M Califf; Jyotsna Garg; Yochai Birnbaum; Liliana Grinfeld; Raymond J Gibbons; Christopher B Granger; Shaun G Goodman; Galen S Wagner; Kenneth W Mahaffey
Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial.
American heart journal 2005;150(4):659-65.
2005: John H Alexander; T. Bruce Ferguson; Diane M Joseph; Michael J Mack; Randall K Wolf; C Michael Gibson; Daniel Gennevois; Todd J Lorenz; Robert A Harrington; eric peterson; Kerry L Lee; Robert M Califf; Nicholas T Kouchoukos
The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics.
American heart journal 2005;150(4):643-9.
2005: Donal N Reddan; Lynda Szczech; Manjushri Bhapkar; David J Moliterno; Robert M Califf; Erik Ohman; Peter B Berger; Judith S Hochman; Frans Van de Werf; Robert A Harrington; L Kristin Newby
Renal function, concomitant medication use and outcomes following acute coronary syndromes.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(10):2105-12.
2005: Stefano Savonitto; Mauricio G. Cohen; Alessandro Politi; Michael P Hudson; David F Kong; Yao Huang; Karen S Pieper; Francesco Mauri; Galen S Wagner; Robert M Califf; Eric J Topol; Christopher B Granger
Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes.
European heart journal 2005;26(20):2106-13.
2005: Karolina E Szummer; Scott D Solomon; Eric J Velazquez; Rakhi Kilaru; John McMurray; Jean-Lucien Rouleau; Kenneth W Mahaffey; Aldo P Maggioni; Robert M Califf; Marc A Pfeffer; Harvey D White
Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry.
European heart journal 2005;26(20):2114-9.
2005: Eric L Eisenstein; Darren K McGuire; Manjushri Bhapkar; Arni Kristinsson; Judith S Hochman; David F Kong; Robert M Califf; Frans Van de Werf; William S Yancy; L Kristin Newby
Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes.
The American journal of medicine 2005;118(9):981-90.
2005: Robert M Califf
Stenting or surgery: an opportunity to do it right.
Journal of the American College of Cardiology 2005;46(4):589-91.
2005: Shelby D Reed; Jasmina I Radeva; Kevin P Weinfurt; john mcmurray; Marc A Pfeffer; Eric J Velazquez; Jennifer S Allsbrook; Leah E Masselink; Mary Ann Sellers; Robert M Califf; Kevin Schulman
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT).
American heart journal 2005;150(2):323-9.
2005: Cheuk-Kit Wong; John K French; Philip E G Aylward; Ralph A H Stewart; Wanzhen Gao; Paul W Armstrong; Frans J J Van De Werf; R John Simes; O Christopher Raffel; Christopher B Granger; Robert M Califf; Harvey D White
Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes.
Journal of the American College of Cardiology 2005;46(1):29-38.
2005: Erik Ohman; Frans Van de Werf; Elliott M Antman; Robert M Califf; James A de Lemos; C Michael Gibson; Renee L Oliverio; Lynn Harrelson; Carolyn McCabe; Peter M DiBattiste; Eugene Braunwald
Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial.
American heart journal 2005;150(1):79-88.
2005: Wei Jiang; Alexander Glassman; Ranga Krishnan; Christopher M O'Connor; Robert M Califf
Depression and ischemic heart disease: what have we learned so far and what must we do in the future?
American heart journal 2005;150(1):54-78.
2005: Donal N Reddan; Lynda A Szczech; Vic Hasselblad; Edmund G Lowrie; Robert M Lindsay; Jonathan Himmelfarb; Robert D Toto; John Stivelman; James Winchester; Linda A Zillman; Robert M Califf; William F Owen
Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial.
Journal of the American Society of Nephrology : JASN 2005;16(7):2162-9.
2005: Scott D Solomon; Hicham Skali; Nagesh S Anavekar; Mikhail Bourgoun; Stale Barvik; Jalal K Ghali; J Wayne Warnica; Margarita Khrakovskaya; J Malcolm O Arnold; Yuri Schwartz; Eric J Velazquez; Robert M Califf; John V McMurray; Marc A Pfeffer
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
Circulation 2005;111(25):3411-9.
2005: Scott D Solomon; Steven Zelenkofske; john mcmurray; Peter V Finn; Eric J Velazquez; George Ertl; Adam Harsanyi; Jean-Lucien Rouleau; Aldo Maggioni; Lars Kober; Harvey White; Frans Van de Werf; Karen Pieper; Robert M Califf; Marc A Pfeffer
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
The New England journal of medicine 2005;352(25):2581-8.
2005: Sana M Al-Khatib; Gillian D Sanders; Daniel B Mark; Kerry L Lee; Gust H Bardy; J Thomas Bigger; Alfred E Buxton; Stuart Connolly; Alan Kadish; Arthur Moss; Arthur M Feldman; Kenneth A Ellenbogen; Steven Singh; Robert M Califf
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004.
American heart journal 2005;149(6):1020-34.
2005: Robert P Giugliano; L Kristin Newby; Robert A Harrington; C Michael Gibson; Frans Van de Werf; Paul Armstrong; Gilles Montalescot; James Gilbert; John Strony; Robert M Califf; Eugene Braunwald
The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationale.
American heart journal 2005;149(6):994-1002.
2005: Rajendra H Mehta; Robert M Califf; Jyotsna Garg; Karen S Pieper; John H Alexander; David J Moliterno; Frans Van de Werf; Erik Ohman; Harvey D White; Eric J Topol; Christopher B Granger
Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapy.
The American journal of cardiology 2005;95(11):1371-5.
2005: Liviu Klein; Christopher M O'Connor; Jeffrey D Leimberger; Wendy Gattis-Stough; Ileana L Piña; G Michael Felker; Kirkwood F Adams; Robert M Califf; Mihai Gheorghiade
Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.
Circulation 2005;111(19):2454-60.
2005: Sana M Al-Khatib; Nancy M Allen LaPointe; Judith M Kramer; Anita Y Chen; Bradley G Hammill; Liz Delong; Robert M Califf
A survey of health care practitioners' knowledge of the QT interval.
Journal of general internal medicine 2005;20(5):392-6.
2005: Mauricio G. Cohen; Robert V Kelly; David F Kong; Venu Menon; Monica Shah; Jorge Ferreira; Karen S Pieper; Douglas Criger; Rosana Poggio; Erik Ohman; Joel Gore; Robert M Califf; Christopher B Granger
Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trials.
The American journal of medicine 2005;118(5):482-8.
2005: John S March; Susan G Silva; Scott Compton; Mark Shapiro; Robert M Califf; Ranga Krishnan
The case for practical clinical trials in psychiatry.
The American journal of psychiatry 2005;162(5):836-46.
2005: Sana M Al-Khatib; Kevin J Anstrom; Eric L Eisenstein; eric peterson; James G Jollis; Daniel B Mark; Yun Li; Christopher M O'Connor; Linda K Shaw; Robert M Califf
Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II.
Annals of internal medicine 2005;142(8):593-600.
2005: Rajendra H Mehta; John H Alexander; Frans Van de Werf; Paul W Armstrong; Karen S Pieper; Jyotsna Garg; Robert M Califf; Christopher B Granger
Relationship of incorrect dosing of fibrinolytic therapy and clinical outcomes.
JAMA : the journal of the American Medical Association 2005;293(14):1746-50.
2005: Robert M Califf; John L Petersen; Vic Hasselblad; Kenneth W Mahaffey; James J Ferguson
A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non-ST-elevation acute coronary syndromes.
American heart journal 2005;149(4 Suppl):S91-9.
2005: Trip J Meine; Sana M Al-Khatib; John H Alexander; Christopher B Granger; Harvey D White; Rakhi Kilaru; Kathryn Williams; Erik Ohman; Eric J Topol; Robert M Califf
Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy.
American heart journal 2005;149(4):670-4.
2005: Eric L Eisenstein; Philip W Lemons; Barbara E Tardiff; Kevin Schulman; M King Jolly; Robert M Califf
Reducing the costs of phase III cardiovascular clinical trials.
American heart journal 2005;149(3):482-8.
2005: Shelby D Reed; Kevin J Anstrom; Ameet Bakhai; Andrew H Briggs; Robert M Califf; David J Cohen; Michael F Drummond; Henry A Glick; Ari Gnanasakthy; Mark A Hlatky; Bernie J O'Brien; Frank M Torti; Anastasios A Tsiatis; Andrew R Willan; Daniel B Mark; Kevin Schulman
Conducting economic evaluations alongside multinational clinical trials: toward a research consensus.
American heart journal 2005;149(3):434-43.
2005: Neal I Muni; Robert M Califf; Jonette R Foy; Ashley B Boam; Bram D Zuckerman; Richard E Kuntz
Coronary drug-eluting stent development: issues in trial design.
American heart journal 2005;149(3):415-33.
2005: Barbara J Drew; Robert M Califf; Marjorie Funk; Elizabeth S Kaufman; Mitchell W Krucoff; Michael M Laks; Peter W Macfarlane; Claire E Sommargren; Steven Swiryn; George F Van Hare
AHA scientific statement: practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association Scientific Statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized electrocardiology and the American Association of Critical-Care Nurses.
The Journal of cardiovascular nursing 2005;20(2):76-106.
2005: Joel Kupersmith; Nancy Sung; Myron Genel; Harold Charles Slavkin; Robert M Califf; Robert Bonow; Louis Sherwood; Nancy E Reame; Veronica Catanese; Catherine Baase; John R. Feussner; Adrian S Dobs; Hugh Tilson; E Albert Reece
Creating a new structure for research on health care effectiveness.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2005;53(2):67-72.
2005: Abdallah G Rebeiz; Per Johanson; Cynthia L Green; Suzanne W Crater; Matthew T Roe; Anatoly Langer; Robert P Giugliano; A Michael Lincoff; L Kristin Newby; Robert A Harrington; Eric J Topol; Robert M Califf; Galen S Wagner; Mitchell W Krucoff
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials).
The American journal of cardiology 2005;95(5):611-4.
2005: Robert M Califf
Simple principles of clinical trials remain powerful.
JAMA : the journal of the American Medical Association 2005;293(4):489-91.
2005: Salvador Borges-Neto; Linda K Shaw; Robert H Tuttle; John H Alexander; William T Smith; Marianna Chambless; R Edward Coleman; Robert A Harrington; Robert M Califf
Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery disease.
The American journal of cardiology 2005;95(2):182-8.
2005: Phillippa J Miranda; Ralph DeFronzo; Robert M Califf; John R Guyton
Metabolic syndrome: definition, pathophysiology, and mechanisms.
American heart journal 2005;149(1):33-45.
2005: Phillippa J Miranda; Ralph DeFronzo; Robert M Califf; John R Guyton
Metabolic syndrome: evaluation of pathological and therapeutic outcomes.
American heart journal 2005;149(1):20-32.
2005: Marino Labinaz; Jasmine Mathias; Karen S Pieper; Christopher B Granger; A Michael Lincoff; David J Moliterno; Frans Van de Werf; R John Simes; Harvey D White; Maarten L Simoons; Robert M Califf; Eric J Topol; Paul W Armstrong; Robert A Harrington
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials.
European heart journal 2005;26(2):128-36.
2004: Paul W Armstrong; L Kristin Newby; Christopher B Granger; Kerry L Lee; R John Simes; Frans Van de Werf; Harvey D White; Robert M Califf
Lessons learned from a clinical trial.
Circulation 2004;110(23):3610-4.
2004: Mary Ann Mascelli; Efthymios Deliargyris; Lakshmi V Damaraju; Elliot S Barnathan; Robert M Califf; Maarten L Simoons; David C Sane
Antibodies to platelet factor 4/heparin are associated with elevated endothelial cell activation markers in patients with acute coronary ischemic syndromes.
Journal of thrombosis and thrombolysis 2004;18(3):171-5.
2004: G Michael Felker; Jeffrey D Leimberger; Robert M Califf; Michael S Cuffe; Barrie Massie; Kirkwood F Adams; Mihai Gheorghiade; Christopher M O'Connor
Risk stratification after hospitalization for decompensated heart failure.
Journal of cardiac failure 2004;10(6):460-6.
2004: Wei Jiang; Maragatha Kuchibhatla; Michael S Cuffe; Eric J Christopher; Jude D Alexander; Greg L Clary; Michael A Blazing; Laura H Gaulden; Robert M Califf; Ranga R Krishnan; Christopher M O'Connor
Prognostic value of anxiety and depression in patients with chronic heart failure.
Circulation 2004;110(22):3452-6.
2004: Robert M Califf; Thomas Ryan; Pamela Douglas; Pascal J Goldschmidt-Clermont
A time of accelerated change in academic cardiovascular medicine: implications for academic divisions of cardiology and their training programs.
Journal of the American College of Cardiology 2004;44(10):1957-65.
2004: Mina Madan; Marino Labinaz; Eric A Cohen; Christopher E Buller; Warren J Cantor; Peter H Seidelin; John Ducas; Ronald G Carere; Madhu K Natarajan; Karen S Pieper; Gail E Hafley; J Conor O'Shea; Michael M Kitt; Robert M Califf; James E Tcheng
A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stenting.
The Canadian journal of cardiology 2004;20(13):1343-9.
2004: Alejandro Barbagelata; Robert M Califf; Elena B Sgarbossa; David Knight; Daniel B Mark; Christopher B Granger; Paul W Armstrong; Marcelo V Elizari; Yochai Birnbaum; Liliana Grinfeld; Erik Ohman; Galen S Wagner
Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy.
American heart journal 2004;148(5):795-802.
2004: Eric J Velazquez; Gary S Francis; Paul W Armstrong; Philip E Aylward; Rafael Diaz; Christopher M O'Connor; Harvey D White; Marc Henis; Lois M Rittenhouse; Rakhi Kilaru; Wiek H van Gilst; Georg Ertl; Aldo P Maggioni; Jiri Spac; W Douglas Weaver; Jean-Lucien Rouleau; john mcmurray; Marc A Pfeffer; Robert M Califf
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
European heart journal 2004;25(21):1911-9.
2004: Robert M Califf; Sidney C Smith
Introduction. Quality of health care.
American heart journal 2004;148(5 Suppl):S27-8.
2004: Barbara J Drew; Robert M Califf; Marjorie Funk; Elizabeth S Kaufman; Mitchell W Krucoff; Michael M Laks; Peter W Macfarlane; Claire E Sommargren; Steven Swiryn; George F Van Hare
Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses.
Circulation 2004;110(17):2721-46.
2004: Robert M Califf; Steven E Nissen; Anthony N DeMaria; Erik Ohman; Bertram Pitt; James T Willerson; David W Bilheimer; Jay N Cohn; David W Feigal; Lindsay Hampson; Beverly H Lorell; Carl J Pepine; Richard L Popp
Task force 2: Investigator participation in clinical research.
Journal of the American College of Cardiology 2004;44(8):1729-36.
2004: Sunil V Rao; James G Jollis; Robert A Harrington; Christopher B Granger; L Kristin Newby; Paul W Armstrong; David J Moliterno; Lauren Lindblad; Karen S Pieper; Eric J Topol; Jonathan S Stamler; Robert M Califf
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes.
JAMA : the journal of the American Medical Association 2004;292(13):1555-62.
2004: Elizabeth Parsons; L Kristin Newby; Manjushri Bhapkar; Karen P Alexander; Harvey D White; Svati H Shah; Cheryl D Bushnell; Robert M Califf
Postmenopausal hormone use in women with acute coronary syndromes.
Journal of women's health (2002) 2004;13(8):863-71.
2004: James A de Lemos; Michael A Blazing; Stephen D Wiviott; William E Brady; Harvey D White; Keith A A Fox; Joanne Palmisano; Karen E Ramsey; David W Bilheimer; Eldrin F Lewis; M Pfeffer; Robert M Califf; Eugene Braunwald
Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial.
European heart journal 2004;25(19):1688-94.
2004: Padma Kaul; Paul W Armstrong; Wei-Ching Chang; C David Naylor; Christopher B Granger; Kerry L Lee; Eric D Peterson; Robert M Califf; Eric J Topol; Daniel B Mark
Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.
Circulation 2004;110(13):1754-60.
2004: Nagesh S Anavekar; john mcmurray; Eric J Velazquez; Scott D Solomon; Lars Kober; Jean-Lucien Rouleau; Harvey D White; Rolf Nordlander; Aldo Maggioni; Kenneth Dickstein; Steven Zelenkofske; Jeffrey D Leimberger; Robert M Califf; Marc A Pfeffer
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
The New England journal of medicine 2004;351(13):1285-95.
2004: David Aguilar; Scott D Solomon; Lars Køber; Jean-Lucien Rouleau; Hicham Skali; john mcmurray; Gary S Francis; Marc Henis; Christopher M O'Connor; Rafael Diaz; Yuri N Belenkov; Sergei Varshavsky; Jeffrey D Leimberger; Eric J Velazquez; Robert M Califf; Marc A Pfeffer
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Circulation 2004;110(12):1572-8.
2004: Sana M Al-Khatib; Linda K Shaw; Kerry L Lee; Christopher O'Connor; Robert M Califf
Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?
The American journal of cardiology 2004;94(6):797-800.
2004: James A de Lemos; Michael A Blazing; Stephen D Wiviott; Eldrin F Lewis; Keith A A Fox; Harvey D White; Jean-Lucien Rouleau; Terje R Pedersen; Laura H Gardner; Robin Mukherjee; Karen E Ramsey; Joanne Palmisano; David W Bilheimer; Marc A Pfeffer; Robert M Califf; Eugene Braunwald
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.
JAMA : the journal of the American Medical Association 2004;292(11):1307-16.
2004: Hassan Kassem-Moussa; Kenneth W Mahaffey; Carmelo Graffagnino; Gudaye Tasissa; Cathy A Sila; R John Simes; Harvey D White; Robert M Califf; Manjushri Bhapkar; L Kristin Newby
Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome.
American heart journal 2004;148(3):439-46.
2004: Jennifer S Li; Katherine Y Berezny; Rakhi Kilaru; Lydie Hazan; Ronald Portman; Ronald Hogg; Randall D Jenkins; Prapti Kanani; Carol M Cottrill; Tej K Mattoo; Ludmila Zharkova; Ludmila Kozlova; Irit Weisman; David Deitchman; Robert M Califf
Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children?
Hypertension 2004;44(3):289-93.
2004: C Michael Gibson; Lisa K Jennings; Sabina A Murphy; David P Lorenz; Robert P Giugliano; Robert A Harrington; Shila Cholera; Rajini Krishnan; Robert M Califf; Eugene Braunwald
Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy.
Circulation 2004;110(6):679-84.
2004: John L Petersen; Kenneth W Mahaffey; Richard C Becker; Shaun G Goodman; Neal S Kleiman; A J Marian; Gregg W Stone; Alexandra J Lansky; A Michael Lincoff; Stanley L Hazen; Christopher C. Nessel; Luis Toro-Figueroa; Lynn Tate; Craig J Reist; Marc Cohen; Robert M Califf; James J Ferguson
Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY Library.
American heart journal 2004;148(2):269-76.
2004: Peter A McCullough; George L Bakris; William F Owen; Preston S Klassen; Robert M Califf
Slowing the progression of diabetic nephropathy and its cardiovascular consequences.
American heart journal 2004;148(2):243-51.
2004: Patricia J M Best; Donal N Reddan; Peter B Berger; Lynda A Szczech; Peter A McCullough; Robert M Califf
Cardiovascular disease and chronic kidney disease: insights and an update.
American heart journal 2004;148(2):230-42.
2004: Kenneth Lee Baughman; Carl J Pepine; Jonathan Abrams; Thomas M Bashore; Robert M Califf; Arthur M Feldman; W Bruce Fye; Brian P Griffin; Robert J Myerburg; Gerald V Naccarelli; Eric S Williams
Working group 1: How to increase the output of cardiologists.
Journal of the American College of Cardiology 2004;44(2):233-7.
2004: John L Petersen; Kenneth W Mahaffey; Vic Hasselblad; Elliott M Antman; Marc Cohen; Shaun G Goodman; Anatoly Langer; Michael A Blazing; Anne Le-Moigne-Amrani; James A de Lemos; Christopher C. Nessel; Robert A Harrington; James J Ferguson; Eugene Braunwald; Robert M Califf
Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview.
JAMA : the journal of the American Medical Association 2004;292(1):89-96.
2004: Michael A Blazing; James A de Lemos; Harvey D White; Keith A A Fox; Freek W A Verheugt; Diego Ardissino; Peter M DiBattiste; Joanne Palmisano; David W Bilheimer; Steven M Snapinn; Karen E Ramsey; Laura H Gardner; Vic Hasselblad; Marc A Pfeffer; Eldrin F Lewis; Eugene Braunwald; Robert M Califf
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2004;292(1):55-64.
2004: James J Ferguson; Robert M Califf; Elliott M Antman; Marc Cohen; Cindy L Grines; Shaun Goodman; Dean J Kereiakes; Anatoly Langer; Kenneth W Mahaffey; Christopher C. Nessel; Paul W Armstrong; Alvaro Avezum; Phil Aylward; Richard C Becker; Luigi Biasucci; Steven Borzak; Jacques Col; Marty J Frey; Ed Fry; Dietrich C Gulba; Sema Guneri; Enrique Gurfinkel; Robert A Harrington; Judith S Hochman; Neal S Kleiman; Martin B Leon; Jose Luis Lopez-Sendon; Carl J Pepine; Witold Ruzyllo; Steven R Steinhubl; Paul S Teirstein; Luis Toro-Figueroa; Harvey White
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.
JAMA : the journal of the American Medical Association 2004;292(1):45-54.
2004: Shelby D Reed; Joëlle Y Friedman; Eric J Velazquez; Ari Gnanasakthy; Robert M Califf; Kevin Schulman
Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
American heart journal 2004;148(1):122-8.
2004: Wei-Ching Chang; eric boersma; Christopher B Granger; Robert A Harrington; Robert M Califf; Maarten L Simoons; Neal S Kleiman; Paul W Armstrong
Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT.
American heart journal 2004;148(1):62-71.
2004: Richard E Waters; Kanwar P Singh; Matthew T Roe; Mat Lotfi; Michael H Sketch; Kenneth W Mahaffey; L Kristin Newby; John H Alexander; Robert A Harrington; Robert M Califf; Christopher B Granger
Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2004;43(12):2153-9.
2004: Marino Labinaz; Padma Kaul; Robert A Harrington; Wei-Ching Chang; Neal S Kleiman; Maarten L Simoons; eric boersma; K Martijn Akkerhuis; Robert M Califf; Paul W Armstrong
Six-month outcomes of percutaneous coronary balloon angioplasty in acute coronary syndromes: Results from the PURSUIT trial.
The Canadian journal of cardiology 2004;20(8):773-8.
2004: Eric D Peterson; John W Hirshfeld; T. Bruce Ferguson; Judith M Kramer; Robert M Califf; Larry G Kessler
Part II: Sealing holes in the safety net.
American heart journal 2004;147(6):985-90.
2004: J Conor O'Shea; Judith M Kramer; Robert M Califf; Eric D Peterson
Part I: Identifying holes in the safety net.
American heart journal 2004;147(6):977-84.
2004: Robert M Califf
Benefit the patient, manage the risk: a system goal.
Pharmacoepidemiology and drug safety 2004;13(5):269-76.
2004: John S March; Susan G Silva; Scott Compton; Ginger Anthony; Joseph DeVeaugh-Geiss; Robert M Califf; Ranga Krishnan
The Child and Adolescent Psychiatry Trials Network (CAPTN).
Journal of the American Academy of Child and Adolescent Psychiatry 2004;43(5):515-8.
2004: C Michael Gibson; Juhana Karha; Sabina A Murphy; James A de Lemos; David A Morrow; Robert P Giugliano; Matthew T Roe; Robert A Harrington; Christopher P Cannon; Elliott M Antman; Robert M Califf; Eugene Braunwald
Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction.
Journal of the American College of Cardiology 2004;43(7):1170-6.
2004: Robert M Califf
Watching the WATCH trial: the role of sponsors and data monitoring committees.
Journal of cardiac failure 2004;10(2):113-4.
2004: Arthur C P Maas; Christina M Wyatt; Cynthia L Green; Galen S Wagner; Kathleen M Trollinger; James E Pope; Anatoly Langer; Paul W Armstrong; Robert M Califf; Maarten L Simoons; Mitchell W Krucoff
Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction.
American heart journal 2004;147(4):698-704.
2004: Robert M Califf; Vance Fowler; Christopher H Cabell; G Ralph Corey
Novel approaches to clinical trials: device-related infections.
American heart journal 2004;147(4):599-604.
2004: Martin J Quinn; Herbert D Aronow; Robert M Califf; Deepak L Bhatt; Shelly Sapp; Neal S Kleiman; Robert A Harrington; David F Kong; David E Kandzari; Eric J Topol
Aspirin dose and six-month outcome after an acute coronary syndrome.
Journal of the American College of Cardiology 2004;43(6):972-8.
2004: John A Bittl; Derek P Chew; Eric J Topol; David F Kong; Robert M Califf
Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty.
Journal of the American College of Cardiology 2004;43(6):936-42.
2004: Peter B Berger; Michael H Sketch; Robert M Califf
Choosing between percutaneous coronary intervention and coronary artery bypass grafting for patients with multivessel disease: what can we learn from the Arterial Revascularization Therapy Study (ARTS)?
Circulation 2004;109(9):1079-81.
2004: David E Kandzari; Vic Hasselblad; James E Tcheng; Gregg W Stone; Robert M Califf; Adnan Kastrati; Franz-Josef Neumann; Sorin J Brener; Gilles Montalescot; David F Kong; Robert A Harrington
Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials.
American heart journal 2004;147(3):457-62.
2004: David F Kong; Eric L Eisenstein; Michael H Sketch; James P Zidar; Thomas J Ryan; Robert A Harrington; Mark F Newman; Peter K Smith; Daniel B Mark; Robert M Califf
Economic impact of drug-eluting stents on hospital systems: a disease-state model.
American heart journal 2004;147(3):449-56.
2004: David E Kandzari; Alan Chu; Bruce R Brodie; Thomas A Stuckey; James Hermiller; George W Vetrovec; Karen L Hannan; Mitchell W Krucoff; Robert H Christenson; Raymond J Gibbons; Kristina N Sigmon; Jyotsna Garg; Vic Hasselblad; Kenneth Collins; Robert A Harrington; Peter B Berger; Nicholas A Chronos; Judith S Hochman; Robert M Califf
Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study).
The American journal of cardiology 2004;93(5):636-9.
2004: Hitinder S Gurm; A Michael Lincoff; David S Lee; W H Wilson Tang; Gang Jia; Joan E Booth; Robert M Califf; Erik Ohman; Frans Van de Werf; Paul W Armstrong; Victor Guetta; Robert Wilcox; Eric J Topol
Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.
Journal of the American College of Cardiology 2004;43(4):542-8.
2004: Elizabeth G Nabel; Harry P Selker; Robert M Califf; John G Canto; Jie J Cao; Patrice Desvigne-Nikkens; Robert J Goldberg; John R Finnegan; Viola Vaccarino; Renu Virmani
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 3: diagnosis and treatment of acute cardiac ischemia: gender issues.
Circulation 2004;109(6):e50-2.
2004: David E Kandzari; Christopher B Granger; Maarten L Simoons; Harvey D White; R John Simes; Kenneth W Mahaffey; Joel Gore; W Douglas Weaver; William T Longstreth; Amanda L Stebbins; Kerry L Lee; Robert M Califf; Eric J Topol
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).
The American journal of cardiology 2004;93(4):458-61.
2004: Padma Kaul; L Kristin Newby; Yuling Fu; Daniel B Mark; Robert M Califf; Eric J Topol; Phil Aylward; Christopher B Granger; Frans Van de Werf; Paul W Armstrong
International differences in evolution of early discharge after acute myocardial infarction.
Lancet 2004;363(9408):511-7.
2004: Karen S Pieper; Anastasios A Tsiatis; Marie Davidian; Vic Hasselblad; Neal S Kleiman; Eric Boersma; Wei-Ching Chang; Jeffrey Griffin; Paul W Armstrong; Robert M Califf; Robert A Harrington
Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods.
Circulation 2004;109(5):641-6.
2004: Matthew T Roe; Kenneth W Mahaffey; Rakhi Kilaru; John H Alexander; K Martijn Akkerhuis; Maarten L Simoons; Robert A Harrington; Barbara E Tardiff; Christopher B Granger; Erik Ohman; David J Moliterno; A Michael Lincoff; Paul W Armstrong; Frans Van de Werf; Robert M Califf; Eric J Topol
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
European heart journal 2004;25(4):313-21.
2004: Stefan K James; Bertil Lindahl; Paul Armstrong; Robert M Califf; Maarten L Simoons; Per Venge; Lars Wallentin
A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes.
International journal of cardiology 2004;93(2-3):113-20.
2004: Stefan K James; Agneta Siegbahn; Paul Armstrong; Elliot S Barnathan; Robert M Califf; Maarten L Simoons; Lars Wallentin
Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy.
American heart journal 2004;147(2):267-74.
2004: Darren K McGuire; L Kristin Newby; Manjushri Bhapkar; David J Moliterno; Judith S Hochman; Werner W Klein; W Douglas Weaver; Matthias Pfisterer; Ramón Corbalán; Mikael Dellborg; Christopher B Granger; Frans Van de Werf; Eric J Topol; Robert M Califf
Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes.
American heart journal 2004;147(2):246-52.
2004: Abdallah G Rebeiz; Matthew T Roe; John H Alexander; Kenneth W Mahaffey; Christopher B Granger; eric peterson; Robert M Califf; Robert A Harrington
Integrating antithrombin and antiplatelet therapies with early invasive management for non-ST-segment elevation acute coronary syndromes.
The American journal of medicine 2004;116(2):119-29.
2004: Patricia A Cowper; Elizabeth R DeLong; David Whellan; Nancy M Allen LaPointe; Robert M Califf
Economic effects of beta-blocker therapy in patients with heart failure.
The American journal of medicine 2004;116(2):104-11.
2004: David L DeMets; Robert M Califf; Dennis Dixon; Susan S Ellenberg; Thomas Fleming; Peter Held; Desmond Julian; Richard S. Kaplan; Robert Levine; James D Neaton; Milton Packer; Stuart Pocock; Frank Rockhold; Belinda Seto; Jay Siegel; Steven M Snapinn; David Stump; Robert Temple; Richard Whitley
Issues in regulatory guidelines for data monitoring committees.
Clinical trials (London, England) 2004;1(2):162-9.
2004: David L DeMets; Thomas R Fleming; Frank Rockhold; Barrie Massie; Thomas Merchant; Alan Meisel; Barbara Mishkin; Janet Wittes; David Stump; Robert M Califf
Liability issues for data monitoring committee members.
Clinical trials (London, England) 2004;1(6):525-31.
2004: Robert M Califf
Defining the balance of risk and benefit in the era of genomics and proteomics.
Health affairs (Project Hope) 2004;23(1):77-87.
2003: L Kristin Newby; Manjushri Bhapkar; Harvey D White; David J Moliterno; Nancy M Allen LaPointe; David E Kandzari; Freek W A Verheugt; Judith M Kramer; Paul W Armstrong; Robert M Califf
Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.
Journal of thrombosis and thrombolysis 2003;16(3):119-28.
2003: Jonathan S Stamler; Robert L Taber; Robert M Califf
Translation of academic discovery into societal benefit: proposal for a balanced approach--part 2.
The American journal of medicine 2003;115(8):683-8.
2003: John H Alexander; Robert A Harrington; Manjushri Bhapkar; Kenneth W Mahaffey; A Michael Lincoff; Erik Ohman; Peter Klootwijk; Olle Pahlm; Bo Henden; Jaap Deckers; Maarten L Simoons; Robert M Califf; Galen S Wagner
Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromes.
The American journal of medicine 2003;115(8):613-9.
2003: Judith M Kramer; L Kristin Newby; Wei Ching Chang; R John Simes; Frans Van de Werf; Christopher B Granger; Kerry L Lee; Harvey D White; Leopoldo Soares Piegas; Eric J Topol; Robert M Califf; Paul W Armstrong
International variation in the use of evidence-based medicines for acute coronary syndromes.
European heart journal 2003;24(23):2133-41.
2003: Marc A Pfeffer; john mcmurray; Eric J Velazquez; Jean-Lucien Rouleau; Lars Køber; Aldo P Maggioni; Scott D Solomon; Karl Swedberg; Frans Van de Werf; Harvey White; Jeffrey D Leimberger; Marc Henis; Susan Edwards; Steven Zelenkofske; Mary Ann Sellers; Robert M Califf
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
The New England journal of medicine 2003;349(20):1893-906.
2003: Kenneth W Mahaffey; Bruce E Lewis; Nancy M Wildermann; Scott Darrell Berkowitz; Renee M Oliverio; Mark Turco; Yoseph Shalev; Peter Ver Lee; Jay H Traverse; A Ralph Rodriguez; Erik Ohman; Robert A Harrington; Robert M Califf
The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results.
The Journal of invasive cardiology 2003;15(11):611-6.
2003: Jonathan S Stamler; Robert L Taber; Robert M Califf
Translation of academic discovery into societal benefit: proposal for a balanced approach--part 1.
The American journal of medicine 2003;115(7):596-9.
2003: Nancy M Allen LaPointe; Anita Chen; Bradley G Hammill; Elizabeth DeLong; Judith M Kramer; Robert M Califf
Evaluation of the dofetilide risk-management program.
American heart journal 2003;146(5):894-901.
2003: Robert M Califf
Issues facing clinical trials of the future.
Journal of internal medicine 2003;254(5):426-33.
2003: Robert M Califf
Supplement on acute coronary syndromes: introduction.
Circulation 2003;108(16 Suppl 1):III1-5.
2003: Matthew T Roe; Erik Ohman; Charles V Pollack; eric peterson; Ralph G Brindis; Robert A Harrington; Robert H Christenson; Sidney C Smith; Robert M Califf; W Brian Gibler
Changing the model of care for patients with acute coronary syndromes.
American heart journal 2003;146(4):605-12.
2003: Stefano Savonitto; P W Armstrong; A M Lincoff; G Jia; C A Sila; J Booth; P Terrosu; Claudio Cavallini; Harvey D White; Diego Ardissino; Robert M Califf; Eric J Topol
Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trial.
European heart journal 2003;24(20):1807-14.
2003: David F Kong; Vic Hasselblad; Robert A Harrington; Harvey D White; James E Tcheng; David E Kandzari; Eric J Topol; Robert M Califf
Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions.
The American journal of cardiology 2003;92(6):651-5.
2003: Cheuk-Kit Wong; Harvey D White; Robert G Wilcox; Douglas A Criger; Robert M Califf; Eric J Topol; Erik Ohman
Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
Cardiac electrophysiology review 2003;7(3):201-7.
2003: Donal N Reddan; Lynda A Szczech; Robert H Tuttle; Linda K Shaw; Robert H Jones; Steve J Schwab; Mark Stafford Smith; Robert M Califf; Daniel B Mark; William F Owen
Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease.
Journal of the American Society of Nephrology : JASN 2003;14(9):2373-80.
2003: Robert M Califf; Lawrence H Muhlbaier
Health Insurance Portability and Accountability Act (HIPAA): must there be a trade-off between privacy and quality of health care, or can we advance both?
Circulation 2003;108(8):915-8.
2003: Victor L Serebruany; Alexander H Glassman; Alex I Malinin; Charles Nemeroff; Dominique L Musselman; Louis T van Zyl; Mitchell S Finkel; K Ranga Rama Krishnan; Michael Gaffney; Wilma Harrison; Robert M Califf; Christopher M O'Connor
Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy.
Circulation 2003;108(8):939-44.
2003: Stefan James; Paul Armstrong; Robert M Califf; Maarten L Simoons; Per Venge; Lars Wallentin; Bertil Lindahl
Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial.
The American journal of medicine 2003;115(3):178-84.
2003: Eric J Velazquez; Marc A Pfeffer; John V McMurray; Aldo P Maggioni; Jean-Lucien Rouleau; Frans Van de Werf; Lars Kober; Harvey D White; Karl Swedberg; Jeffrey D Leimberger; Paul Gallo; Mary Ann Sellers; Susan Edwards; Marc Henis; Robert M Califf
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context.
European journal of heart failure 2003;5(4):537-44.
2003: Thaddeus R Tolleson; L Kristin Newby; Robert A Harrington; Manjushri Bhapkar; Freek W A Verheugt; Peter B Berger; David J Moliterno; Harvey D White; Erik Ohman; Frans Van de Werf; Eric J Topol; Robert M Califf
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials).
The American journal of cardiology 2003;92(3):330-3.
2003: Eric J Topol; Donald Easton; Robert A Harrington; Pierre Amarenco; Robert M Califf; Carmelo Graffagnino; Stephen Davis; Hans-Christophe Diener; James Ferguson; Desmond Fitzgerald; Jeffrey Granett; Ashfaq Shuaib; Peter J Koudstaal; Pierre Theroux; Frans Van de Werf; Kristina N Sigmon; Karen Pieper; Marc Vallee; James T Willerson
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease.
Circulation 2003;108(4):399-406.
2003: Stefan K James; Bertil Lindahl; Agneta Siegbahn; Mats Stridsberg; Per Venge; Paul Armstrong; Elliot S Barnathan; Robert M Califf; Eric J Topol; Maarten L Simoons; Lars Wallentin
N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
Circulation 2003;108(3):275-81.
2003: Robert M Califf; Michael A Morse; Janet Wittes; Steven Goodman; Daniel Nelson; David L DeMets; R Peter Iafrate; Jeremy Sugarman
Toward protecting the safety of participants in clinical trials.
Controlled clinical trials 2003;24(3):256-71.
2003: R Taylor Williams; Lakshmi V Damaraju; Mary Ann Mascelli; Elliot S Barnathan; Robert M Califf; Maarten L Simoons; Efthymios Deliargyris; David C Sane
Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes.
Circulation 2003;107(18):2307-12.
2003: Jill J F Belch; Eric J Topol; Giancarlo Agnelli; Michel Bertrand; Robert M Califf; Denis L Clement; Mark A Creager; J Donald Easton; James R Gavin; Philip Greenland; Graeme Hankey; Peter Hanrath; Alan T Hirsch; Jürgen Meyer; Sidney C Smith; frank sullivan; Michael A Weber
Critical issues in peripheral arterial disease detection and management: a call to action.
Archives of internal medicine 2003;163(8):884-92.
2003: Sana M Al-Khatib; Nancy M Allen LaPointe; Judith M Kramer; Robert M Califf
What clinicians should know about the QT interval.
JAMA : the journal of the American Medical Association 2003;289(16):2120-7.
2003: Robert P Giugliano; Matthew T Roe; Robert A Harrington; C Michael Gibson; Uwe Zeymer; Frans Van de Werf; Kenneth W Baran; Hans-Peter Hobbach; Lynn H Woodlief; Karen L Hannan; Sally Greenberg; Joanne Miller; Michael M Kitt; John Strony; Carolyn H McCabe; Eugene Braunwald; Robert M Califf
Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial.
Journal of the American College of Cardiology 2003;41(8):1251-60.
2003: Nancy M Allen LaPointe; Sana M Al-Khatib; Judith M Kramer; Robert M Califf
Knowledge deficits related to the QT interval could affect patient safety.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2003;8(2):157-60.
2003: James E Tcheng; Mina Madan; J Conor O'Shea; Eric A Cohen; Christopher E Buller; A Michael Lincoff; Jeffrey J Popma; Paul S Teirstein; Michael M Kitt; Todd J Lorenz; Sally Greenberg; NORMAN FOST; Robert M Califf
Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention.
Journal of interventional cardiology 2003;16(2):97-105.
2003: William H Campbell; Robert M Califf
Improving communication of drug risks to prevent patient injury: proceedings of a workshop.
Pharmacoepidemiology and drug safety 2003;12(3):183-94.
2003: Donal N Reddan; Lynda A Szczech; Susan I O'Shea; Robert M Califf
Anticoagulation in acute cardiac care in patients with chronic kidney disease.
American heart journal 2003;145(4):586-94.
2003: Robert M Califf; David P Faxon
Need for centers to care for patients with acute coronary syndromes.
Circulation 2003;107(11):1467-70.
2003: G Michael Felker; Raymond L Benza; A Bleakley Chandler; Jeffrey D Leimberger; Michael S Cuffe; Robert M Califf; Mihai Gheorghiade; Christopher M O'Connor
Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study.
Journal of the American College of Cardiology 2003;41(6):997-1003.
2003: Stefan K James; Paul Armstrong; Elliot S Barnathan; Robert M Califf; Bertil Lindahl; Agneta Siegbahn; Maarten L Simoons; Eric J Topol; Per Venge; Lars Wallentin
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy.
Journal of the American College of Cardiology 2003;41(6):916-24.
2003: Fadi H Khadour; Yuling Fu; Wei-Ching Chang; Xin Ma; Daniel Mark; Christopher B Granger; Eric J Topol; Robert M Califf; Paul W Armstrong
Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromes.
The Canadian journal of cardiology 2003;19(3):257-63.
2003: Sunil V Rao; Robert M Califf
Lessons learned from clinical trials: a roundtable discussion.
Critical pathways in cardiology 2003;2(1):55-9.
2003: Sana M Al-Khatib; Amanda L Stebbins; Robert M Califf; Kerry L Lee; Christopher B Granger; Harvey D White; Paul W Armstrong; Eric J Topol; Erik Ohman
Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial.
American heart journal 2003;145(3):515-21.
2003: A Hersi; Yuling Fu; B Wong; Kenneth W Mahaffey; Robert A Harrington; Robert M Califf; Frans Van de Werf; Paul W Armstrong
Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?
European heart journal 2003;24(6):522-31.
2003: Padma Kaul; L Kristin Newby; Yuling Fu; Vic Hasselblad; Kenneth W Mahaffey; Robert H Christenson; Robert A Harrington; Erik Ohman; Eric J Topol; Robert M Califf; Frans Van de Werf; Paul W Armstrong
Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients.
Journal of the American College of Cardiology 2003;41(3):371-80.
2003: Wayne B Batchelor; Daniel B Mark; J David Knight; Christopher B Granger; Paul W Armstrong; Robert M Califf; eric peterson
Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: potential impact on cardiac catheterization use in the United States and Canada.
American heart journal 2003;145(2):349-55.
2003: Lesley H Curtis; Truls Østbye; Veronica Sendersky; Steve Hutchison; Nancy M Allen LaPointe; Sana M Al-Khatib; Sally Usdin Yasuda; PETER DANS; Alan Wright; Robert M Califf; Raymond L Woosley; Kevin Schulman
Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients.
The American journal of medicine 2003;114(2):135-41.
2003: Leslie Cho; Deepak L Bhatt; Steven P Marso; Danielle Brennan; David R Holmes; Robert M Califf; Eric J Topol
An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trial.
The American journal of medicine 2003;114(2):106-11.
2003: Harry P Selker; Merritt H Raitt; Christopher Schmid; Michael M Laks; Joni R Beshansky; John Griffith; Robert M Califf; Ronald H Selvester; Charles Maynard; Ralph B D'Agostino; W Douglas Weaver
Time-dependent predictors of primary cardiac arrest in patients with acute myocardial infarction.
The American journal of cardiology 2003;91(3):280-6.
2003: William S Yancy; Eric C Westman; Patricia A French; Robert M Califf
Diets and clinical coronary events: the truth is out there.
Circulation 2003;107(1):10-6.
2003: L Kristin Newby; V Hasselblad; P W Armstrong; Frans Van de Werf; D B Mark; H D White; Eric J Topol; Robert M Califf
Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making.
European heart journal 2003;24(2):182-9.
2003: L Kristin Newby; Manjushri Bhapkar; Harvey D White; Eric J Topol; F C Dougherty; Robert A Harrington; M C Smith; L F Asarch; Robert M Califf
Predictors of 90-day outcome in patients stabilized after acute coronary syndromes.
European heart journal 2003;24(2):172-81.
2003: Robert M Califf
Cardiac markers in acute coronary syndromes-refining our knowledge.
European heart journal 2003;24(2):136-7.
2003: Sana M Al-Khatib; Nancy M Allen LaPointe; Lesley H Curtis; Judith M Kramer; Joslyn Swann; Peter Honig; Robert M Califf
Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000.
The American journal of cardiology 2003;91(1):91-4.
2002: J Conor O'Shea; Robert G Wilcox; Allan M Skene; Amanda L Stebbins; Christopher B Granger; Paul W Armstrong; Christoph Bode; Diego Ardissino; Hakan Emanuelsson; Philip E Aylward; Harvey D White; Zygmunt Sadowski; Eric J Topol; Robert M Califf; Erik Ohman
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone.
The American journal of cardiology 2002;90(12):1374-7.
2002: Robert M Califf; eric peterson; Raymond J Gibbons; Arthur Garson; Ralph G Brindis; George A Beller; Sidney C Smith
Integrating quality into the cycle of therapeutic development.
Journal of the American College of Cardiology 2002;40(11):1895-901.
2002: Robert M Califf; Karen P Alexander
Cardiovascular research in the elderly: challenges, opportunities, and impact.
Postgraduate medicine 2002;112(6 Suppl Heart):6-11.
2002: Robert M Califf
Heart failure roundtable: beta-blockers in the elderly. Introduction.
Postgraduate medicine 2002;112(6 Suppl Heart):5.
2002: Debabrata Mukherjee; Kenneth W Mahaffey; David J Moliterno; Robert A Harrington; Jay S Yadav; Karen S Pieper; Dianne Gallup; Christopher Dyke; Matthew T Roe; Lisa G Berdan; Michael Lauer; Matti Mänttäri; Harvey D White; Robert M Califf; Eric J Topol
Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).
American heart journal 2002;144(6):995-1002.
2002: L Kristin Newby; Joseph S Alpert; Erik Ohman; Kristian Thygesen; Robert M Califf
Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations.
American heart journal 2002;144(6):957-80.
2002: James C Blankenship; Craig Balog; Shelly K Sapp; Robert M Califf; A Michael Lincoff; James E Tcheng; Eric J Topol
Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2002;57(4):476-83.
2002: A Michael Lincoff; Robert M Califf; Frans Van de Werf; James T Willerson; Harvey D White; Paul W Armstrong; Victor Guetta; W Brian Gibler; Judith S Hochman; Christoph Bode; Alec Vahanian; Philippe Gabriel STEG; Diego Ardissino; Stefano Savonitto; Frits Bar; Zygmunt Sadowski; Amadeo Betriu; Joan E Booth; Kathy Wolski; Michael Waller; Eric J Topol
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial.
JAMA : the journal of the American Medical Association 2002;288(17):2130-5.
2002: Robert M Califf
Matching resources to treatment decisions for patients with acute coronary syndromes.
Clinical cardiology 2002;25(11 Suppl 1):I2-8.
2002: Mark E Anderson; Sana M Al-Khatib; Dan Mark Roden; Robert M Califf
Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management.
American heart journal 2002;144(5):769-81.
2002: M Ashequl Islam; James C Blankenship; Craig Balog; Elias A Iliadis; A Michael Lincoff; James E Tcheng; Robert M Califf; Eric J Topol
Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT).
The American journal of cardiology 2002;90(9):916-21.
2002: Kevin Schulman; Damon M Seils; Justin W Timbie; Jeremy Sugarman; Lauren A Dame; Kevin P Weinfurt; Daniel B Mark; Robert M Califf
A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors.
The New England journal of medicine 2002;347(17):1335-41.
2002: Robert M Califf
Evaluating the costs and effectiveness of cardiovascular therapies: who cares about economic analyses?
Statistics in medicine 2002;21(19):2889-97.
2002: Eugene Braunwald; Elliott M Antman; John W Beasley; Robert M Califf; Melvin D Cheitlin; Judith S Hochman; Robert H Jones; Dean J Kereiakes; Joel Kupersmith; Thomas N Levin; Carl J Pepine; John W Schaeffer; Earl E Smith; David E Steward; Pierre Theroux; Raymond J Gibbons; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Sidney C Smith
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina).
Journal of the American College of Cardiology 2002;40(7):1366-74.
2002: Michael S Lee; Andreas U Wali; Venu Menon; Scott Darrell Berkowitz; Trevor D Thompson; Robert M Califf; Eric J Topol; Christopher B Granger; Judith S Hochman
The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIb.
Journal of thrombosis and thrombolysis 2002;14(2):91-101.
2002: Eugene Braunwald; Elliott M Antman; John W Beasley; Robert M Califf; Melvin D Cheitlin; Judith S Hochman; Robert H Jones; Dean J Kereiakes; Joel Kupersmith; Thomas N Levin; Carl J Pepine; John W Schaeffer; Earl E Smith; David E Steward; Pierre Theroux; Raymond J Gibbons; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Sidney C Smith
ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
Circulation 2002;106(14):1893-900.
2002: Stefan James; Paul Armstrong; Robert M Califf; Steen E Husted; Fredrik Kontny; M Niemminen; M Pfisterer; Maarten L Simoons; Lars Wallentin
Safety and efficacy of abciximab combined with dalteparin in treatment of acute coronary syndromes.
European heart journal 2002;23(19):1538-45.
2002: Cheuk-Kit Wong; Harvey D White; Robert G Wilcox; Douglas A Criger; Robert M Califf; Eric J Topol; Erik Ohman
Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.
Heart (British Cardiac Society) 2002;88(4):357-62.
2002: Rajendra H Mehta; Douglas A Criger; Christopher B Granger; Karen K Pieper; Robert M Califf; Eric J Topol; Eric R Bates
Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capability.
Journal of the American College of Cardiology 2002;40(6):1034-40; discussion 1041-3.
2002: Wayne B Batchelor; Thaddeus R Tolleson; Yao Huang; Rhonda L Larsen; R Michael Mantell; Patricia Dillard; Marie Davidian; Daowen Zhang; Warren J Cantor; Michael H Sketch; Erik Ohman; James P Zidar; Daniel Gretler; Peter M DiBattiste; James E Tcheng; Robert M Califf; Robert A Harrington
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide.
Circulation 2002;106(12):1470-6.
2002: Dean J Kereiakes; A Michael Lincoff; Keaven M Anderson; Robert Achenbach; Kamlesh Patel; Elliot Barnathan; Robert M Califf; Eric J Topol
Abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile.
The American journal of cardiology 2002;90(6):628-30.
2002: David F Kong; Vic Hasselblad; David E Kandzari; L Kristin Newby; Robert M Califf
Seeking the optimal aspirin dose in acute coronary syndromes.
The American journal of cardiology 2002;90(6):622-5.
2002: Marino Labinaz; Mina Madan; J O'Conor O'Shea; Rakhi Kilaru; Wai Chin; Karen S Pieper; Darren K McGuire; Jorge F Saucedo; J David Talley; Henry Lui; Michael M Kitt; Robert M Califf; James T Tcheng
Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial).
The American journal of cardiology 2002;90(6):585-90.
2002: William B Hillegass; Brigitta C Brott; Gregory D Chapman; Harry R Phillips; Richard S Stack; James E Tcheng; Robert M Califf
Relationship between activated clotting time during percutaneous intervention and subsequent bleeding complications.
American heart journal 2002;144(3):501-7.
2002: Robert M Califf; David L DeMets
Principles from clinical trials relevant to clinical practice: Part II.
Circulation 2002;106(9):1172-5.
2002: Robert M Califf; David L DeMets
Principles from clinical trials relevant to clinical practice: Part I.
Circulation 2002;106(8):1015-21.
2002: Jassim Al Suwaidi; Donal N Reddan; Kathryn Williams; Karen S Pieper; Robert A Harrington; Robert M Califf; Christopher B Granger; Erik Ohman; David R Holmes
Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes.
Circulation 2002;106(8):974-80.
2002: Milton Packer; Robert M Califf; Marvin A Konstam; Henry Krum; John J McMurray; Jean-Lucien Rouleau; Karl Swedberg
Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
Circulation 2002;106(8):920-6.
2002: Alexander H Glassman; Christopher M O'Connor; Robert M Califf; Karl Swedberg; Peter Schwartz; J Thomas Bigger; K Ranga Rama Krishnan; Louis T van Zyl; J Robert Swenson; Mitchell S Finkel; Charles Landau; Peter A Shapiro; Carl J Pepine; Jack Mardekian; Wilma M Harrison; David Barton; Michael Mclvor
Sertraline treatment of major depression in patients with acute MI or unstable angina.
JAMA : the journal of the American Medical Association 2002;288(6):701-9.
2002: David L DeMets; Robert M Califf
Lessons learned from recent cardiovascular clinical trials: Part II.
Circulation 2002;106(7):880-6.
2002: David L DeMets; Robert M Califf
Lessons learned from recent cardiovascular clinical trials: Part I.
Circulation 2002;106(6):746-51.
2002: L Kristin Newby; Robert A Harrington; Manjushri Bhapkar; Frans Van de Werf; Judith S Hochman; Christopher B Granger; R John Simes; Catherine G Davis; Eric J Topol; Robert M Califf; David J Moliterno
An automated strategy for bedside aPTT determination and unfractionated heparin infusion adjustment in acute coronary syndromes: insights from PARAGON A.
Journal of thrombosis and thrombolysis 2002;14(1):33-42.
2002: Nancy M Allen LaPointe; Judith M Kramer; Kevin P Weinfurt; Robert M Califf
Practitioner acceptance of the dofetilide risk-management program.
Pharmacotherapy 2002;22(8):1041-6.
2002: david kent; Rodney A Hayward; John Griffith; Sandeep Vijan; Joni R Beshansky; Robert M Califf; Harry P Selker
An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase.
The American journal of medicine 2002;113(2):104-11.
2002: Kandice Kottke-Marchant; Maria Cecilia Bahit; Christopher B Granger; P Zoldhelyi; D Ardissino; L Brooks; J H Griffin; R F Potthoff; Frans Van de Werf; Robert M Califf; Eric J Topol
Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes; the GUSTO-IIb haemostasis substudy.
European heart journal 2002;23(15):1202-12.
2002: Sana M Al-Khatib; Christopher B Granger; Yao Huang; Kerry L Lee; Robert M Califf; Maarten L Simoons; Paul W Armstrong; Frans Van de Werf; Harvey D White; R John Simes; David J Moliterno; Eric J Topol; Robert A Harrington
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes.
Circulation 2002;106(3):309-12.
2002: Christopher M O'Connor; Eric J Velazquez; Laura H Gardner; Peter K Smith; Mark F Newman; Kevin Paul Landolfo; Kerry L Lee; Robert M Califf; Robert H Jones
Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank).
The American journal of cardiology 2002;90(2):101-7.
2002: Martin P Moya; Andrew J Gow; Robert M Califf; Ronald N Goldberg; Jonathan S Stamler
Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn.
Lancet 2002;360(9327):141-3.
2002: David E Kandzari; Robert M Califf
TARGET versus GUSTO-IV: appropriate use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes and percutaneous coronary intervention.
Current opinion in cardiology 2002;17(4):332-9.
2002: David Whellan; Elizabeth J Cohen; David B Matchar; Robert M Califf
Disease management in healthcare organizations: results of in-depth interviews with disease management decision makers.
The American journal of managed care 2002;8(7):633-41.
2002: Eric J Topol; A Michael Lincoff; Dean J Kereiakes; Neal S Kleiman; Eric A Cohen; James J Ferguson; James E Tcheng; Shelly K Sapp; Robert M Califf
Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization.
The American journal of medicine 2002;113(1):1-6.
2002: R David Anderson; Harvey D White; Erik Ohman; Galen S Wagner; Mitchell W Krucoff; Paul W Armstrong; W Douglas Weaver; W Brian Gibler; Amanda L Stebbins; Robert M Califf; Eric J Topol
Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries.
American heart journal 2002;144(1):81-8.
2002: Ian C Gilchrist; Scott Darrell Berkowitz; Trevor D Thompson; Robert M Califf; Christopher B Granger
Heparin dosing and outcome in acute coronary syndromes: the GUSTO-IIb experience. Global Use of Strategies to Open Occluded Coronary Arteries.
American heart journal 2002;144(1):73-80.
2002: Wei-Ching Chang; Robert A Harrington; Maarten L Simoons; Robert M Califf; A Michael Lincoff; Paul W Armstrong
Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial.
European heart journal 2002;23(14):1102-11.
2002: Ronnier J Aviles; Arman T Askari; Bertil Lindahl; Lars Wallentin; Gang Jia; Erik Ohman; Kenneth W Mahaffey; L Kristin Newby; Robert M Califf; Maarten L Simoons; Eric J Topol; Peter Berger; Michael Lauer
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction.
The New England journal of medicine 2002;346(26):2047-52.
2002: Eelko Ronner; eric boersma; Gert-Jan Laarman; G Aernout Somsen; Robert A Harrington; Jaap Deckers; Eric J Topol; Robert M Califf; Maarten L Simoons
Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable angina: Receptor Suppression Using Integrilin Therapy.
Journal of the American College of Cardiology 2002;39(12):1924-9.
2002: L Kristin Newby; Arni Kristinsson; Manjushri Bhapkar; Philip E Aylward; Alexios P Dimas; Werner W Klein; Darren K McGuire; David J Moliterno; Freek W A Verheugt; W Douglas Weaver; Robert M Califf
Early statin initiation and outcomes in patients with acute coronary syndromes.
JAMA : the journal of the American Medical Association 2002;287(23):3087-95.
2002: Warren J Cantor; L Kristin Newby; Robert H Christenson; Robert H Tuttle; Vic Hasselblad; Paul W Armstrong; David J Moliterno; Robert M Califf; Eric J Topol; Erik Ohman
Prognostic significance of elevated troponin I after percutaneous coronary intervention.
Journal of the American College of Cardiology 2002;39(11):1738-44.
2002: Robert M Califf
The need for a national infrastructure to improve the rational use of therapeutics.
Pharmacoepidemiology and drug safety 2002;11(4):319-27.
2002: L Kristin Newby; Robert M Califf; Harvey D White; Robert A Harrington; Frans Van de Werf; Christopher B Granger; R John Simes; Vic Hasselblad; Paul W Armstrong
The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events.
The American journal of medicine 2002;112(8):647-58.
2002: Monica R Shah; Vic Hasselblad; Sandra S Stinnett; Judith M Kramer; Steven Grossman; Mihai Gheorghiade; Kirkwood F Adams; Karl Swedberg; Robert M Califf; Christopher M O'Connor
Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure.
European journal of heart failure 2002;4(3):297-304.
2002: Lynda A Szczech; P J Best; E Crowley; Maria Mori Brooks; Peter B Berger; V Bittner; Bernard J Gersh; R Jones; Robert M Califf; H H Ting; P J Whitlow; Katherine M Detre; D Holmes
Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation.
Circulation 2002;105(19):2253-8.
2002: Nancy M Allen LaPointe; Judith M Kramer; Elizabeth R DeLong; Truls Ostbye; Bradley G Hammill; Lawrence H Muhlbaier; Charles B McCants; Anita Chen; Robert M Califf
Patient-reported frequency of taking aspirin in a population with coronary artery disease.
The American journal of cardiology 2002;89(9):1042-6.
2002: Kevin Kip; Edwin L Alderman; Martial G Bourassa; Maria Mori Brooks; Leonard Schwartz; David R Holmes; Robert M Califf; Patrick L Whitlow; Bernard R Chaitman; Katherine M Detre
Differential influence of diabetes mellitus on increased jeopardized myocardium after initial angioplasty or bypass surgery: bypass angioplasty revascularization investigation.
Circulation 2002;105(16):1914-20.
2002: Robert M Califf
The coxib story: some lessons and more questions.
The American journal of cardiology 2002;89(8):971-2.
2002: Michael S Cuffe; Robert M Califf; Kirkwood F Adams; Raymond L Benza; Robert Bourge; Wilson S Colucci; Barrie Massie; Christopher M O'Connor; Ileana Pina; Rebecca Quigg; Marc A Silver; Mihai Gheorghiade
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2002;287(12):1541-7.
2002: Robert M Califf; Elizabeth R DeLong; Truls Ostbye; Lawrence H Muhlbaier; Anita Chen; Nancy Allen LaPointe; Bradley G Hammill; Charles B McCants; Judith M Kramer
Underuse of aspirin in a referral population with documented coronary artery disease.
The American journal of cardiology 2002;89(6):653-61.
2002: J Conor O'Shea; Christopher E Buller; Warren J Cantor; A Bleakley Chandler; Eric A Cohen; David J Cohen; Ian C Gilchrist; Neal S Kleiman; Marino Labinaz; Mina Madan; Gail E Hafley; Robert M Califf; Michael M Kitt; John Strony; James E Tcheng
Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention.
JAMA : the journal of the American Medical Association 2002;287(5):618-21.
2002: Kenneth W Mahaffey; Matthew T Roe; Christopher K Dyke; L Kristin Newby; Neal S Kleiman; Patty Connolly; Lisa G Berdan; rodney sparapani; Kerry L Lee; Paul W Armstrong; Eric J Topol; Robert M Califf; Robert A Harrington
Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Trial.
American heart journal 2002;143(2):242-8.
2002: Robert M Califf
Publication policy, informed consent, and the randomized clinical trial.
American heart journal 2002;143(2):187-8.
2002: W Brian Gibler; Paul W Armstrong; Erik Ohman; W Douglas Weaver; Amanda L Stebbins; Joel M Gore; L Kristin Newby; Robert M Califf; Eric J Topol
Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience.
Annals of emergency medicine 2002;39(2):123-30.
2002: Eelko Ronner; eric boersma; K Martijn Akkerhuis; Robert A Harrington; A Michael Lincoff; Jaap Deckers; K Karsch; N S Kleiman; A Vahanian; Eric J Topol; Robert M Califf; Maarten L Simoons
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker.
European heart journal 2002;23(3):239-46.
2002: Marino Labinaz; Rakhi Kilaru; Karen S Pieper; Steven P Marso; Michael M Kitt; Maarten L Simoons; Robert M Califf; Eric J Topol; Paul W Armstrong; Robert A Harrington
Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
Circulation 2002;105(3):322-7.
2002: eric boersma; Robert A Harrington; David J Moliterno; Harvey White; Pierre Théroux; Frans Van de Werf; Anneke de Torbal; Paul W Armstrong; Lars Wallentin; Robert G Wilcox; R John Simes; Robert M Califf; Eric J Topol; Maarten L Simoons
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.
Lancet 2002;359(9302):189-98.
2002: Stefano Savonitto; Christopher B Granger; Diego Ardissino; Laura Gardner; Claudio Cavallini; Marcello Galvani; Filippo Ottani; Harvey D White; Paul W Armstrong; Erik Ohman; Karen S Pieper; Robert M Califf; Eric J Topol
The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes.
Journal of the American College of Cardiology 2002;39(1):22-9.
2002: Arno Breeman; Nestor Mercado; Mattie Lenzen; Marcel M J van den Brand; Robert A Harrington; Robert M Califf; Eric J Topol; Maarten L Simoons; eric boersma
Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy).
Cardiology 2002;98(4):195-201.
2002: Yochai Birnbaum; Kenneth W Mahaffey; Douglas A Criger; Kathy B Gates; Gabriel I Barbash; Alejandro Barbagelata; Peter Clemmensen; Elena B Sgarbossa; Raymond J Gibbons; M Atiar Rahman; Robert M Califf; Chistopher B Granger; Galen S Wagner
Grade III ischemia on presentation with acute myocardial infarction predicts rapid progression of necrosis and less myocardial salvage with thrombolysis.
Cardiology 2002;97(3):166-74.
2001: Rowena J Dolor; David L Witsell; A S Hellkamp; J W Williams; Robert M Califf; D L Simel
Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2001;286(24):3097-105.
2001: Matthew T Roe; Christopher B Granger; JA Puma; Anne S Hellkamp; Judith S Hochman; Erik Ohman; Harvey D White; Frans Van de Werf; Paul W Armstrong; S G Ellis; Robert M Califf; Eric J Topol
Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.
The American journal of cardiology 2001;88(12):1403-6, A6.
2001: Marco Roffi; Derek P Chew; Debabrata Mukherjee; Deepak L Bhatt; J A White; Christopher Heeschen; C W Hamm; David J Moliterno; Robert M Califf; Harvey D White; Neal S Kleiman; P Théroux; Eric J Topol
Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes.
Circulation 2001;104(23):2767-71.
2001: Frans Van de Werf; H V Barron; P W Armstrong; Christopher B Granger; S Berioli; G Barbash; K Pehrsson; F W Verheugt; J Meyer; A Betriu; Robert M Califf; X Li; NL Fox
Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA.
European heart journal 2001;22(24):2253-61.
2001: Mark P Donahue; V Fuster; Robert M Califf
Results of Expert Meetings: Obesity and Cardiovascular Disease. Introduction: Cardiologists should target obesity.
American heart journal 2001;142(6):1088-90.
2001: James E Tcheng; J D Talley; J Conor O'Shea; Ian C Gilchrist; Neal S Kleiman; Cindy L Grines; C J Davidson; A Michael Lincoff; Robert M Califf; L K Jennings; Michael M Kitt; Todd J Lorenz
Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study).
The American journal of cardiology 2001;88(10):1097-102.
2001: Monica R Shah; Vic Hasselblad; Mihai Gheorghiade; Kirkwood F Adams; Karl Swedberg; Robert M Califf; Christopher M O'Connor
Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy.
The American journal of cardiology 2001;88(9):987-93.
2001: David E Kandzari; L C Lam; Eric L Eisenstein; Nancy E Clapp-Channing; J T Fine; Robert M Califf; Daniel B Mark; James G Jollis
Advanced coronary artery disease: Appropriate end points for trials of novel therapies.
American heart journal 2001;142(5):843-51.
2001: Yochai Birnbaum; S Goodman; A Barr; Kathy B Gates; Gabriel I Barbash; Alexander Battler; Alejandro Barbagelata; Peter Clemmensen; Elena B Sgarbossa; Christopher B Granger; Robert M Califf; Galen S Wagner
Comparison of primary coronary angioplasty versus thrombolysis in patients with ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogram.
The American journal of cardiology 2001;88(8):842-7.
2001: Michael P Hudson; Christopher B Granger; Eric J Topol; Karen S Pieper; Paul W Armstrong; G I Barbash; AD Guerci; A Vahanian; Robert M Califf; Erik Ohman
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.
Circulation 2001;104(11):1229-35.
2001: Christopher M O'Connor; Wendy A Gattis; Anne S Hellkamp; Anatoly Langer; R L Larsen; Robert A Harrington; Scott Darrell Berkowitz; Patrick T O'Gara; Stephen L Kopecky; Mihai Gheorghiade; R Daly; Robert M Califf; V Fuster
Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS).
The American journal of cardiology 2001;88(5):541-6.
2001: Elizabeth R DeLong; C L Nelson; John Wong; DB Pryor; eric peterson; K L Lee; Daniel B Mark; Robert M Califf; Stephen G Pauker
Using observational data to estimate prognosis: an example using a coronary artery disease registry.
Statistics in medicine 2001;20(16):2505-32.
2001: Wei Jiang; J Alexander; Eric J Christopher; Maragatha Kuchibhatla; Laura H Gaulden; Michael S Cuffe; Michael A Blazing; C Davenport; Robert M Califf; Ranga R Krishnan; Christopher M O'Connor
Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure.
Archives of internal medicine 2001;161(15):1849-56.
2001: Michael A Blazing; James A de Lemos; Christopher K Dyke; Robert M Califf; David W Bilheimer; Eugene Braunwald
The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy.
American heart journal 2001;142(2):211-7.
2001: K Martijn Akkerhuis; Jaap Deckers; A Michael Lincoff; J E Tcheng; eric boersma; K Anderson; C Balog; Robert M Califf; Eric J Topol; Maarten L Simoons
Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention.
JAMA : the journal of the American Medical Association 2001;286(1):78-82.
2001: P Kaul; Yuling Fu; W C Chang; Robert A Harrington; Galen S Wagner; Shaun G Goodman; Christopher B Granger; D J Moliterno; Frans Van de Werf; Robert M Califf; Eric J Topol; Paul W Armstrong
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network.
Journal of the American College of Cardiology 2001;38(1):64-71.
2001: K P Alexander; L K Newby; A S Hellkamp; Robert A Harrington; E D Peterson; Stephen L Kopecky; A Langer; Patrick T O'Gara; C M O'Connor; R N Daly; Robert M Califf; S Khan; V Fuster
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up.
Journal of the American College of Cardiology 2001;38(1):1-7.
2001: David Whellan; Linda K Shaw; Bradley A Bart; William E Kraus; Robert M Califf; Christopher M O'Connor
Cardiac rehabilitation and survival in patients with left ventricular systolic dysfunction.
American heart journal 2001;142(1):160-6.
2001: Conor F Lundergan; Allan M Ross; WF McCarthy; Jonathan S Reiner; D Boyle; C Fink; Robert M Califf; Eric J Topol; M L Simoons; M Van Den Brand; F Van de Werf; KS Coyne
Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO-I angiographic experience.
American heart journal 2001;142(1):43-50.
2001: Sana M Al-Khatib; Karen S Pieper; K L Lee; Kenneth W Mahaffey; Judith S Hochman; C J Pepine; S L Kopecky; M Akkerhuis; J Stepinska; Maarten L Simoons; Eric J Topol; Robert M Califf; Robert A Harrington
Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial.
The American journal of cardiology 2001;88(1):A7, 76-9.
2001: Lynda A Szczech; Donal N Reddan; William F Owen; Robert M Califf; Michael J Racz; R H Jones; Edward L Hannan
Differential survival after coronary revascularization procedures among patients with renal insufficiency.
Kidney international 2001;60(1):292-9.
2001: L Kristin Newby; Erik Ohman; Robert H Christenson; D J Moliterno; Robert A Harrington; Harvey D White; Paul W Armstrong; Frans Van de Werf; M Pfisterer; Vic Hasselblad; Robert M Califf; Eric J Topol
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy.
Circulation 2001;103(24):2891-6.
2001: KM Anderson; Robert M Califf; G W Stone; F J Neumann; Gilles Montalescot; DP Miller; James J Ferguson; J T Willerson; HF Weisman; Eric J Topol
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention.
Journal of the American College of Cardiology 2001;37(8):2059-65.
2001: Sana M Al-Khatib; Robert M Califf; V Hasselblad; John H Alexander; D C McCrory; Jeremy Sugarman
Medicine. Placebo-controls in short-term clinical trials of hypertension.
Science (New York, N.Y.) 2001;292(5524):2013-5.
2001: Monica R Shah; Vic Hasselblad; Sandra S Stinnett; Mihai Gheorghiade; Karl Swedberg; Robert M Califf; Christopher M O'Connor
Hemodynamic profiles of advanced heart failure: association with clinical characteristics and long-term outcomes.
Journal of cardiac failure 2001;7(2):105-13.
2001: Warren J Cantor; Anne S Hellkamp; eric peterson; James P Zidar; Patricia A Cowper; Michael H Sketch; J E Tcheng; Robert M Califf; Erik Ohman
Achieving optimal results with standard balloon angioplasty: can baseline and angiographic variables predict stent-like outcomes?
Journal of the American College of Cardiology 2001;37(7):1883-90.
2001: Monica R Shah; Sandra S Stinnett; S E McNulty; Mihai Gheorghiade; Faiez Zannad; B Uretsky; Kirkwood F Adams; Robert M Califf; Christopher M O'Connor
Hemodynamics as surrogate end points for survival in advanced heart failure: an analysis from FIRST.
American heart journal 2001;141(6):908-14.
2001: J Conor O'Shea; Robert M Califf
International differences in treatment effects in cardiovascular clinical trials.
American heart journal 2001;141(5):875-80.
2001: J Conor O'Shea; Robert M Califf
International differences in cardiovascular clinical trials.
American heart journal 2001;141(5):866-74.
2001: J Conor O'Shea; Robert M Califf
International differences in cardiovascular clinical trials. Introduction.
American heart journal 2001;141(5):864-5.
2001: S T Mast; K R Gersing; Kevin J Anstrom; K R Krishnan; Robert M Califf; James G Jollis
Association between selective serotonin-reuptake inhibitor therapy and heart valve regurgitation.
The American journal of cardiology 2001;87(8):989-93: A4.
2001: Herbert D Aronow; Eric J Topol; M T Roe; Penny L Houghtaling; Kathy Wolski; A Michael Lincoff; Robert A Harrington; Robert M Califf; Erik Ohman; Neal S Kleiman; Mátyás Keltai; Robert G Wilcox; Alec Vahanian; Paul W Armstrong; Michael Lauer
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study.
Lancet 2001;357(9262):1063-8.
2001: L Pilote; D P Miller; Robert M Califf; Eric J Topol
Recurrent ischemia after thrombolysis for acute myocardial infarction.
American heart journal 2001;141(4):559-65.
2001: M R Shah; Christopher M O'Connor; G Sopko; Vic Hasselblad; Robert M Califf; L W Stevenson
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale.
American heart journal 2001;141(4):528-35.
2001: Maria Cecilia Bahit; Eric J Topol; Robert M Califf; Paul W Armstrong; Douglas A Criger; Vic Hasselblad; A Betriu; J Hirsh; D Ardissino; Christopher B Granger
Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes.
Journal of the American College of Cardiology 2001;37(4):1001-7.
2001: M A Morse; Robert M Califf; Jeremy Sugarman
Monitoring and ensuring safety during clinical research.
JAMA : the journal of the American Medical Association 2001;285(9):1201-5.
2001: Marino Labinaz; M H Sketch; Stephen G Ellis; Bruce M. Abramowitz; Amanda L Stebbins; Karen S Pieper; D R Holmes; Robert M Califf; Eric J Topol
Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy.
American heart journal 2001;141(3):469-77.
2001: Mauricio G. Cohen; C M Pacchiana; R Corbalán; J E Perez; C I Ponte; E S Oropeza; R Diaz; EA Paolasso; D Izasa; M A Rodas; C E Urrutia; Robert A Harrington; Eric J Topol; Robert M Califf
Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial.
American heart journal 2001;141(3):391-401.
2001: JG Peterson; Eric J Topol; M T Roe; Shelly K Sapp; A Michael Lincoff; J W Deckers; Eugene Blackstone; Robert A Harrington; Robert M Califf; Michael Lauer
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.
The American journal of cardiology 2001;87(5):532-6.
2001: G I Barbash; Y Birnbaum; Kris Bogaerts; M Hudson; E Lesaffre; Y Fu; S Goodman; K Houbracken; K Munsters; C B Granger; K Pieper; Robert M Califf; Eric J Topol; F Van De Werf
Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies.
Circulation 2001;103(7):954-60.
2001: Adam B Greenbaum; Robert A Harrington; Michael P Hudson; C M MacAulay; Robert G Wilcox; Maarten L Simoons; Lisa G Berdan; AD Guerci; D V Cokkinos; Michael M Kitt; A Michael Lincoff; Eric J Topol; Robert M Califf; Erik Ohman
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators.
Journal of the American College of Cardiology 2001;37(2):492-8.
2001: Robert M Califf; S S Ellenberg
Statistical approaches and policies for the operations of Data and Safety Monitoring Committees.
American heart journal 2001;141(2):301-5.
2001: Stefano Savonitto; Rossana Fusco; Christopher B Granger; Mauricio G. Cohen; TD Thompson; Diego Ardissino; Robert M Califf
Clinical, electrocardiographic, and biochemical data for immediate risk stratification in acute coronary syndromes.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2001;6(1):64-77.
2001: Matthew T Roe; Erik Ohman; Arthur C P Maas; Robert H Christenson; Kenneth W Mahaffey; Christopher B Granger; Robert A Harrington; Robert M Califf; Mitchell W Krucoff
Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion.
Journal of the American College of Cardiology 2001;37(1):9-18.
2001: Robert M Califf; Kerry L Lee
Data and safety monitoring committees: philosophy and practice.
American heart journal 2001;141(1):154-5.
2000: Robert M Califf
Introduction: evidence to practice in acute coronary syndromes.
The American journal of cardiology 2000;86(12B):1M-3M.
2000: A B Greenbaum; Robert M Califf; Robert H Jones; Laura H Gardner; Harry R Phillips; Michael H Sketch; Richard S Stack; JA Puma
Comparison of medicine alone, coronary angioplasty, and left internal mammary artery-coronary artery bypass for one-vessel proximal left anterior descending coronary artery disease.
The American journal of cardiology 2000;86(12):1322-6.
2000: Steven P Marso; D L Bhatt; M T Roe; Penny L Houghtaling; Marino Labinaz; N S Kleiman; CM Dyke; M L Simmoons; Robert M Califf; Robert A Harrington; Eric J Topol
Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT Investigators.
Circulation 2000;102(24):2952-8.
2000: A Michael Lincoff; D B Mark; James E Tcheng; Robert M Califf; M V Bala; KM Anderson; L Davidson-Ray; J D Knight; CF Cabot; Eric J Topol
Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade.
Circulation 2000;102(24):2923-9.
2000: K R Campbell; Kenneth W Mahaffey; Bruce E Lewis; J I Weitz; Scott Darrell Berkowitz; Erik Ohman; Robert M Califf
Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
The Journal of invasive cardiology 2000;12 Suppl F():14F-9.
2000: A D Auerbach; M B Hamel; Robert M Califf; R B Davis; N S Wenger; N Desbiens; Lee Goldman; Humberto Vidaillet; A F Connors; J Lynn; Neal V Dawson; R S Phillips
Patient characteristics associated with care by a cardiologist among adults hospitalized with severe congestive heart failure. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
Journal of the American College of Cardiology 2000;36(7):2119-25.
2000: Robert M Califf; Eric L Eisenstein
Critical concepts in cost-effectiveness for cardiovascular specialists.
American heart journal 2000;140(6 Suppl):S143-7.
2000: Cheuk-Kit Wong; Harvey D White; Robert G Wilcox; Douglas A Criger; Robert M Califf; Eric J Topol; Erik Ohman
New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience.
American heart journal 2000;140(6):878-85.
2000: Venu Menon; Judith S Hochman; Amanda L Stebbins; Matthias Pfisterer; Jacques Col; R D Anderson; D Hasdai; D R Holmes; Eric R Bates; Eric J Topol; Robert M Califf; Erik Ohman
Lack of progress in cardiogenic shock: lessons from the GUSTO trials.
European heart journal 2000;21(23):1928-36.
2000: Howard C Herrmann; David J Moliterno; Erik Ohman; Amanda L Stebbins; C Bode; A Betriu; F Forycki; J S Miklin; W B Bachinsky; A Michael Lincoff; Robert M Califf; Eric J Topol
Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial.
Journal of the American College of Cardiology 2000;36(5):1489-96.
2000: Marc A Pfeffer; J McMurray; Alain Leizorovicz; Aldo P Maggioni; Jean-Lucien Rouleau; Frans Van de Werf; Marc Henis; ERIC NEUHART; P Gallo; Susan Edwards; Mary Ann Sellers; Eric J Velazquez; Robert M Califf
Valsartan in acute myocardial infarction trial (VALIANT): rationale and design.
American heart journal 2000;140(5):727-50.
2000: D K McGuire; H Emanuelsson; Christopher B Granger; E Magnus Ohman; D J Moliterno; H D White; D Ardissino; J W Box; Robert M Califf; Eric J Topol
Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators.
European heart journal 2000;21(21):1750-8.
2000: M R Shah; Christopher B Granger; BA Bart; J J McMurray; M C Petrie; Eric L Michelson; Gail Tudor; Karl Swedberg; L W Stevenson; Robert M Califf; Marc A Pfeffer
Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry.
The American journal of medicine 2000;109(6):489-92.
2000: Christopher M O'Connor; Wendy A Gattis; L Shaw; Michael S Cuffe; Robert M Califf
Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function.
The American journal of cardiology 2000;86(8):863-7.
2000: Yochai Birnbaum; Galen S Wagner; Kathy B Gates; TD Thompson; Gabriel I Barbash; R J Siegel; Christopher B Granger; M C Fishbein; B S Crenshaw; Robert M Califf
Clinical and electrocardiographic variables associated with increased risk of ventricular septal defect in acute anterior myocardial infarction.
The American journal of cardiology 2000;86(8):830-4.
2000: Eric J Topol; Erik Ohman; Paul W Armstrong; Robert Wilcox; A M Skene; Philip E Aylward; R John Simes; A Dalby; Amadeo Betriu; C Bode; Harvey D White; Judith S Hochman; H Emanuelson; A Vahanian; Shelly K Sapp; Amanda L Stebbins; David J Moliterno; Robert M Califf
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial.
Circulation 2000;102(15):1761-5.
2000: Wei-Ching Chang; Yuling Fu; Erik Ohman; M Gupta; A Morris; S N Roth; Christopher B Granger; Robert M Califf; Eric J Topol; Daniel B Mark; Paul W Armstrong
Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators.
The Canadian journal of cardiology 2000;16(10):1231-9.
2000: Robert M Califf
Genetics, genomics, proteomics: what is a cardiologist to do?
American heart journal 2000;140(4):S48-50.
2000: Yuling Fu; Wei-Ching Chang; Daniel Mark; Robert M Califf; B Mackenzie; Christopher B Granger; Eric J Topol; M Hlatky; Paul W Armstrong
Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators.
Circulation 2000;102(12):1375-81.
2000: Robert M Califf
Cigarette smoking: how much worse can it get?
Circulation 2000;102(12):1340-1.
2000: Eugene Braunwald; Elliott M Antman; John W Beasley; Robert M Califf; Melvin D Cheitlin; Judith S Hochman; Robert H Jones; Dean J Kereiakes; Joel Kupersmith; Thomas N Levin; Carl J Pepine; John W Schaeffer; Earl E Smith; David E Steward; Pierre Theroux; Raymond J Gibbons; Joseph S Alpert; Kim A Eagle; David P Faxon; Valentin Fuster; Timothy J Gardner; Gabriel Gregoratos; Richard O Russell; Sidney C Smith
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina).
Circulation 2000;102(10):1193-209.
2000: M T Roe; Robert A Harrington; D M Prosper; Karen S Pieper; D L Bhatt; A Michael Lincoff; Maarten L Simoons; M Akkerhuis; Erik Ohman; Michael M Kitt; A Vahanian; W Ruzyllo; K Karsch; Robert M Califf; Eric J Topol
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators.
Circulation 2000;102(10):1101-6.
2000: A Michael Lincoff; Robert A Harrington; Robert M Califf; Judith S Hochman; AD Guerci; Erik Ohman; Carl J Pepine; S L Kopecky; Neal S Kleiman; Cindy M Pacchiana; Lisa G Berdan; Michael M Kitt; Maarten L Simoons; Eric J Topol
Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
Circulation 2000;102(10):1093-100.
2000: Eugene Braunwald; Elliott M Antman; John W Beasley; Robert M Califf; Melvin D Cheitlin; Judith S Hochman; Robert H Jones; Dean J Kereiakes; Joel Kupersmith; Thomas N Levin; Carl J Pepine; John W Schaeffer; Earl E Smith; David E Steward; Pierre Theroux; Joseph S Alpert; Kim A Eagle; David P Faxon; Valentin Fuster; Timothy J Gardner; Gabriel Gregoratos; Richard O Russell; Sidney C Smith
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
Journal of the American College of Cardiology 2000;36(3):970-1062.
2000: Shaun G Goodman; Marc Cohen; Frederique Bigonzi; Enrique P Gurfinkel; David Radley; V Le Iouer; GJ Fromell; C Demers; Alexander G G Turpie; Robert M Califf; Keith A A Fox; Anatoly Langer
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events.
Journal of the American College of Cardiology 2000;36(3):693-8.
2000: David Hasdai; Robert A Harrington; Judith S Hochman; Robert M Califf; Alexander Battler; J W Box; Maarten L Simoons; J Deckers; Eric J Topol; David R Holmes
Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation.
Journal of the American College of Cardiology 2000;36(3):685-92.
2000: Elena B Sgarbossa; P M Meyer; Sergio L Pinski; B Pavlovic-Surjancev; Alejandro Barbagelata; Shaun G Goodman; A S Lum; D A Underwood; Kathy B Gates; Robert M Califf; Eric J Topol; Galen S Wagner
Negative T waves shortly after ST-elevation acute myocardial infarction are a powerful marker for improved survival rate.
American heart journal 2000;140(3):385-94.
2000: David Hasdai; Eric J Topol; Robert M Califf; P B Berger; David R Holmes
Cardiogenic shock complicating acute coronary syndromes.
Lancet 2000;356(9231):749-56.
2000: Robert A Harrington; Paul W Armstrong; Carmelo Graffagnino; Frans Van de Werf; Dean J Kereiakes; Kristina N Sigmon; T Card; Diane M Joseph; R Samuels; Jeffrey Granett; R Chan; Robert M Califf; Eric J Topol
Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease.
Circulation 2000;102(7):728-35.
2000: A Michael Lincoff; L A LeNarz; G J Despotis; P K Smith; Joan E Booth; R E Raymond; Shelly K Sapp; CF Cabot; James E Tcheng; Robert M Califf; M B Effron; Eric J Topol
Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing.
The Annals of thoracic surgery 2000;70(2):516-26.
2000: Leslie Cho; Eric J Topol; Craig Balog; JoAnne M Foody; Joan E Booth; CF Cabot; Neal S Kleiman; James E Tcheng; Robert M Califf; A Michael Lincoff
Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stent.
Journal of the American College of Cardiology 2000;36(2):381-6.
2000: Neal S Kleiman; Robert M Califf
Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000. American College of Cardiology.
Journal of the American College of Cardiology 2000;36(1):310-25.
2000: David C Sane; Lakshmi V Damaraju; Eric J Topol; C F Cabot; Mary Ann Mascelli; Robert A Harrington; Maarten L Simoons; Robert M Califf
Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy.
Journal of the American College of Cardiology 2000;36(1):75-83.
2000: Dean J Kereiakes; Scott Darrell Berkowitz; A Michael Lincoff; James E Tcheng; K Wolski; R Achenbach; R Melsheimer; K Anderson; Robert M Califf; Eric J Topol
Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade.
American heart journal 2000;140(1):74-80.
2000: D B Brieger; K H Mak; D P Miller; Robert M Califf; Eric J Topol
Hierarchy of risk based on history and location of prior myocardial infarction in the thrombolytic era. GUSTO-I Investigators.
American heart journal 2000;140(1):29-33.
2000: Robert M Califf
Dual randomization in cardiovascular trials.
American heart journal 2000;140(1):1.
2000: Alejandro Barbagelata; Robert M Califf; Elena B Sgarbossa; Shaun G Goodman; D Knight; Daniel B Mark; Christopher B Granger; D A Agranatti; B Mautner; Erik Ohman; L D Suárez; Paul W Armstrong; Kathy B Gates; Galen S Wagner
Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial).
The American journal of cardiology 2000;86(1):24-9.
2000: Maria Mori Brooks; R H Jones; R G Bach; Bernard R Chaitman; M J Kern; T A Orszulak; dean follmann; George Sopko; Eugene Blackstone; Robert M Califf
Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators.
Circulation 2000;101(23):2682-9.
2000: eric boersma; K S Pieper; E W Steyerberg; Robert G Wilcox; W C Chang; K L Lee; K Martijn Akkerhuis; Robert A Harrington; Jaap Deckers; Paul W Armstrong; A Michael Lincoff; Robert M Califf; Eric J Topol; Maarten L Simoons
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.
Circulation 2000;101(22):2557-67.
2000: Marc Cohen; Sandra S Stinnett; B D Weatherley; Enrique P Gurfinkel; GJ Fromell; Shaun G Goodman; Keith A A Fox; Robert M Califf
Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy.
American heart journal 2000;139(6):962-70.
2000: Eric J Topol; J Donald Easton; P Amarenco; Robert M Califf; Robert A Harrington; Carmelo Graffagnino; S Davis; H C Diener; J Ferguson; D Fitzgerald; Ashfaq Shuaib; Peter J Koudstaal; Pierre Theroux; Frans Van de Werf; James T Willerson; R Chan; R Samuels; B Ilson; Jeffrey Granett
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.
American heart journal 2000;139(6):927-33.
2000: Robert M Califf; Karen S Pieper; K L Lee; Frans Van de Werf; R J Simes; Paul W Armstrong; Eric J Topol
Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial.
Circulation 2000;101(19):2231-8.
2000: E J Velazquez; Robert M Califf
All that glitters is not gold.
Lancet 2000;355(9215):1568-9.
2000: Christina M Puchalski; Zhenshao Zhong; M M Jacobs; E Fox; Joanne Lynn; Joan Harrold; A Galanos; Russell S Phillips; Robert M Califf; Joan M Teno
Patients who want their family and physician to make resuscitation decisions for them: observations from SUPPORT and HELP. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Hospitalized Elderly Longitudinal Project.
Journal of the American Geriatrics Society 2000;48(5 Suppl):S84-90.
2000: Neil S Wenger; Russell S Phillips; Joan M Teno; Robert K Oye; Neal V Dawson; Honghu Liu; Robert M Califf; P Layde; R Hakim; Joanne Lynn
Physician understanding of patient resuscitation preferences: insights and clinical implications.
Journal of the American Geriatrics Society 2000;48(5 Suppl):S44-51.
2000: David Hasdai; C B Granger; S S Srivatsa; D A Criger; S G Ellis; Robert M Califf; Eric J Topol; David R Holmes
Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb Angioplasty Substudy. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes.
Journal of the American College of Cardiology 2000;35(6):1502-12.
2000: David Hasdai; David R Holmes; Douglas A Criger; Eric J Topol; Robert M Califf; Robert A Harrington
Age and outcome after acute coronary syndromes without persistent ST-segment elevation.
American heart journal 2000;139(5):858-66.
2000: Deepak L Bhatt; A Michael Lincoff; Robert M Califf; Maarten L Simoons; James E Tcheng; Sorin J Brener; Kathy Wolski; Eric J Topol
The benefit of abciximab in percutaneous coronary revascularization is not device-specific.
The American journal of cardiology 2000;85(9):1060-4.
2000: K Martijn Akkerhuis; Arthur C P Maas; PA Klootwijk; Mitchell W Krucoff; Simon H Meij; Robert M Califf; Maarten L Simoons
Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: relation with death and myocardial infarction. PURSUIT ECG-Ischemia Monitoring Substudy Investigators. Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy.
Journal of electrocardiology 2000;33(2):127-36.
2000: A Michael Lincoff; Robert M Califf; Eric J Topol
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.
Journal of the American College of Cardiology 2000;35(5):1103-15.
2000: L Kristin Newby; A L Kaplan; B B Granger; F Sedor; Robert M Califf; Erik Ohman
Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit.
The American journal of cardiology 2000;85(7):801-5.
2000: Christopher B Granger; G Ertl; Jerzy Kuch; A P Maggioni; john mcmurray; J L Rouleau; L W Stevenson; Karl Swedberg; J Young; Salim Yusuf; Robert M Califf; BA Bart; Peter Held; Eric L Michelson; M A Sellers; G Ohlin; rodney sparapani; Marc A Pfeffer
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors.
American heart journal 2000;139(4):609-17.
2000: M Gent; Robert M Califf
Chronic ischemic heart disease.
American heart journal 2000;139(4):S182-8.
2000: L Kristin Newby; E L Eisenstein; Robert M Califf; T D Thompson; C L Nelson; eric peterson; P W Armstrong; Frans Van de Werf; Harvey D White; Eric J Topol; Daniel B Mark
Cost effectiveness of early discharge after uncomplicated acute myocardial infarction.
The New England journal of medicine 2000;342(11):749-55.
2000: Wayne B Batchelor; Christopher B Granger; Neal S Kleiman; H R Phillips; Stephen G Ellis; A Betriu; Douglas A Criger; Amanda L Stebbins; Eric J Topol; Robert M Califf
A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes.
The American journal of cardiology 2000;85(6):692-7.
2000: Robert M Califf; C M O'Connor
Beta-blocker therapy for heart failure: the evidence is in, now the work begins.
JAMA : the journal of the American Medical Association 2000;283(10):1335-7.
2000: Robert H Christenson; R T Vollmer; Erik Ohman; S Peck; T D Thompson; Show-Hong Duh; S G Ellis; LK Newby; Eric J Topol; Robert M Califf
Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group.
The American journal of cardiology 2000;85(5):543-7.
2000: Eric L Eisenstein; eric peterson; James G Jollis; Barbara E Tardiff; Robert M Califf; J David Knight; Daniel B Mark
Evaluating the potential 'economic attractiveness' of new therapies in patients with non-ST elevation acute coronary syndrome.
PharmacoEconomics 2000;17(3):263-72.
2000: A Shah; Galen S Wagner; Christopher B Granger; Christopher M O'Connor; Cynthia L Green; Kathleen M Trollinger; Robert M Califf; Mitchell W Krucoff
Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment.
Journal of the American College of Cardiology 2000;35(3):666-72.
2000: Sorin J Brener; Stephen G Ellis; Shelly K Sapp; A Betriu; C B Granger; JE Burchenal; David J Moliterno; Robert M Califf; Eric J Topol
Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trials.
American heart journal 2000;139(3):476-81.
2000: David Hasdai; David R Holmes; Douglas A Criger; Eric J Topol; Robert M Califf; Robert G Wilcox; Ernesto Andres Cesar Paolasso; M Simoons; J Deckers; Robert A Harrington
Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide. The PURSUIT trial investigators.
American heart journal 2000;139(3):454-60.
2000: K Martijn Akkerhuis; Jaap Deckers; eric boersma; Robert A Harrington; J Stepinska; Kenneth W Mahaffey; Robert G Wilcox; A Michael Lincoff; Mátyás Keltai; Eric J Topol; Robert M Califf; Maarten L Simoons
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT.
European heart journal 2000;21(5):371-81.
2000: Neal S Kleiman; A Michael Lincoff; G C Flaker; Karen S Pieper; Robert G Wilcox; Lisa G Berdan; Todd J Lorenz; D V Cokkinos; Maarten L Simoons; E Boersma; Eric J Topol; Robert M Califf; Robert A Harrington
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators.
Circulation 2000;101(7):751-7.
2000: M C Thel; Robert M Califf; Barbara E Tardiff; Laura H Gardner; Kristina N Sigmon; A Michael Lincoff; Eric J Topol; Michael M Kitt; James C Blankenship; James E Tcheng
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.
The American journal of cardiology 2000;85(4):427-34.
2000: Daniel B Mark; Robert A Harrington; A Michael Lincoff; Robert M Califf; Charlotte L Nelson; Anastasios A Tsiatis; Hope E Buell; Kenneth W Mahaffey; Linda Davidson-Ray; Eric J Topol
Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes.
Circulation 2000;101(4):366-71.
2000: A D Auerbach; Mary Beth Hamel; Roger B Davis; Alfred F Connors; C Regueiro; Norman A Desbiens; L Goldman; Robert M Califf; Neal V Dawson; Neil Wenger; Humberto Vidaillet; Russell S Phillips
Resource use and survival of patients hospitalized with congestive heart failure: differences in care by specialty of the attending physician. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
Annals of internal medicine 2000;132(3):191-200.
2000: Robert M Califf
Combination therapy for acute myocardial infarction: fibrinolytic therapy and glycoprotein IIb/IIIa inhibition.
American heart journal 2000;139(2 Pt 2):S33-7.
2000: John H Alexander; rodney sparapani; Kenneth W Mahaffey; Jaap Deckers; L Kristin Newby; Erik Ohman; R Corbalán; S L Chierchia; J B Boland; Maarten L Simoons; Robert M Califf; Eric J Topol; Robert A Harrington
Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.
JAMA : the journal of the American Medical Association 2000;283(3):347-53.
2000: B S Crenshaw; Christopher B Granger; Y Birnbaum; Karen S Pieper; D C Morris; Neal S Kleiman; A Vahanian; Robert M Califf; Eric J Topol
Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators.
Circulation 2000;101(1):27-32.
2000: Eugene Braunwald; Robert M Califf; C P Cannon; K A Fox; V Fuster; W B Gibler; Robert A Harrington; S B King; N S Kleiman; P Theroux; Eric J Topol; F Van de Werf; H D White; J T Willerson
Redefining medical treatment in the management of unstable angina.
The American journal of medicine 2000;108(1):41-53.
2000: Russell S Phillips; Mary Beth Hamel; Joan M Teno; J Soukup; Joanne Lynn; Robert M Califf; Humberto Vidaillet; Roger B Davis; Paul E Bellamy; L Goldman
Patient race and decisions to withhold or withdraw life-sustaining treatments for seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
The American journal of medicine 2000;108(1):14-9.
2000: David Hasdai; Robert M Califf; T D Thompson; Judith S Hochman; Erik Ohman; M Pfisterer; Eric R Bates; Alec Vahanian; P W Armstrong; D A Criger; Eric J Topol; David R Holmes
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction.
Journal of the American College of Cardiology 2000;35(1):136-43.
2000: Robert M Califf; J N Cohn
Cardiac protection: evolving role of angiotensin receptor blockers.
American heart journal 2000;139(1 Pt 2):S15-22.
2000: Michael S Cuffe; Robert M Califf; Kirkwood F Adams; Robert Bourge; Wilson S Colucci; B Massie; Christopher M O'Connor; Ileana Pina; Rebecca Quigg; M Silver; L A Robinson; Jeffrey D Leimberger; Mihai Gheorghiade
Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure.
American heart journal 2000;139(1 Pt 1):15-22.
2000: Neal S Kleiman; R P Tracy; J D Talley; Kristina N Sigmon; D Joseph; Eric J Topol; Robert M Califf; Michael M Kitt; Erik Ohman
Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction.
Journal of thrombosis and thrombolysis 2000;9(1):5-12.
1999: Eric J Topol; D B Mark; A Michael Lincoff; E Cohen; J Burton; Neal S Kleiman; D Talley; Shelly K Sapp; J Booth; CF Cabot; KM Anderson; Robert M Califf
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.
Lancet 1999;354(9195):2019-24.
1999: Erik Ohman; Paul W Armstrong; Harvey D White; Christopher B Granger; Robert G Wilcox; W Douglas Weaver; W Brian Gibler; Amanda L Stebbins; C Cianciolo; Robert M Califf; Eric J Topol
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries.
The American journal of cardiology 1999;84(11):1281-6.
1999: Robert M Califf; D R Holmes
Should the emergence of new agents change the management of patients with acute coronary syndromes without ST-segment elevation?
American heart journal 1999;138(6 Pt 2):S586-94.
1999: David R Holmes; Peter B Berger; Judith S Hochman; Christopher B Granger; T D Thompson; Robert M Califf; Alec Vahanian; Eric R Bates; Eric J Topol
Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation.
Circulation 1999;100(20):2067-73.
1999: David F Kong; Eric J Topol; John A Bittl; Harvey D White; P Théroux; Vic Hasselblad; Robert M Califf
Clinical outcomes of bivalirudin for ischemic heart disease.
Circulation 1999;100(20):2049-53.
1999: eric boersma; K Martijn Akkerhuis; P Théroux; Robert M Califf; Eric J Topol; Maarten L Simoons
Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention.
Circulation 1999;100(20):2045-8.
1999: Patrick L Whitlow; A P Dimas; T M Bashore; Robert M Califf; Martial G Bourassa; Bernard R Chaitman; AD Rosen; Kevin Kip; M L Stadius; Edwin L Alderman
Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI).
Journal of the American College of Cardiology 1999;34(6):1750-9.
1999: Mauricio G. Cohen; Christopher B Granger; Erik Ohman; Amanda L Stebbins; Liliana Grinfeld; Arturo Cagide; Marcelo V Elizari; A Betriu; David F Kong; Eric J Topol; Robert M Califf
Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1999;34(6):1729-37.
1999: Kenneth W Mahaffey; JA Puma; N A Barbagelata; M F DiCarli; M A Leesar; K F Browne; P R Eisenberg; Roberto Bolli; A C Casas; V Molina-Viamonte; C Orlandi; R Blevins; Raymond J Gibbons; Robert M Califf; Christopher B Granger
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial.
Journal of the American College of Cardiology 1999;34(6):1711-20.
1999: I C Gilchrist; Laura H Gardner; J B Muhlestein; A M Arnold; A Michael Lincoff; Robert M Califf; James E Tcheng; Eric J Topol
Effect of institutional volume and academic status on outcomes of coronary interventions: the IMPACT-II experience.
American heart journal 1999;138(5 Pt 1):976-82.
1999: D K McGuire; Robert M Califf
Diabetes and cardiovascular disease: current opinions and future directions.
American heart journal 1999;138(5 Pt 1):S327-9.
1999: David F Kong; Robert M Califf
Glycoprotein IIb/IIIa receptor antagonists in non-ST elevation acute coronary syndromes and percutaneous revascularisation: a review of trial reports.
Drugs 1999;58(4):609-20.
1999: A Langer; M Fisher; Robert M Califf; S Goodman; C M O'Connor; Robert A Harrington; V Fuster
Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada. The CARS Investigators (Coumadin/Aspirin Reinfarction Study).
The Canadian journal of cardiology 1999;15(10):1095-102.
1999: Julie M Miller; R Smalling; Erik Ohman; Christoph Bode; A Betriu; Neal S Kleiman; J S Schildcrout; E Bastos; Eric J Topol; Robert M Califf
Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteries.
The American journal of cardiology 1999;84(7):779-84.
1999: Thomas Ryan; Elliott M Antman; N H Brooks; Robert M Califf; L David Hillis; Loren F Hiratzka; E Rapaport; B Riegel; Richard O Russell; E E Smith; W D Weaver; Raymond J Gibbons; Joseph S Alpert; Kim A Eagle; Timothy J Gardner; Arthur Garson; Gabriel Gregoratos; T J Ryan; Sidney C Smith
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
Journal of the American College of Cardiology 1999;34(3):890-911.
1999: Kenneth W Mahaffey; Christopher B Granger; Michael A Sloan; Cynthia L Green; Joel M Gore; W Douglas Weaver; Harvey D White; Maarten L Simoons; Gabriel I Barbash; Eric J Topol; Robert M Califf
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries.
American heart journal 1999;138(3 Pt 1):493-9.
1999: Thomas Ryan; Elliott M Antman; N H Brooks; Robert M Califf; L David Hillis; Loren F Hiratzka; E Rapaport; B Riegel; Richard O Russell; E E Smith; W D Weaver; Raymond J Gibbons; Joseph S Alpert; Kim A Eagle; Timothy J Gardner; Arthur Garson; Gabriel Gregoratos; Sidney C Smith
1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
Circulation 1999;100(9):1016-30.
1999: F Van De Werf; J Adgey; D Ardissino; P W Armstrong; P Aylward; G Barbash; A Betriu; A S Binbrek; Robert M Califf; R Diaz; R Fanebust; K Fox; C Granger; J Heikkilä; S Husted; P Jansky; A Langer; E Lupi; A Maseri; J Meyer; J Mlczoch; D Mocceti; D Myburgh; A Oto; Ernesto Andres Cesar Paolasso; K Pehrsson; R Seabra-Gomes; L Soares-Piegas; D Sùgrue; M Tendera; Eric J Topol; P Toutouzas; A Vahanian; F Verheugt; L Wallentin; H White
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.
Lancet 1999;354(9180):716-22.
1999: BA Bart; G Ertl; P Held; Jerzy Kuch; A P Maggioni; john mcmurray; Eric L Michelson; J L Rouleau; L Warner Stevenson; Karl Swedberg; James B Young; Salim Yusuf; M A Sellers; Christopher B Granger; Robert M Califf; Marc A Pfeffer
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry.
European heart journal 1999;20(16):1182-90.
1999: M L Simoons; M van den Brand; M Lincoff; Robert A Harrington; R van der Wieken; Alec Vahanian; W Rutsch; J Kootstra; E Boersma; Robert M Califf; Eric J Topol
Minimal myocardial damage during coronary intervention is associated with impaired outcome.
European heart journal 1999;20(15):1112-9.
1999: A Michael Lincoff; Robert M Califf; David J Moliterno; Stephen G Ellis; J Ducas; J H Kramer; Neal S Kleiman; Eric A Cohen; Joan E Booth; Shelly K Sapp; CF Cabot; Eric J Topol
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
The New England journal of medicine 1999;341(5):319-27.
1999: Judith S Hochman; Jacqueline E Tamis; T D Thompson; W Douglas Weaver; Harvey D White; Frans Van de Werf; Philip E Aylward; Eric J Topol; Robert M Califf
Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators.
The New England journal of medicine 1999;341(4):226-32.
1999: Peter B Berger; Stephen G Ellis; David R Holmes; Christopher B Granger; Douglas A Criger; A Betriu; Eric J Topol; Robert M Califf
Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial.
Circulation 1999;100(1):14-20.
1999: Wayne B Batchelor; eric peterson; Daniel B Mark; J David Knight; Christopher B Granger; Paul W Armstrong; Robert M Califf
A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications.
Journal of the American College of Cardiology 1999;34(1):12-9.
1999: Robert M Califf
Glycoprotein IIb/IIIa blockade and thrombolytics: early lessons from the SPEED and GUSTO IV trials.
American heart journal 1999;138(1 Pt 2):S12-5.
1999: Christopher M O'Connor; Wendy A Gattis; B F Uretsky; Kirkwood F Adams; SE McNulty; S H Grossman; WJ McKenna; F Zannad; Karl Swedberg; Mihai Gheorghiade; Robert M Califf
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST).
American heart journal 1999;138(1 Pt 1):78-86.
1999: David Hasdai; David R Holmes; Robert M Califf; TD Thompson; Judith S Hochman; M Pfisterer; Eric J Topol
Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries.
American heart journal 1999;138(1 Pt 1):21-31.
1999: M W McClure; Scott Darrell Berkowitz; rodney sparapani; R Tuttle; Neal S Kleiman; Lisa G Berdan; A Michael Lincoff; Jaap Deckers; R Diaz; K R Karsch; D Gretler; Michael M Kitt; Maarten L Simoons; Eric J Topol; Robert M Califf; Robert A Harrington
Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience.
Circulation 1999;99(22):2892-900.
1999: D F Kong; Robert M Califf
Coronary interventions "to go": Is faster better?
The Journal of invasive cardiology 1999;11(6):401-2.
1999: Kenneth W Mahaffey; Robert A Harrington; Maarten L Simoons; Christopher B Granger; Carmelo Graffagnino; Mark J Alberts; Daniel T Laskowitz; Julie M Miller; Michael A Sloan; Lisa G Berdan; C M MacAulay; A Michael Lincoff; Jaap Deckers; Eric J Topol; Robert M Califf
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators.
Circulation 1999;99(18):2371-7.
1999: John H Alexander; Christopher B Granger; Zygmunt Sadowski; Philip E Aylward; Harvey D White; TD Thompson; Robert M Califf; Eric J Topol
Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators.
American heart journal 1999;137(5):799-805.
1999: Robert M Califf; D Stump; Eric J Topol; Daniel B Mark
Economic and cost-effectiveness in evaluating the value of cardiovascular therapies. The impact of the cost-effectiveness study of GUSTO-1 on decision making with regard to fibrinolytic therapy.
American heart journal 1999;137(5):S90-3.
1999: Robert M Califf
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluating the economic implications of cardiovascular therapeutics.
American heart journal 1999;137(5):S35-7.
1999: A Michael Lincoff; James E Tcheng; Robert M Califf; Dean J Kereiakes; T A Kelly; G C Timmis; Neal S Kleiman; Joan E Booth; Craig Balog; CF Cabot; KM Anderson; HF Weisman; Eric J Topol
Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade.
Circulation 1999;99(15):1951-8.
1999: John H Alexander; Robert A Harrington; Robert H Tuttle; Lisa G Berdan; A Michael Lincoff; Jaap Deckers; Maarten L Simoons; AD Guerci; Judith S Hochman; Robert G Wilcox; Michael M Kitt; P R Eisenberg; Robert M Califf; Eric J Topol; K Karsh; W Ruzyllo; J Stepinska; P Widimsky; J B Boland; Paul W Armstrong
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy.
The American journal of cardiology 1999;83(8):1147-51.
1999: Kirkwood F Adams; Carla A Sueta; Mihai Gheorghiade; Christopher M O'connor; Todd A Schwartz; Gary G Koch; Barry F Uretsky; K Swedberg; W McKenna; J Soler-Soler; Robert M Califf
Gender differences in survival in advanced heart failure. Insights from the FIRST study.
Circulation 1999;99(14):1816-21.
1999: David Hasdai; Amir Lerman; Charanjit S Rihal; Douglas A Criger; Kirk N Garratt; A Betriu; Harvey D White; Eric J Topol; Christopher B Granger; Stephen G Ellis; Robert M Califf; David R Holmes
Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction.
American heart journal 1999;137(4 Pt 1):612-20.
1999: Robert M Califf
What to do with acute atrial fibrillation?
American heart journal 1999;137(4 Pt 1):601-2.
1999: Christopher M O'Connor; Wendy A Gattis; F Zannad; SE McNulty; Mihai Gheorghiade; Kirkwood F Adams; Robert M Califf; WJ McKenna; J Soler-Soler; Karl Swedberg
Beta-blocker therapy in advanced heart failure: clinical characteristics and long-term outcomes.
European journal of heart failure 1999;1(1):81-8.
1999: CR Narins; DP Miller; Robert M Califf; Eric J Topol
The relationship between periprocedural myocardial infarction and subsequent target vessel revascularization following percutaneous coronary revascularization: insights from the EPIC trial. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications.
Journal of the American College of Cardiology 1999;33(3):647-53.
1999: Stefano Savonitto; Diego Ardissino; Christopher B Granger; G Morando; M D Prando; Antonio Mafrici; Claudio Cavallini; G Melandri; TD Thompson; A Vahanian; Erik Ohman; Robert M Califf; F Van de Werf; Eric J Topol
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
JAMA : the journal of the American Medical Association 1999;281(8):707-13.
1999: Peter B Berger; R H Tuttle; David R Holmes; Eric J Topol; P E Aylward; J H Horgan; Robert M Califf
One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: results from the GUSTO-I trial.
Circulation 1999;99(7):873-8.
1999: JA Puma; Michael H Sketch; TD Thompson; R J Simes; D C Morris; Harvey D White; Eric J Topol; Robert M Califf
Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy.
The American journal of cardiology 1999;83(4):482-7.
1999: Katherine M Detre; P Guo; Richard Holubkov; Robert M Califf; George Sopko; R Bach; Maria Mori Brooks; Martial G Bourassa; R J Shemin; AD Rosen; RJ Krone; Robert L Frye; Frederick Feit
Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI).
Circulation 1999;99(5):633-40.
1999: David R Holmes; Harvey D White; K S Pieper; Stephen G Ellis; Robert M Califf; Eric J Topol
Effect of age on outcome with primary angioplasty versus thrombolysis.
Journal of the American College of Cardiology 1999;33(2):412-9.
1999: M C Thel; Robert M Califf; James E Tcheng; Kristina N Sigmon; A Michael Lincoff; Eric J Topol; Stephen G Ellis
Clinical risk factors for ischemic complications after percutaneous coronary interventions: results from the EPIC trial. The EPIC Investigators.
American heart journal 1999;137(2):264-73.
1999: Robert A Harrington; Robert M Califf; D R Holmes; Karen S Pieper; A Michael Lincoff; Lisa G Berdan; T D Thompson; Eric J Topol
Is all unstable angina the same? insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I). The CAVEAT-Investigators.
American heart journal 1999;137(2):227-33.
1999: C Y Tung; Christopher B Granger; Michael A Sloan; Eric J Topol; J D Knight; W Douglas Weaver; Kenneth W Mahaffey; H White; Nancy E Clapp-Channing; Maarten L Simoons; J M Gore; Robert M Califf; Daniel B Mark
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study.
Circulation 1999;99(3):370-6.
1999: K A Reimer; Robert M Califf
Good news for experimental concept but bad news for clinically effective therapy.
Circulation 1999;99(2):198-200.
1999: Alejandro Barbagelata; Marcelo F Di Carli; Elena B Sgarbossa; Robert M Califf; Peter Clemmensen; Douglas A Criger; Kathy B Gates; R J Gibbons; H Casabe; Christopher B Granger; Galen S Wagner; Kenneth W Mahaffey
The use of tomographic myocardial perfusion scanning to evaluate an electrocardiographic salvage estimation method in patients with acute myocardial infarction: an AMISTAD substudy. Acute Myocardial Infarction Study Adenosine.
Journal of electrocardiology 1999;32 Suppl():111-3.
1999: David Hasdai; David R Holmes; Eric J Topol; Peter B Berger; Douglas A Criger; Judith S Hochman; Eric R Bates; A Vahanian; P W Armstrong; R Wilcox; Erik Ohman; Robert M Califf
Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries.
European heart journal 1999;20(2):128-35.
1999: Barbara E Tardiff; Robert M Califf; James E Tcheng; A Michael Lincoff; Kristina N Sigmon; Robert A Harrington; Kenneth W Mahaffey; Erik Ohman; P S Teirstein; James C Blankenship; Michael M Kitt; Eric J Topol
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II.
Journal of the American College of Cardiology 1999;33(1):88-96.
1999: Neal S Kleiman; C B Granger; H D White; P Armstrong; Diego Ardissino; F V de Werf; P Zoldeyhi; TD Thompson; Robert M Califf; Eric J Topol
Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: experience from GUSTO-IIb. Global Utilization of Strategies for Total Occlusion.
American heart journal 1999;137(1):12-23.
1998: David F Kong; Robert M Califf; D P Miller; David J Moliterno; Harvey D White; Robert A Harrington; James E Tcheng; A Michael Lincoff; Vic Hasselblad; Eric J Topol
Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease.
Circulation 1998;98(25):2829-35.
1998: Robert M Califf
Ten years of benefit from a one-hour intervention.
Circulation 1998;98(24):2649-51.
1998: KH Newby; T Thompson; Amanda L Stebbins; Eric J Topol; Robert M Califf; Andrea Natale
Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators.
Circulation 1998;98(23):2567-73.
1998: G R Simons; E Sgarbossa; G Wagner; Robert M Califf; Eric J Topol; Andrea Natale
Atrioventricular and intraventricular conduction disorders in acute myocardial infarction: a reappraisal in the thrombolytic era.
Pacing and clinical electrophysiology : PACE 1998;21(12):2651-63.
1998: K P Alexander; eric peterson; Christopher B Granger; A C Casas; Frans Van de Werf; Paul W Armstrong; AD Guerci; Eric J Topol; Robert M Califf
Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial.
Journal of the American College of Cardiology 1998;32(7):2023-30.
1998: Stephen G Ellis; A Michael Lincoff; D Miller; James E Tcheng; Neal S Kleiman; Dean J Kereiakes; Robert M Califf; Eric J Topol
Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Blockade.
Journal of the American College of Cardiology 1998;32(6):1619-23.
1998: Paul W Armstrong; Yuling Fu; Wei-Ching Chang; Eric J Topol; Christopher B Granger; Amadeo Betriu; Frans Van de Werf; Kerry L Lee; Robert M Califf
Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators.
Circulation 1998;98(18):1860-8.
1998: L Kristin Newby; Robert H Christenson; Erik Ohman; Paul W Armstrong; T D Thompson; K L Lee; C W Hamm; H A Katus; C Cianciolo; Christopher B Granger; Eric J Topol; Robert M Califf
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators.
Circulation 1998;98(18):1853-9.
1998: Deepak L Bhatt; A Michael Lincoff; Dean J Kereiakes; James E Tcheng; Maarten L Simoons; L R van der Wieken; N Godfrey; Robert M Califf; Eric J Topol
Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention.
The American journal of cardiology 1998;82(9):1105-6, A6.
1998: K M Zabel; Christopher B Granger; R C Becker; E G Bovill; J Hirsh; P E Aylward; Eric J Topol; Robert M Califf
Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
American heart journal 1998;136(5):868-76.
1998: Robert M Califf
A perspective on the regulation of the evaluation of new antithrombotic drugs.
The American journal of cardiology 1998;82(8B):25P-35P.
1998: Michael A Sloan; Cathy A Sila; Kenneth W Mahaffey; Christopher B Granger; W T Longstreth; Peter J Koudstaal; Harvey D White; Joel M Gore; Maarten L Simoons; W Douglas Weaver; Cynthia L Green; Eric J Topol; Robert M Califf
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage.
Circulation 1998;98(14):1376-82.
1998: Robert M Califf; Robert A Harrington
Improved outlook for patients with acute myocardial infarction: an interim progress report.
European heart journal 1998;19(10):1416-8.
1998: Robert M Califf
Role and significance of coagulation markers in understanding and treating acute coronary syndromes. Introduction.
American heart journal 1998;136(4 Pt 2 Su):S1-6.
1998: R David Anderson; Erik Ohman; D R Holmes; Robert A Harrington; Gregory W Barsness; N M Wildermann; Harry R Phillips; Eric J Topol; Robert M Califf
Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions.
Journal of the American College of Cardiology 1998;32(4):936-41.
1998: Marc Cohen; C Demers; Enrique P Gurfinkel; Alexander G G Turpie; GJ Fromell; S Goodman; Anatoly Langer; Robert M Califf; Keith A A Fox; J Premmereur; Frederique Bigonzi
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.
The American journal of cardiology 1998;82(5B):19L-24L.
1998: Conor F Lundergan; Jonathan S Reiner; WF McCarthy; KS Coyne; Robert M Califf; Allan M Ross
Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1998;32(3):641-7.
1998: Matthias Pfisterer; J L Cox; C B Granger; S J Brener; C D Naylor; Robert M Califf; F van de Werf; Amanda L Stebbins; K L Lee; Eric J Topol; P W Armstrong
Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1998;32(3):634-40.
1998: Robert M Califf
Robert McKinnon Califf, MD: a conversation with the editor. Interview by William Clifford Roberts.
The American journal of cardiology 1998;82(5):639-58.
1998: Harlan Krumholz; Russell S Phillips; Mary Beth Hamel; Joan M Teno; Paul E Bellamy; S K Broste; Robert M Califf; Humberto Vidaillet; Roger B Davis; L H Muhlbaier; Alfred F Connors; Joanne Lynn; L Goldman
Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
Circulation 1998;98(7):648-55.
1998: Scott Darrell Berkowitz; David C Sane; Kristina N Sigmon; J H Shavender; Robert A Harrington; James E Tcheng; Eric J Topol; Robert M Califf
Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group.
Journal of the American College of Cardiology 1998;32(2):311-9.
1998: D F Kong; Robert M Califf
Post-procedure heparin: boon or burden?
American heart journal 1998;136(2):183-5.
1998: Sasan Ghaffari; Dean J Kereiakes; A Michael Lincoff; T A Kelly; G C Timmis; Neal S Kleiman; James J Ferguson; DP Miller; Robert M Califf; Eric J Topol
Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. EPILOG Investigators. Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Receptor Blockade.
The American journal of cardiology 1998;82(1):7-12.
1998: Robert M Califf; H Vidaillet; L Goldman
Advanced congestive heart failure: What do patients want?
American heart journal 1998;135(6 Pt 2 Su):S320-6.
1998: Kevin Schulman; D B Mark; Robert M Califf
Outcomes and costs within a disease management program for advanced congestive heart failure.
American heart journal 1998;135(6 Pt 2 Su):S285-92.
1998: J S Mandak; James C Blankenship; Laura H Gardner; Scott Darrell Berkowitz; FV Aguirre; Kristina N Sigmon; G C Timmis; I C Gilchrist; Michael E. McIvor; Jon R Resar; B H Weiner; BS George; J D Talley; A Michael Lincoff; James E Tcheng; Robert M Califf; Eric J Topol
Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.
Journal of the American College of Cardiology 1998;31(7):1518-24.
1998: B K Metz; Harvey D White; Christopher B Granger; R J Simes; Paul W Armstrong; J Hirsh; V Fuster; C M MacAulay; Robert M Califf; Eric J Topol
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.
Journal of the American College of Cardiology 1998;31(7):1493-8.
1998: P Jaagosild; Neal V Dawson; C Thomas; N S Wenger; Joel Tsevat; William A Knaus; Robert M Califf; L Goldman; Humberto Vidaillet; Alfred F Connors
Outcomes of acute exacerbation of severe congestive heart failure: quality of life, resource use, and survival. SUPPORT Investigators. The Study to Understand Prognosis and Preferences for Outcomes and Risks of Treatments.
Archives of internal medicine 1998;158(10):1081-9.
1998: Neal S Kleiman; A Michael Lincoff; Dean J Kereiakes; DP Miller; FV Aguirre; KM Anderson; HF Weisman; Robert M Califf; Eric J Topol
Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators.
Circulation 1998;97(19):1912-20.
1998: Daniel B Mark; Patricia A Cowper; Scott Darrell Berkowitz; Linda Davidson-Ray; Elizabeth R DeLong; Alexander G G Turpie; Robert M Califf; Beth D Weatherley; Marc Cohen
Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction].
Circulation 1998;97(17):1702-7.
1998: J Hochrein; F Sun; Karen S Pieper; Kerry L Lee; K B Gates; Paul W Armstrong; W Douglas Weaver; Shaun G Goodman; Eric J Topol; Robert M Califf; Christopher B Granger; Galen S Wagner
Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries.
The American journal of cardiology 1998;81(9):1078-84.
1998: Allan M Ross; KS Coyne; E Moreyra; Jonathan S Reiner; Samuel W Greenhouse; P L Walker; M L Simoons; YC Draoui; Robert M Califf; Eric J Topol; F Van de Werf; Conor F Lundergan
Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial.
Circulation 1998;97(16):1549-56.
1998: Robert M Califf; J M Kramer
What have we learned from the calcium channel blocker controversy?
Circulation 1998;97(16):1529-31.
1998: Eugene Braunwald; A Maseri; P W Armstrong; Robert M Califf; W B Gibler; C W Hamm; M L Simoons; Frans Van de Werf
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.
European heart journal 1998;19 Suppl D():D22-30.
1998: Robert M Califf; C B Granger
Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points.
Diabetes care 1998;21(4):655-7.
1998: Eugene Braunwald; A Maseri; P W Armstrong; Robert M Califf; W B Gibler; C W Hamm; M L Simoons; Frans Van de Werf
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.
American heart journal 1998;135(4):S56-66.
1998: Anatoly Langer; M W Krucoff; PA Klootwijk; Maarten L Simoons; Christopher B Granger; Aiala Barr; Robert M Califf; Paul W Armstrong
Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy.
Journal of the American College of Cardiology 1998;31(4):783-9.
1998: Dean J Kereiakes; A Michael Lincoff; DP Miller; James E Tcheng; CF Cabot; KM Anderson; HF Weisman; Robert M Califf; Eric J Topol
Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators.
Circulation 1998;97(9):857-64.
1998: Kenneth W Mahaffey; Christopher B Granger; Michael A Sloan; TD Thompson; Joel M Gore; W Douglas Weaver; Harvey D White; Maarten L Simoons; Gabriel I Barbash; Eric J Topol; Robert M Califf
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I.
Circulation 1998;97(8):757-64.
1998: Robert H Christenson; Show-Hong Duh; LK Newby; Erik Ohman; Robert M Califf; Christopher B Granger; S Peck; K S Pieper; P W Armstrong; H A Katus; Eric J Topol
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators.
Clinical chemistry 1998;44(3):494-501.
1998: James Gebel; Cathy A Sila; Michael A Sloan; Christopher B Granger; Kenneth W Mahaffey; J Weisenberger; Cynthia L Green; Harvey D White; Joel M Gore; W Douglas Weaver; Robert M Califf; Eric J Topol
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Stroke; a journal of cerebral circulation 1998;29(3):563-9.
1998: Christopher B Granger; R Becker; R P Tracy; Robert M Califf; Eric J Topol; Karen S Pieper; A M Ross; S Roth; C Lambrew; E G Bovill
Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1998;31(3):497-505.
1998: Shaun G Goodman; Anatoly Langer; A M Ross; N M Wildermann; Alejandro Barbagelata; Elena B Sgarbossa; Galen S Wagner; Christopher B Granger; Robert M Califf; Eric J Topol; Maarten L Simoons; Paul W Armstrong
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
Circulation 1998;97(5):444-50.
1998: W R Hathaway; eric peterson; Galen S Wagner; Christopher B Granger; K M Zabel; Karen S Pieper; K A Clark; LH Woodlief; Robert M Califf
Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
JAMA : the journal of the American Medical Association 1998;279(5):387-91.
1998: D B Brieger; Koon-Hou Mak; Harvey D White; Neal S Kleiman; DP Miller; Alec Vahanian; A M Ross; Robert M Califf; Eric J Topol
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries.
The American journal of cardiology 1998;81(3):282-7.
1998: N A Omoigui; M J Silver; L A Rybicki; M Rosenthal; Lisa G Berdan; K Pieper; S V King; Robert M Califf; Eric J Topol
Influence of a randomized clinical trial on practice by participating investigators: lessons from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). CAVEAT I and II Investigators.
Journal of the American College of Cardiology 1998;31(2):265-72.
1998: Robert M Califf; A E Abdelmeguid; R E Kuntz; Jeffrey J Popma; C J Davidson; E A Cohen; Neal S Kleiman; Kenneth W Mahaffey; Eric J Topol; C J Pepine; R J Lipicky; Christopher B Granger; Robert A Harrington; Barbara E Tardiff; B S Crenshaw; RP Bauman; B D Zuckerman; B R Chaitman; J A Bittl; Erik Ohman
Myonecrosis after revascularization procedures.
Journal of the American College of Cardiology 1998;31(2):241-51.
1998: James C Blankenship; A S Hellkamp; FV Aguirre; S L Demko; Eric J Topol; Robert M Califf
Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial.
The American journal of cardiology 1998;81(1):36-40.
1998: Elena B Sgarbossa; Sergio L Pinski; Eric J Topol; Robert M Califf; Alejandro Barbagelata; Shaun G Goodman; Kathy B Gates; Christopher B Granger; D P Miller; D A Underwood; Galen S Wagner
Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-type plasminogen activator] for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1998;31(1):105-10.
1998: A Betriu; Robert M Califf; X Bosch; A Guerci; Amanda L Stebbins; N A Barbagelata; Philip E Aylward; A Vahanian; Frans Van de Werf; Eric J Topol
Recurrent ischemia after thrombolysis: importance of associated clinical findings. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-plasminogen activator] for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1998;31(1):94-102.
1998: M M Khan; Stephen G Ellis; FV Aguirre; HF Weisman; N M Wildermann; Robert M Califf; Eric J Topol; Neal S Kleiman
Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications.
Journal of the American College of Cardiology 1998;31(1):31-6.
1997: Robert M Califf
The GUSTO trial and the open artery theory.
European heart journal 1997;18 Suppl F():F2-10.
1997: Robert M Califf; S L Karnash; LH Woodlief
Developing systems for cost-effective auditing of clinical trials.
Controlled clinical trials 1997;18(6):651-60; discussion 661-6.
1997: Kenneth W Mahaffey; Christopher B Granger; C A Toth; Harvey D White; Amanda L Stebbins; Gabriel I Barbash; A Vahanian; Eric J Topol; Robert M Califf
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1997;30(7):1606-10.
1997: Erik Ohman; Robert M Califf; Eric J Topol
Trials in myocardial infarction.
Circulation 1997;96(10):3814-6.
1997: A Shah; Galen S Wagner; Robert M Califf; R E Boineau; Cynthia L Green; NM Wildermann; Kathleen M Trollinger; James E Pope; Mitchell W Krucoff
Comparative prognostic significance of simultaneous versus independent resolution of ST segment depression relative to ST segment elevation during acute myocardial infarction.
Journal of the American College of Cardiology 1997;30(6):1478-83.
1997: Robert M Califf; Daniel B Mark
Issues of cost-effectiveness in the use of antithrombotic therapy for ischemic heart disease.
American heart journal 1997;134(5 Pt 2):S88-96.
1997: MC Thel; A L Armstrong; S E McNulty; Robert M Califf; Christopher M O'Connor
Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff.
Lancet 1997;350(9087):1272-6.
1997: Gregory W Barsness; eric peterson; Erik Ohman; Charlotte L Nelson; Elizabeth R DeLong; Joseph Gerald Reves; Peter K Smith; R David Anderson; R H Jones; Daniel B Mark; Robert M Califf
Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty.
Circulation 1997;96(8):2551-6.
1997: Koon-Hou Mak; R Challapalli; Mark J Eisenberg; KM Anderson; Robert M Califf; Eric J Topol
Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. EPIC Investigators. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications.
The American journal of cardiology 1997;80(8):985-8.
1997: Bradley A Bart; Linda K Shaw; Charles B McCants; D F Fortin; Kerry L Lee; Robert M Califf; Christopher M O'Connor
Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy.
Journal of the American College of Cardiology 1997;30(4):1002-8.
1997: Harry P Selker; John Griffith; Joni R Beshansky; Christopher Schmid; Robert M Califf; R B D'Agostino; M M Laks; K L Lee; Charles Maynard; Ronald H Selvester; Galen S Wagner; W D Weaver
Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument.
Annals of internal medicine 1997;127(7):538-56.
1997: Robert H Christenson; Erik Ohman; Eric J Topol; S Peck; LK Newby; Show-Hong Duh; D J Kereiakes; S J Worley; G L Alosozana; T C Wall; Robert M Califf
Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7.
Circulation 1997;96(6):1776-82.
1997: R David Anderson; Erik Ohman; D R Holmes; I Col; Amanda L Stebbins; Eric R Bates; Robert J Stomel; Christopher B Granger; Eric J Topol; Robert M Califf
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1997;30(3):708-15.
1997: Marc Cohen; C Demers; Enrique P Gurfinkel; Alexander G G Turpie; GJ Fromell; S Goodman; Anatoly Langer; Robert M Califf; Keith A A Fox; J Premmereur; Frederique Bigonzi
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
The New England journal of medicine 1997;337(7):447-52.
1997: Eric J Topol; James J Ferguson; HF Weisman; James E Tcheng; Stephen G Ellis; Neal S Kleiman; R J Ivanhoe; A L Wang; D P Miller; KM Anderson; Robert M Califf
Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication.
JAMA : the journal of the American Medical Association 1997;278(6):479-84.
1997: B S Crenshaw; S R Ward; Christopher B Granger; Amanda L Stebbins; Eric J Topol; Robert M Califf
Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1997;30(2):406-13.
1997: Robert M Califf; Kirkwood F Adams; WJ McKenna; Mihai Gheorghiade; B F Uretsky; SE McNulty; Harald Darius; Kevin Schulman; F Zannad; E Handberg-Thurmond; F E Harrell; W Wheeler; J Soler-Soler; Karl Swedberg
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).
American heart journal 1997;134(1):44-54.
1997: Peter B Berger; David R Holmes; A L Stebbins; Eric R Bates; Robert M Califf; Eric J Topol
Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study.
Circulation 1997;96(1):122-7.
1997: R Q Migrino; James B Young; Stephen G Ellis; Harvey D White; Conor F Lundergan; D P Miller; Christopher B Granger; Allan M Ross; Robert M Califf; Eric J Topol
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators.
Circulation 1997;96(1):116-21.
1997: T J Mattimore; Neil S Wenger; Norman A Desbiens; Joan M Teno; Mary Beth Hamel; Honghu Liu; Robert M Califf; Alfred F Connors; Joanne Lynn; Robert K Oye
Surrogate and physician understanding of patients' preferences for living permanently in a nursing home.
Journal of the American Geriatrics Society 1997;45(7):818-24.
1997: Koon-Hou Mak; David J Moliterno; Christopher B Granger; DP Miller; Harvey D White; Robert G Wilcox; Robert M Califf; Eric J Topol
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1997;30(1):171-9.
1997: A Michael Lincoff; Robert M Califf; KM Anderson; HF Weisman; FV Aguirre; Neal S Kleiman; Robert A Harrington; Eric J Topol
Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic Complications.
Journal of the American College of Cardiology 1997;30(1):149-56.
1997: Scott Darrell Berkowitz; Christopher B Granger; Karen S Pieper; Kerry L Lee; Joel M Gore; Maarten L Simoons; Paul W Armstrong; Eric J Topol; Robert M Califf
Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators.
Circulation 1997;95(11):2508-16.
1997: E K Moen; C R Asher; DP Miller; W D Weaver; Harvey D White; Robert M Califf; Eric J Topol
Long-term follow-up of gender-specific outcomes after thrombolytic therapy for acute myocardial infarction from the GUSTO-I trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Journal of women's health / the official publication of the Society for the Advancement of Women's Health Research 1997;6(3):285-93.
1997: Christopher M O'Connor; W R Hathaway; Eric R Bates; J D Leimberger; Kristina N Sigmon; Dean J Kereiakes; BS George; J K Samaha; C W Abbottsmith; R J Candela; Eric J Topol; Robert M Califf
Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model.
American heart journal 1997;133(6):663-73.
1997: Robert M Califf; L H Woodlief; F E Harrell; Kerry L Lee; H D White; AD Guerci; G I Barbash; R J Simes; W D Weaver; Maarten L Simoons; Eric J Topol
Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators.
American heart journal 1997;133(6):630-9.
1997: T S Tsang; Robert M Califf; A L Stebbins; Kerry L Lee; S Cho; A M Ross; Paul W Armstrong
Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary Arteries.
The American journal of cardiology 1997;79(9):1232-5.
1997: Robert M Califf; K L Lee; C B Granger; Erik Ohman
Predictors of outcome of reperfusion therapy.
European heart journal 1997;18(5):728-35.
1997: Nicole E Jelesoff; Mark N Feinglos; C B Granger; Robert M Califf
Outcomes of diabetic patients following acute myocardial infarction: a review of the major thrombolytic trials.
Journal of cardiovascular risk 1997;4(2):100-11.
1997: JA Puma; Michael H Sketch; James E Tcheng